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Summary 
 
In Switzerland, between 2005 and 2014 there was an average of nearly 250 new cases of cancer 
in children per year. Based on a five year survival rate of more than 80%, almost 50 deaths due 
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to childhood cancer per year can be estimated. According to the World Health Organization 
and international medical guidelines, pediatric palliative care should begin at the diagnosis of 
a life-threatening illness, continue throughout a child’s illness trajectory, through death and 
beyond. In the pediatric setting, shared decision-making has become the predominant approach 
to facilitate the decision-making process among physicians, parents, and the child. However, 
there is evidence that shared decision-making in pediatric oncology needs further improvement 
and that it is still understudied. Thus, the goal of this thesis is to propose ethically sound and 
practically feasible ways to enhance shared decision-making regarding palliative care in 
pediatric oncology. 
In order to meet this objective, a mixed-methods approach that employed various quantitative 
and qualitative methods is used. Furthermore, this thesis integrates empirical and normative 
analyses for addressing ethical concerns that contribute to the overall bioethical debate on 
shared decision-making regarding palliative care in pediatric oncology. The empirical bioethics 
methodology used to integrate empirical and normative analyses is Critical Applied Ethics. The 
thesis is arranged in three main parts: (1) background (chapter 1), (2) journal articles (chapter 
2  9), and (3) general discussion (chapter 10).  
First, the background (chapter 1) provides an introduction to pediatric palliative care, to shared 
decision-making, and to the ethico-legal imperative for shared decision-making. Further, after 
a general overview over the emerging field of empirical bioethics it delineates the particular 
empirical bioethics methodology that was used in this thesis, namely Critical Applied Ethics. 
Finally, the background presents the research objectives and the description of the mixed 
methods approach.  
Second, each of the following eight chapters (chapter 2  9) comprises one journal article. 
Chapter 2 gives insights into how shared decision-making occurs in Swiss Pediatric Oncology 
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Group centers from the viewpoints of parents and physicians. Quantitative analysis of 
questionnaires reveals systematic differences between parents’ and physicians’ perceptions of 
the same child. Further, sex and age predict a child’s involvement in decision-making. 
Chapter 3 explores the provision of pediatric palliative care and related decision-making in 
Swiss pediatric oncology settings. Results from a retrospective review of medical records of 
deceased children show that there are still high numbers of late or non-referrals and even 
children older than 12 years were not involved. Also, leukemia patients were less likely to 
receive palliative care than the overall sample.  
Chapter 4 examines children’s and their families’ burden due to adherence to cancer treatment. 
Quantitative analysis of medical records of deceased children reveals that children and their 
families face a significant burden of treatment. Moreover, leukemia patients had a higher 
number of inpatient stays, spent more time in hospital both during the entire illness and during 
the last month of their life, and were more likely to die in the hospital than patients with CNS 
neoplasms and other diagnoses.  
Chapter 5 addresses the understanding of pediatric palliative care in pediatric oncology centers 
in Switzerland. Qualitative analysis of focus group interviews with various stakeholders show 
that there are still difficulties regarding the implementation of the rather philosophical 
definition of pediatric palliative care as set out by the World Health Organization and that 
palliative care, frequently, is not initiated at diagnosis. 
Chapter 6 evaluates the timing of palliative care in pediatric oncology patients through a 
systematic literature review. Data reveals that pediatric palliative care consultation does not 
occur until late in the illness and palliative care does not begin until close to death.  
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Chapter 7 identifies barriers and recommendations for the proper implementation of pediatric 
palliative care through a systematic literature review of articles that discuss international 
guidelines. Identified barriers in the literature are: gaps within medical practice, lack of 
evidence-based research, absence of clear guidance regarding bereavement care, and 
challenges involved in multidisciplinary teams. Common recommendations that can be found 
in the literature are: training and education, multidisciplinarity, research on the benefits of and 
raising awareness about pediatric palliative care. Finally, the question arises whether pediatric 
palliative care has not lost sight of end-of-life issues, focusing too narrowly on quality of life. 
Chapter 8 covers conceptual confusion of three core domains of pediatric palliative care. Five 
online databases were searched systematically, in addition to a google search. Analysis focused 
on the language used to determine the domains of pediatric palliative care. Analysis revealed 
that, first, psychological care is not sufficiently demarcated from emotional care; second, it 
remains unclear what separates social from psychosocial care; third, spiritual care is not 
sufficiently distinguished from existential and religious care. Finally, it is shown that this 
confusion negatively affects clinical practice.  
Chapter 9 argues that decision-making capacity would benefit from being treated as an 
essentially contested concept as this warns against any reification of what it means to have 
capacity. Further, using decisional capacity in a questioning mode gives space to alternative 
interpretations that might advance the ongoing debate surrounding decision-making. 
Third, the general discussion (chapter 10) provides an integration of empirical results and 
ethical analysis which is structured in three subparts: conceptual background of shared 
decision-making, pre-existing conditions of shared decision-making, and the process of shared 
decision-making. Moreover, it illustrates the application of the used empirical bioethics 
methodology (Critical Applied Ethics) within the reported research project. Next, limitations 
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and implications for further research are addressed. The thesis closes with the conclusions 
section that contains seven recommendations for practice and theory which represent the very 
essence of the reported findings.  
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Zusammenfassung 
 
Zwischen 2005 und 2014 erkrankten in der Schweiz jährlich etwa 250 Kinder an Krebs. Dies 
bedeutet bei einer 5-Jahres-Überlebensrate von knapp mehr als 80%, dass schweizweit 
durchschnittlich etwa 50 Kinder pro Jahr aufgrund ihrer Krebserkrankung sterben. Gemäss 
Weltgesundheitsorganisation und internationaler medizinischer Richtlinien sollte Pediatric 
Palliative Care bei der Diagnosestellung einer lebensbedrohlichen Erkrankung beginnen und 
für die Dauer der Erkrankung sowie über den Tod des Kindes hinaus zum Tragen kommen. Im 
pädiatrischen Setting hat sich die partizipative Entscheidungsfindung als präferierter Weg, eine 
von Ärzten, Eltern und dem Kind gemeinsam gefundene Entscheidung zu treffen, durchgesetzt. 
Allerdings zeigt eine Vielzahl von Studien, dass die Umsetzung der partizipativen 
Entscheidungsfindung in der Praxis nach wie vor verbessert werden muss sowie dass es 
weiterer Forschung zum Thema bedarf. Vor diesem Hintergrund ist es Ziel dieser Arbeit, 
ethisch vertretbare sowie praktisch umsetzbare Möglichkeiten aufzuzeigen, die partizipative 
Entscheidungsfindung bezüglich Palliative Care in der pädiatrischen Onkologie weiter zu 
verbessern.       
Um dieses Ziel zu erreichen wurde ein Mixed-Methods-Ansatz, bestehend aus verschiedenen 
qualitativen und quantitativen Methoden, gewählt. Zudem integriert die vorliegende Arbeit 
empirische Forschung und normative Analyse, um ethisch relevante Aspekte zu adressieren 
und um somit schliesslich die bioethische Debatte zu partizipativer Entscheidungsfindung 
bezüglich Palliative Care in der pädiatrischen Onkologie zu bereichern. Die genutzte 
empirische Bioethik-Methodologie ist Critical Applied Ethics. Die vorliegende Arbeit ist in 
drei Hauptteile gegliedert: (1) Hintergrund (Kapitel 1), (2) Artikel in Fachzeitschriften (Kapitel 
2  9) und (3)  Diskussion (Kapitel 10).  
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Kapitel 1. Der Hintergrund führt in die Bereiche Pediatric Palliative Care, partizipative 
Entscheidungsfindung und in den ethisch-rechtlichen Rahmen ein. Darüber hinaus wird, nach 
einem Überblick über das Feld der empirischen Bioethik, die in der vorliegenden Arbeit 
gewählte empirische Bioethik-Methodologie beschrieben (Critical Applied Ethics). 
Schliesslich umfasst der Hintergrund die Forschungsziele sowie Ausführungen zum gewählten 
Mixed-Methods-Ansatz. Jedes der folgenden acht Kapitel (Kapitel 2  9) besteht aus einem 
Fachzeitschriften-Artikel.   
Kapitel 2 liefert Einblicke in die partizipative Entscheidungsfindung in Spitälern der 
Schweizerischen Pädiatrischen Onkologie Gruppe. Die quantitative Analyse der von Eltern 
und Ärzten ausgefüllten Fragebögen zeigt systematische Unterschiede zwischen der elterlichen 
und ärztlichen Perspektive auf das Kind. Ausserdem sagen das Alter und das Geschlecht eines 
Kindes dessen Involvierung in die Entscheidungsfindung vorher.     
Kapitel 3 befasst sich mit der Durchführung der Pediatric Palliative Care auf 
Kinderkrebsstationen in der Schweiz. Die Ergebnisse der retrospektiven Auswertung der 
Spitalakten an Krebs verstorbener Kinder verdeutlichen, dass nach wie vor viele späte 
Überweisungen in die Palliative Care stattfinden, mitunter sogar gar keine. Auch werden 
manche Kinder, die älter als 12 Jahre sind, nicht in die Entscheidungsfindung einbezogen. 
Darüber hinaus erhalten an Leukämie erkrankte Kinder seltener Palliative Care.  
Kapitel 4 untersucht die Belastung infolge der Krebsbehandlung auf Seiten des Kindes und der 
Eltern. Die quantitative Analyse der Spitalakten der verstorbenen Kinder zeigt, dass Kinder 
und ihre Familien infolge der Krebserkrankung hoch belastet sind. Zudem sind 
Leukämiepatienten häufiger und länger (über die gesamte Erkrankung hinweg sowie im letzten 
Monats ihres Lebens) in stationärer Behandlung, und sterben häufiger im Spital als Kinder mit 
anderen Diagnosen.      
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Kapitel 5 befasst sich mit dem Verständnis von Pediatric Palliative Care innerhalb der 
pädiatrischen Onkologie in der Schweiz. Die qualitative Analyse der Fokusgruppen-Interviews 
mit verschiedenen Stakeholdern macht deutlich, dass Schwierigkeiten bei der Implementierung 
der eher philosophischen Weltgesundheitsorganisations-Definition der Pediatric Palliative 
Care bestehen. Auch wird Pediatric Palliative Care häufig nicht zur Diagnose begonnen.    
Kapitel 6 untersucht mithilfe eines systematischen Literatur-Reviews den Zeitpunkt der 
Initiierung der Palliative Care in der pädiatrischen Onkologie. Die Daten zeigen, dass die erste 
Konsultation zu Pediatric Palliative Care spät im Krankheitsverlauf initiiert und dass Pediatric 
Palliative Care selbst erst kurz vor dem Tod begonnen wird.   
Kapitel 7 identifiziert vermittels eines systematischen Literatur-Reviews von Artikeln, die 
internationale Richtlinien diskutieren, Barrieren und Empfehlungen zu einer angemessenen 
Implementierung der Pediatric Palliative Care. Identifizierte Barrieren sind: Schwierigkeiten 
in der medizinischen Praxis, Mangel an evidenz-basierter Forschung, Abwesenheit klarer 
Richtlinien bezüglich Trauerpflege und Herausforderungen durch multidisziplinäre Teams. 
Häufige Empfehlungen, die in der Literatur gefunden wurden, sind: Training und Ausbildung, 
multidisziplinäre Teams, Forschung zum Benefit der Pediatric Palliative Care sowie zur 
Sensibilisierung der Bevölkerung für diese. Schliesslich stellt sich die Frage, ob Pediatric 
Palliative Care sich nicht zu weit von ihrem ursprünglichen Fokus auf End-of-Life-Care 
entfernt hat und sich nunmehr zu sehr auf das Thema Lebensqualität konzentriert.   
Kapitel 8 analysiert die Konzeptualisierung der Domänen der Pediatric Palliative Care. Hierzu 
wurden fünf online Datenbanken durchsucht sowie eine Google-Suche durchgeführt. Die 
Analyse fokussierte auf die Sprache, die genutzt wurde, um die Domänen der Pediatric 
Palliative Care zu beschreiben. Es zeigt sich, dass, erstens, der Begriff „psychological care“ 
nicht hinreichend gut vom Begriff „emotional care“ abgegrenzt wird; dass es, zweitens, unklar 
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ist, was die Begriffe „psychosocial care“ und „social care“ unterscheidet; sowie, drittens, dass 
der Begriff „spiritual care“ nicht klar genug von „existential care“ und „religious care“ 
unterschieden wird. Schliesslich wird aufgezeigt, wie diese unzureichenden 
Konzeptualisierungen die klinische Praxis negativ beeinflussen können.   
Kapitel 9 postuliert, dass es vorteilhaft ist, das Konzept „decision-making capacity“ als ein 
„essentially contested concept“ zu verstehen. Zudem warnt es davor, die Frage danach, was es 
heisst „decision-making capacity“ zu haben, schlichtweg mit einer Vergegenständlichung des 
Konzepts zu beantworten. Abschliessend bietet diese Sichtweise die Möglichkeit, alternative 
Ansätze, welche die Debatte voranbringen können, ernsthaft zu erwägen.     
Kapitel 10 stellt eine umfassende Diskussion der vorher aufgeführten Forschungsergebnisse 
dar. Dazu werden empirische Ergebnisse und ethische Analyse zusammengebracht und in drei 
Abschnitten mit jeweils verschiedenem Schwerpunkt präsentiert: konzeptueller Hintergrund 
partizipativer Entscheidungsfindung, der partizipativen Entscheidungsfindung vorausliegende 
Bedingungen sowie der Prozess partizipativer Entscheidungsfindung selbst. Weiterhin wird 
dargestellt, wie die empirische Bioethik-Methodologie (Critical Applied Ethics) innerhalb der 
vorgestellten Forschung angewandt wurde, bevor die Limitierungen und Implikationen für 
zukünftige Forschung diskutiert werden. Den Abschluss der vorliegenden Arbeit bilden sieben 
Empfehlungen für Praxis und Theorie, welche auf den vorgestellten Ergebnissen aufbauen und 
gewissermassen deren Kerngehalt widerspiegeln.
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1 Introduction 
 
1.1 Pediatric Palliative Care 
Pediatric palliative care (PPC) is an active and holistic approach to care for children with life-
limiting and life-threatening illnesses which embraces multiple domains of care, such as 
psychological, physical, social, and spiritual care1-3. Due to its multifaceted nature, PPC 
requires that numerous factors are fulfilled to allow children1 and their families to live to their 
fullest potential despite the life-threatening condition they are facing. In clinical practice, the 
absence of a single factor (e.g. a required skill or service, involvement of family in decision-
making), already compromises the provision of PPC. Such an understanding borrows from a 
notion of Aristotle, who, in the Nicomachean Ethics, demarcated erroneous and correct actions 
by means of distinguishing between polymorphism and monomorphism: “Further, it is possible 
to err in many ways (…), whereas there is only one way to be correct. That is why erring is 
easy and being correct difficult, since it is easy to miss the target but difficult to hit it.”4, NE, II.6, 
1106a29-32, trans. Reeve  
Per analogiam, adequate PPC provisions are all alike with respect to one critical feature. In all 
those cases the needs of the child and the family are met (monomorphic: the “one way to be 
correct”). In contrast, inadequate PPC provisions can take different forms because at least one 
of the various needs is insufficiently met (polymorphic: the possibility “to err in many ways”). 
Hence, the Aristotelean view offers a useful perspective on the provision of PPC: there is one 
ideal way of providing PPC, namely tailoring care to the particular needs of the child and the 
family, and there are numerous ways of providing inadequate PPC, namely not meeting or 
mistakenly addressing one or more of these needs. Further, this perspective implicitly 
                                                 
1 The terms “child”, “adolescent”, and “minor patient” are used to denominate persons who have not yet attained 
the legal age of majority. Subsequently, if not stated differently, the term “children” collectively refers to infants, 
children, and adolescents. 
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disqualifies the notion of a universal way to provide PPC that can be applied across cases and 
situations. Instead, it affirms the idea of some sort of clinical casuistry, according to which PPC 
has to consider the particular needs of the child and the family, while taking into consideration 
relevant circumstances. Thus, within each palliative situation provided care has to correspond 
to the individual patient and its family and if so, it is adequate. The purpose of this thesis is to 
cast light on some of the reasons for not providing adequate PPC.    
As lined out by the World Health Organization and emphasized by international guidelines, 
PPC begins at the time of diagnosis and continues, irrespective of whether treatment is also 
directed at curing, throughout a child’s illness-trajectory, through death and beyond (figure 
1)1,3,5,6. Furthermore, it is provided by a multidisciplinary team and focuses on the enhancement 
of quality of life of the child and his or her family1. Under all circumstances, PPC must be an 
individually tailored endeavor that is strongly oriented towards the idiosyncratic needs of the 
child and the family3. This life-affirming approach is further characterized by a general 
emphasis on communication through the application of shared decision-making (SDM)7. 
Finally, it is part of the philosophy of PPC that every child with a life-limiting or life-
threatening condition must have access to it3. According to the Association of Children’s 
Palliative Care, four categories of life-limiting and life-threatening conditions can be 
distinguished based on the properties of the illness, such as diagnosis and severity3. Pediatric 
cancer patients are assigned to category 1, which contains life-threatening conditions that are 
theoretically curable. For these children, PPC services must be accessible when the condition 
deteriorates acutely or in cases of failed curative measures, become dispensable in cases of 
long term remission or cure, and need to be assessed at any point along the illness trajectory 
for each child individually3. One important tenet of PPC is that this assessment has to be based 
on a child’s needs but not on diagnosis or prognosis per se. 
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Figure 1. Model of pediatric palliative care 
Note. Adapted from World Health Organization8.  
 
Despite improved 5-year-survival rates of more than 80% in high-income countries, cancer is 
still the leading disease-related cause of death in children in the western world9. Worldwide, 
annual incidence rates of childhood cancer vary between 50 and 200 per million (overall 140) 
for children aged between 0 and 14 and between 90 and 300 per million (overall 185) for 
adolescents aged between 15 and 1810,11. Moreover, empirical data shows a global increase of 
13% in incidence rates in 2001-2010 as compared to the 1980s10. For Switzerland, between 
2005 and 2014, cancer was diagnosed in 1.987 children aged 0 to 14 (161 per million) and in 
501 adolescents aged 15 to 20 (168 per million), corresponding to 249 childhood cancer 
diagnoses per year9. Accordingly, based on a 5-year-survival rate of more than 80%, nearly 50 
annual deaths due to childhood cancer can be estimated for Switzerland. 
Although palliative care was developed four decades ago12, recent studies from various 
countries indicate that parts of the public are still unfamiliar with this type of care13-16. Also 
within clinical practice, it is still often confused with hospice care and end-of-life care. Those 
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practitioners who were able to demarcate the concepts commonly associated palliative care 
with death and dying, and, moreover, palliative care has been fraught with uncertainties about 
how to put it into practice13,17,18. Hence, conceptual clarification of the concept is a prerequisite 
for research in the field of PPC. The distinction between palliative and hospice care traces back 
to 1990, when the World Health Organization formally delineated palliative and hospice care 
for the first time19. In contrast to hospice care that was closely related to end-of-life care, 
palliative care’s earlier applicability in the illness trajectory was underlined8. In 2002, the 
World Health Organization articulated a revised definition of palliative care, which adds that 
palliative care ought to be provided for any person with a life-threatening illness6. Delving into 
the characteristics of hospice care, a conceptual analysis found that, compared to palliative 
care, hospice care is more narrowly defined as a community based program for patients with 
terminal illnesses (frequently equated with expected survival of less than 6 months), in which 
volunteers play a major role and which focuses on bereavement care20. Furthermore, hospice 
care does not include curative attempts, implicitly acknowledging that death is inevitable, and 
is provided in an inpatient-setting21. Hospice care can be considered as a particular model for 
the delivery of palliative care at the end-of-life aiming to improve the quality of death and 
dying21. 
 
1.2 Theoretical Background: Shared Decision-Making  
Decision-making regarding the initiation of palliative care is burdensome and fraught with 
uncertainties that cause high levels of psychological strain on the part of the parents22. 
Moreover, numerous aspects have to be considered, such as: age of the child, capacity to make 
treatment decisions, disease experience, and finally, how, when, and by whom a decision 
should be made. Different types of decisions in the pediatric setting have evoked different legal 
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and ethical2 debates: decisions about who decides (e.g. parents versus competent adolescents), 
decisions about treatments (e.g. stopping or not starting treatments, life-sustaining treatments), 
and decisions about the criteria for decisions (e.g. quality of life or resources)23. Against the 
background of medical ethics’ transition from paternalism towards respecting individual 
autonomy24, SDM has become the predominant approach to pediatric medical decision-
making, especially for children suffering from chronic health conditions25.  
Generally, decision-making in pediatrics is characterized by including multiple steps and 
involves at least three parties: the health care provider (e.g. physician, nurses), parents3, and 
patient. This triad shares the process aiming to arrive at a decision that is in the best interest of 
the child. However, this triadic decision-making represents a major challenge in this context26. 
Literature stresses four main attributes of SDM: (1) at least two parties are involved, (2) the 
parties share all relevant information, (3) parties actively work towards a consensus, and (4) an 
agreement is reached on the course of treatment27,28. Besides, informing and involving the child 
in a developmentally appropriate way is universally recommended by international medical 
guidelines on decision-making within PPC1-3,7,29-34. 
With respect to PPC, decision-making is structurally equal (triadic constellation), but it appears 
to be in particular emotionally burdensome and difficult for all involved parties22. Decisions 
on discontinuing curative treatment in cases of progression, not starting curative treatment in 
cases of relapse, or not resuscitating the child in cases of a life-threatening emergency represent 
important challenges.  
                                                 
2 The terms “ethics“ and “morality“ or “ethical” and “moral”, respectively, are often used interchangeably. 
Throughout this thesis, both terms are linguistically distinguished. Whereas “ethics” refers to a philosophical 
discipline that systematically and methodology-based reflects upon morality, the term “morality” refers to societal 
and personal value-systems that are embedded in the lifeworld. However, when referring to approaches by other 
authors, their terminology is maintained and, therefore, may be different. 
3 Throughout this thesis, the term “parents” does not only refer to biological parents, but to caretakers of a child 
in general. Hence, it also includes, for example, stepparents who adopted their child(ren) or foster parents.  
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In their “decisional priority in pediatric oncology model”, Whitney and colleagues present a 
decision-making model for treatment decisions that starts from the distinction between 
decisional authority and decisional priority35. The former refers to the nondelegable right of 
the parents to decide, while the latter refers to identifying the single best course of action. 
Further, they delineate two pivotal attributes of decisions for pediatric cancer patients, namely 
whether the illness is curable and whether there is a superior treatment option. These two 
continuous dimensions represent two axes of a decisional plane in which all pediatric oncology 
decisions can be located. In situations where there is little chance of a cure (unlikely curability) 
and exclusive palliative care services are the best possible treatment (one best option), this 
model proposes that the physician takes the lead. Exercising decisional priority, the physician 
should explain to the parents (and child) that there are no curative options left and that, 
henceforth, symptom management has to be prioritized over continued curative therapy. Of 
course, decisional authority remains with the parents who are legally and ethically responsible 
to promote their child’s interests. However, as the child matures, decisions are increasingly 
shared with the child. Apart from this model that understands itself as both descriptive and 
normative35, several international and national, ethical and legal documents are relevant for 
SDM in the context of PPC (figure 2).  
 
1.3 The Ethico-legal Imperative for Shared Decision-Making 
Since direct inferences from descriptive data to normative claims are invalid, a normative 
framework is required to evaluate empirical data’s significance for normative conclusions36. 
The ethico-legal framework presented in this chapter meets general quality criteria for a 
normative background, namely, coherence, simplicity, and clarity. At the same time, it meets 
more specific quality criteria for the selection of an ethical theory in empirical ethics, as 
evolved by Salloch and colleagues who plead for a systematic and reasoned selection of ethical 
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theories36. First, the ethico-legal framework is adequate for decision-making regarding PPC, 
since it is comprised of universally accepted principles and rights, specific guidelines on PPC, 
and relevant legislation. Second, it is suitable for the purposes and design of this thesis, as the 
purpose is to examine clinical practice against the background of a relevant normative 
framework (as opposed to a not yet relevant normative background whose applicability should 
be investigated). Third, the theoretical background of this thesis (SDM) can be linked to the 
normative framework (SDM, autonomy, human dignity, and capacity of judgment), as both 
share the central premise of autonomous agents who are, in principle, capable of acting and 
have to be involved in decision-making in a developmentally appropriate way37. The normative 
framework is outlined in the following (figure 2). 
The respect for autonomy, one of Beauchamp and Childress’ principles of biomedical ethics, 
has to be considered when analyzing SDM in pediatric oncology. Yet, as shown later, it needs 
to be complemented by relational aspects which it is failing to consider sufficiently38. 
According to the authors, the respect for autonomy demands the acknowledgment of “a 
person's right to hold views, to make choices, and to take actions based on personal values and 
beliefs”39,p.63. It is important to note that this respect should be translated into respectful action, 
not simply into a respectful attitude39. With regard to PPC, it is of crucial importance to enable 
children and their families to act autonomously (within a SDM approach), which entails 
facilitating reasoned and informed decisions. Moreover, two conditions need to be fulfilled in 
order to allow individuals to act in accordance with a self-determined intent: first, liberty 
(absence of controlling influences), and second, agency (being capable of intentional action)39. 
However, although Beauchamp and Childress’s work is a landmark study on autonomy, they 
support a rather individualistic understanding of autonomy that disregards children’s deep 
embeddedness into relationships. Such an individualistic understanding is closely linked to a 
cognitivist model of decision-making capacity. According to the cognitivist model, decision-
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making capacity is as a mental trait residing within an individual mainly identified through 
logic and rationality40,41. Capacity assessment is based on the (mental) process that leads to the 
decision and is considered independent from the content of the decision42. The main critique 
regarding an individualistic understanding of autonomy is that it neglects the interdependence 
of the human self which, according to the critiques, always needs to be recognized as a situated 
and deeply embedded subject38,43-46. Also, the individualistic understanding of autonomy 
devalues persons who are highly dependent, such as children38. A more substantive approach 
to autonomy that takes non-cognitive determinants (e.g. social, cultural, emotional ones) into 
account is especially appropriate for children who are traditionally deemed incapable based on 
cognitive factors and who are emotionally, socially, and financially dependent on external 
factors46,47. Children’s autonomy, their decision-making capacity, as well as their involvement 
are highly determined by their related-ness; children are embedded into relationships (with 
family members, professionals) on which they rely during the illness experience and also in 
face of decision-making, they are fundamentally inter-dependent. On the contrary, since the 
traditional individualistic understanding and the related cognition-based capacity assessment 
increase a child’s likelihood of being excluded from decision-making, they hamper children’s 
ability to participate in health-related decision-making and, thereby, reinforce their 
vulnerability. Therefore, doing justice to children requires broadening the perspective on 
autonomy by relational aspects and moving beyond merely applying an individualistic 
understanding.  
Finally, from the recognition of respecting autonomy arises the imperative to share decision-
making in a clinical setting, because SDM increases the chances for patient autonomy while 
guaranteeing both not to leave behind the patient as well as having the possibility to influence 
how the patient is benefited27,48,49. Moreover, SDM ultimately develops decisional capacity of 
a child who is guided and seconded in finding a good decision. Given this close relation 
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between autonomy and SDM, the respect for autonomy (in all its shades) marks a cornerstone 
when thinking about SDM in pediatric oncology.   
 
Figure 2. Ethico-legal framework for shared decision-making 
 
     Note. UN = United Nations, WHO = World Health Organization. 
 
Although not legally binding, the Universal Declaration of Human Rights is a highly influential 
document that represents a global consensus and has been further elaborated in numerous 
international, national, and regional legislations and policies50. The recognition of every human 
being as equal in dignity and as a subject of rights instantaneously leads to the derivation of 
fundamental human rights, such as the right to life, and with respect to PPC, to the derivation 
of autonomy and access to adequate medical care. Accordingly, a human being has the right to 
make decisions regarding his or her health, illness, and well-being. 
Two other documents published by the United Nations offer a background against which SDM 
can be evaluated: the World Health Organization’s “Cancer pain relief and palliative care in 
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children“ and the United Nations’ “Convention on the rights of a child”5,51. While the former 
recommends the inclusion of the family in decision-making, the latter grants the following 
rights to children. First, it grants the right to freedom of expression, which includes the 
“freedom to seek, receive and impart information and ideas of all kinds” and which shall be 
restricted only by law and if necessary (Art.13)51. Second, it grants the right “to express (…) 
[their own] views freely in all matters affecting the child”; furthermore, those views are 
weighted according to a child’s age and maturity (Art.12)51. Moreover, international guidelines 
on PPC unanimously recommend sharing decision-making with the child and the parents 
underscoring a developmentally appropriate involvement of children1-3,7,29-34.     
While the aforementioned documents claim transnational applicability, Swiss documents also 
must be taken into consideration when analyzing decision-making in the Swiss pediatric 
oncology setting. First, the Swiss Academy of Medical Sciences points out that the child-
centeredness of PPC and involvement of the child have to be tailored to a child’s age, 
development, condition, and individual needs52. Further exemplifying the involvement of the 
child, the Academy underlines that minor patients can be capable of judgment with respect to 
treatment decisions, but capacity of judgement needs to be assessed for each situation and 
action present. This implies that a child’s capacity of judgement can vary across situations and 
actions and that fundamentally, children, under certain circumstances, may be the final arbiter 
in SDM. Finally, guidelines of the Swiss Academy of Medical Sciences are incorporated in the 
code of professional conduct of the Swiss Medical Association, which is binding for all its 
members, and a violation of the medical-ethical guidelines can be sanctioned by the Swiss 
Medical Association53.   
Second, Swiss legislation (Swiss Civil Code, Art.16) with regard to children’s decision-making 
rights does not distinguish between minor and major patients, but between patients with and 
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without capacity4 of judgment. Minority per se does not deem a child incapable, it is a child’s 
mental ability that determines whether or not the child is capable of judgement54. Thus, this 
decision-making capacity demarcates autonomy from dependency. It is generally assumed that 
adults are competent, but children as a class are usually considered incompetent with the 
underlying assumption that they also lack decisional capacity. Hence, decision-making 
capacity is a necessary criterion for legal competence: once a child is evaluated as capable of 
judgement he or she alone can legally consent to (or refuse) treatment55. For the medical 
context, minor patients between 12 and 18 years of age are mostly expected to be capable of 
judgement, but need to be evaluated on an individual basis54. Again, capacity of judgement 
therefore is relative with respect to time and the object in question. However, if a child is 
considered incapable of judgement (mostly assessed by physicians), his or her decision-making 
rights and autonomy are limited. In these cases, parents have to provide legally valid consent 
to treatments. Naturally, it is important to note that this Swiss legislation is legally enforceable 
and thereby different from principles of biomedical ethics, as well as from United Nations’ 
documents and guidelines from medical associations. 
From all the described documents, it is evident that normative premises can be derived for the 
purposes of decision-making in PPC. Thus, there is an espoused ideal of clinical practice that 
reflects how decision-making in pediatric oncology ought to be: building upon the respect for 
patients’ autonomy decision-making should be shared. Presupposing a fundamental 
complementarity between the normative and the empirical, the question can be raised how this 
ideal of decision-making is translated into practice. Before that, however, it needs to be 
thoroughly outlined how the normative and empirical interrelate and how the chasm between 
them can be bridged. This meta-ethical reflection is undertaken in the following section.  
                                                 
4 In this thesis, the term „capacity“ refers to the cognitive decision-making ability within the clinical setting. The 
term “competence” describes a person’s authority to translate such decisions into legally binding ones.  
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2 Empirical Bioethics Methodology  Bridging the                          
Empirical-Normative Divide 
 
As outlined in the previous section, decision-making in PPC is neither an ethical nor a legal 
adiaphoron but rather a highly normatively loaded concept. Since this thesis aims to empirically 
study decision-making in PPC and to integrate the empirical data with normative ethical 
analysis, it is of preeminent importance to a priori think about how empirical research can be 
integrated with normative bioethical reflection. 
 
2.1 Empirical Bioethics 
Shifting away from a purely theoretical discipline and thereby gradually relinquishing its 
autonomy regarding the evaluation of ethical issues in the medical sphere to other disciplines, 
bioethics has been incorporating social scientific empirical methods for more than three 
decades56. This so called “empirical turn” usually describes the steadily growing number of 
empirical research studies to inform normative approaches in bioethics57. Almost twenty years 
ago, Birnbacher argued that empirical research does not supplement (applied) ethics, but 
complements it and ultimately calls for a co-operation of social sciences and ethics58. 
Critizising traditional ethical approaches that risk neglecting the realities of lived experiences, 
empirical bioethics generally underlines the necessity of utilizing social sciences in order to 
become more contextually aware59-62. Although different reasons for using empirical data exist 
among ethicists, all empirical bioethics approaches  as a starting point  deny the 
incompatibility of empirical data and moral theory and conceive both as complements58,63,64. 
By way of exemplification, factual statements about how the world is (derived from 
quantitative or qualitative methods) are seen as compatible with normative statements about 
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how the world ought to be (based on practical ethical reasoning), or to put it more concisely: 
empirical and normative analyses converge in the field of empirical bioethics. 
According to Leget, “empirical bioethicists use qualitative, quantitative or mixed methods to 
gather data relevant to judgements concerning moral matters in medicine and medical 
science.”65,p.228 Moreover, there are basic assumptions underlying any sort of empirical ethics: 
(a) studying an actual practice provides meaningful information for the bioethical endeavor 
which, in any case, should begin from this particular premise, (b) social sciences’ methodology 
is well suited to map this reality, (c) empirical and normative approaches are compatible and 
fundamentally complementary (d) empirical ethics, in its overall meaning, is not a 
methodology of doing ethics, but a methodological attitude regarding the use of empirical 
research in ethical reflection, (e) empirical ethics is not an anti-theorist approach, in which the 
empirical is the final moral arbiter66. 
Why conduct empirical bioethics?  
If there were no benefits of conducting empirical research on PPC in order to improve practice, 
solely working from a normative standpoint would suffice. Nonetheless, empirical bioethics is 
not an end in itself, but needs to be justified. De Vries and van Leeuwen give the following 
five practical reasons for using empirical data67. First, by including moral experiences and 
relevant expertise of practitioners in ethical reasoning, relevant aspects of the medical practice 
(e.g. internal norms, practical wisdom, context-driven paths for putting abstract principles into 
practice) can be better understood. Second, the particularities of medical practice (e.g. 
inpatient-settings, minors’ possible incapacity of judgement, triadic decision-making 
constellation, physicians’ attitudes) should be considered in order to familiarize bioethics with 
daily life within a certain setting. Third, the likelihood of successfully implementing the results 
of ethical reasoning is increased if special characteristics of the medical practice are taken into 
consideration. Fourth, the ethical analysis is strengthened by acknowledging moral dilemmas 
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that occur in medical practice. Fifth, empirical data decreases the odds for biased conclusions 
and self-justification on the part of the researcher or the research team. Further, without 
empirical input, it remains unclear on which norms the normative judgment should be based. 
The normative becomes disconnected from “lived morality”, which, however, has to be 
considered because many normative questions cannot be answered due to a lack of a 
universally shared normative framework65. As follows from the previous considerations, 
empirical bioethics represents an indispensable step towards drawing normative conclusions 
through the integration of empirical and normative analysis61. Without referring back to 
empirical analyses, bioethics to a large extent forfeits its ecological validity, which means the 
degree to which its concepts and norms are applicable in practice. 
How to conduct empirical bioethics?  
With regard to practical research strategies for empirical bioethics, numerous typologies of 
how to bring together the empirical and the normative have been put forward59,60,63,65,68. Some 
authors have distinguished different relations between the empirical and the ethical spheres59,68. 
Kon presents four hierarchically ordered levels on which empirical research informs 
bioethics68. On the bottom level  the lay of the land research  studies describe and reveal the 
current practices, opinions, beliefs or other aspects of the status quo. On the second level  
ideal versus reality  studies explore to which extent actual clinical practice matches with an 
espoused ideal. Upon this builds the third level  improving care  where studies examine how 
practice can be made more consistent with ethical norms. Finally, on the fourth level  
changing ethical norms  based on the work of the previous three levels, amendments of ethical 
norms are recommended. Although to different extents, this thesis’ empirical work informs 
bioethical considerations on SDM within the context of PPC on all four levels.  
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Three categories (containing ten subcategories) of how the is can contribute to the ought are 
sketched by Solomon: (a) facilitating the move from ethical analysis to ethically justifiable 
behavior, (b) enhancing ethical analysis and justification, and (c) generating new normative 
concerns59. The first and the last category offer subcategories that capture the role of empirical 
analysis within this thesis: documenting gaps between ideal and actual practice, and describing 
the environmental context that mediates moral action (subcategories of the first category), as 
well as identifying new moral problems, specifying acknowledged problems, and clarifying 
causal mechanisms (subcategories of the third category)59.  
In a different and more practical strategy that depends on what  theory or data or both  is the 
final moral arbiter (e.g. locus of moral authority), Molewijk et al. distinguish five different 
research strategies of how to arrive at a normative conclusion (figure 3)63. First, in prescriptive 
applied ethics moral theory is the final moral arbiter and empirical data cannot cause substantial 
adjustments of a moral theory, if it does not concur with the morality of a particular practice 
(one way interaction: top down between theory and data). Second, theorists use empirical data 
in order to improve or refine a moral theory (one way interaction: bottom-up between data and 
theory). Third, according to particularists the morality within a particular practice is the only 
moral arbiter (e.g. casuistry; no interaction between theory and data). These three strategies 
lack a two-way interaction that actually brings theory and data together. The following two 
strategies offer insights into how to draw normative conclusions by integrating moral theory 
and empirical data. The fourth strategy  critical applied ethics (CAE)  does not accept moral 
authority of either theory or data, instead it simultaneously lets data criticize theory and applies 
critical thinking of ethics to the data throughout a fivefold process (two-way interaction). 
Finally, integrated empirical ethics overcomes the theoretical hybridization of normative and 
empirical disciplines, stresses instead that the empirical and the normative are mutually 
constitutive, and integrates theory and data through intensive cooperation between ethicists and 
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descriptive scientists in order to reach normative conclusions (no interaction, since normative 
and empirical fall together). 
The outlined typologies of relating the empirical and ethical spheres are valuable as they shape 
the field of empirical bioethics in terms of the aims of (Kon68, Solomon59) and in terms of the 
moral authority (Molewijk et al.63) within a particular research project. In short, they represent 
ways of thinking about the research project, however, they do not (fully) dig into details and 
differences of the different methodologies within each typology60. Therefore, the approach to 
integrating ethical theory and empirical data as applied in this thesis is carved out in detail in 
the following. 
 
2.2 Approach to Conducting Empirical Bioethics in this Thesis 
Out of the introduced five methodologies by Molewijk63, the first three do not intend any two-
way  interaction between normative and empirical and, because of that, are not sharing this 
thesis’ view of a mutual co-determination of the normative and the empirical. Whilst integrated 
empirical ethics (fifth strategy) might be an appealing approach, Leget and colleagues’ 
criticism contains a valid point that, taken seriously, renders the latter less appropriate for 
bioethical research as compared to CAE (fourth strategy)65. They argue that integrated 
empirical ethics is “both conceptually contradictory and methodologically impaired”: 
conceptually because it cannot but draw on the distinction between fact and value when 
explaining how the postulated empirical-ethical-hybrid should be formed, thereby referring 
back to the distinction they seek to overcome, and methodologically, since the critical 
interdependence between social science (that could not be critically explored with regard to its 
normative dimensions anymore) and normative ethics (that could not be studied by empirical 
researchers anymore) dispersed65,p.231. Consequently, in order to draw normative conclusions 
through integrating the empirical and the normative this thesis’ approach draws on CAE as 
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established by Leget et al.65,69, but reaches beyond this methodology by enriching it through 
further methodological in-depth considerations as suggested by Davies et al.60 (figure 3).  
 
Figure 3. Empirical bioethics approach 
 
          Note. This figure was synthesized based on the works of Molewijk et al., Leget et al., and Davies et al.60,63,65 
 
CAE uses empirical data for a continuous, fivefold process (figure 3) of reassessing and 
refining the normative60,65,69. At all five stages, CAE appreciates the normative and the 
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empirical as two co-determining poles of the bioethical ellipse which offer a double and 
mutually clarifying critical look to the issue at stake (figure 3)65. 
CAE begins with the determination of the problem, either in normative ethics or in empirical 
research. Once a moral problem is identified at the first stage, it has to be accurately described 
at the subsequent stage, again, from both perspectives: the normative ethics analyses the 
(sometimes hidden) values that are inherent to the categories used in the determination of the 
problem, while empirical research carefully studies how the respective practice actually looks 
like. At the third stage, effects and possible alternatives to envisaged actions become relevant. 
Not only effects (e.g. does training for practitioners lead to better care outcomes?) can be 
assessed by empirical research, also premises of normative arguments can be tested (e.g. 
whether children actually want to be involved in decision-making). However, the function of 
empirical data at this stage is limited, in particular when the moral issues are essentially non-
consequentialist and normative ethics refers to deontological approaches as well as to the 
possibility of a morality that is supported by ethical theory, but not by data. At the fourth stage 
 the normative weighing  the normative and empirical are densely amalgamated in critical 
reciprocity. Most importantly, ethics monitors that the normative power of the descriptive is 
evaluated properly. Empirical research, in turn, has to critically question the ethical theories 
that are utilized. Since bioethics needs a constant evaluation of its outcomes, the effects of a 
decision need to be evaluated at the final stage. Empirical research explores the effects, while 
ethicists reflect upon the effects and ensure that consequentialism is not  unreflected  
triumphant over possibly more appropriate theories.         
In their systematic review of empirical bioethics methodologies, Davies and colleagues seek to 
highlight in detail how normative conclusions are drawn based on the integration of social 
scientific empirical data collection/analysis and normative/ethical theorizing60. They identify 
two poles of a continuum of methodological orientation, namely dialogical and consultative 
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methodologies (figure 3). While the former class revolves around a close dialogue between 
stakeholders and researchers to reach, first, a common understanding, and, second, a commonly 
drawn conclusion in face of a discrete problem, CAE falls within the latter class of consultative 
methodologies. Consultative approaches rely on an external “thinker” (e.g. research group, 
individual researcher) who analyses data and develops normative conclusions after and 
independently of the data collection. In this way, participants are consulted to obtain their 
attitudes and experiences, but are not involved in data analysis and ethical reflection.  
Consultative methodologies can be further sub-categorized based on the process by which the 
“thinker” forms a normative conclusion60. Three forms of non-specific integration (bottom up, 
top down, equal weighing) and two coherence seeking methodologies can be distinguished: 
reflective equilibrium based (employing one of numerous versions of the precisely defined 
methodology reflective equilibrium60) and non-reflective equilibrium based (not employing the 
particular methodology reflective equilibrium, although still reflective in nature) with CAE 
being part of the latter. In this regard, CAE seeks coherence, thereby localizes moral authority 
in rationality and consistency, and balances the relevant and equally weighted considerations 
until a coherent position is found60.  
Finally, Davies et al. recommend to thoroughly think through three central questions within 
any empirical bioethics endeavor, namely regarding the justification of a normative conclusion 
(through consensus or coherence), the analytic process that leads to the conclusion (prioritizing 
the thinker, theory, or data), and the kind of conclusion (aiming for particularity or 
generalizability)60. In short, this thesis seeks for coherence, prioritizes the “thinker” (in the 
form of an interdisciplinary research team), and aims to evaluate and enhance a particular 
medical practice, namely decision-making regarding PPC in pediatric oncology.  
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3 Research Objectives and Empirical Methods 
  
3.1 Research Objectives 
This thesis is part of a larger mixed-method research project titled “Attitudes and motives 
concerning end-of-life decisions: Competency and autonomy of children and adolescents in 
paediatric oncology”. The first prospective part of the project targeted children in their 
decision-making processes throughout the whole course of illness and treatment. The 
prospective study gathered data from children (interviews), parents (interviews, 
questionnaires), and physicians (interviews, questionnaires), but could not gather sufficient 
information on decision-making regarding palliative care; because of two main reasons. First, 
the sensitive nature of the topic might have withheld families of participating in the study. 
Second, (fortunately) only few children (7 out of 21) were considered palliative. Hence a 
follow-up study was designed to retrospectively understand the end-of-life situation and to 
examine how and by whom palliative care decisions are made. 
Unlike curative treatment decision-making regarding palliative care is not guided by protocols 
and thus lacks a universal approach. Further research on the involvement of children as well as 
on the dynamics of the triadic constellation of decision-making is needed26,70. Thus, the goal 
of this thesis is to propose ethically sound and practically feasible ways to facilitate SDM 
regarding palliative care in the context of pediatric oncology. To fulfil this objective, this thesis 
aims to answer the following research questions.  
1. What are parents’ and oncologists’ perceptions of children with respect to their 
involvement in decision-making? (chapter 2) 
2. Which factors determine parents` and oncologists` decisions to respect or limit a child’s 
role in decision-making? (chapter 2, 3) 
3. Which additional factors influence shared decision-making? (chapter 3, 4, 5, 6, 7, 8, 9) 
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4. What are stakeholders’ attitudes towards and experiences with the involvement of children 
in decision-making? (chapter 5) 
5. How are decisions regarding the transition from curative to palliative care structured and 
made? (chapter 3, 6) 
6. What are barriers to the implementation of pediatric palliative care and what are possible 
strategies to overcome them? (chapter 5, 7, 8, 9) 
7. How do international guidelines and practitioners understand PPC? (chapter 6, 7, 8) 
Referring back to Kon’s four levels on which empirical research can inform bioethics, it can 
be noted that the presented research questions apply to all four levels68. Accordingly, this thesis 
seeks to define current medical practice, to assess the congruency of the “is” and the “ought”, 
to improve care and to recommend changes in the respective normative background.  
This thesis has its origin in the realization that SDM in pediatric oncology needs further 
improvement and is still understudied. According to a recent systematic literature review, 
further research that identifies factors contributing to favorable participation of the child in 
decision-making regarding palliative care is needed70. Furthermore, despite recommendations 
by international guidelines2,7,33 and the findings of the first phase of the overall project which 
indicate that children value to be included in decision-making71,72, children’s participation is 
often still limited 70,73-77. Also the actual parental roles in decision-making were shown not to 
match the preferred roles with the former being too passive78. Moreover, with regard to PPC, 
studies show that there are still high numbers of late or non-referrals which do not meet 
recommendations to start PPC at diagnosis74,79-82. Finally, practitioners lack formalized training 
in PPC and often need to rely on trial and error learning74,83,84. 
 
3.2 Empirical Methods 
This thesis followed a mixed-methods design. The particular methods are described in detail 
in the methods sections of the articles below and, therefore, are not presented here. However, 
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it is crucial for the reader’s comprehension to outline how these different qualitative and 
quantitative methods were combined by briefly presenting this thesis’ mixed-methods 
approach. The empirical research in this thesis was comprised by two mixed methods designs: 
a convergent parallel design and an explanatory sequential design (figure 4)85,86. 
 
 Figure 4. Mixed methods design  
 
            Note. M = Module.  
 
Quantitative results of surveys completed by physicians and parents of children diagnosed with 
cancer (stemming from the first prospective part of the project) as well as quantitative results 
of extractions of medical records of deceased children represented the first quantitative module. 
Concurrently, guidelines on PPC were analysed. This represented the first qualitative module. 
Subsequently, the results of module I (quantitative) and module II (qualitative) were merged, 
analysed, and interpreted. In this phase, the researchers were able to determine the extent to 
which the results of the two modules converged. Furthermore, these results and interpretations 
informed module III (qualitative), namely focus group interviews with different stakeholders 
of decision-making regarding PPC. In this phase, the researchers addressed follow-up 
questions to experts and, thereby, reached a deeper understanding of the issue through an 
explanation of the previous results.   
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Abstract 
 
Objective: The goal is to present how shared decision-making in paediatric oncology occurs 
from the viewpoints of parents and physicians.  
Methods: Eight Swiss Pediatric Oncology Group centres participated in this prospective 
study. The sample comprised a parent and physician of the minor patient (<18 years). 
Surveys were statistically analysed by comparing physicians’ and parents’ perspectives and 
by evaluating factors associated with children’s actual involvement.  
Results: Perspectives of ninety-one parents and twenty physicians were obtained for 151 
children. Results indicate that for six aspects of information provision examined, parents’ and 
physicians’ perceptions differed. Moreover, parents felt that the children were more 
competent to understand diagnosis and prognosis, assessed the disease of the children as 
worse, and reported higher satisfaction with decision-making on the part of the children. A 
patient’s age and gender predicted involvement. Older children and girls were more likely to 
be involved. In the decision-making process, parents held a less active role than they actually 
wanted.  
Conclusion: Physicians should take measures to ensure that provided information is 
understood correctly. Furthermore, they should work towards creating awareness for 
systematic differences between parents and physicians with respect to the perception of the 
child, the disease, and shared decision-making. 
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Introduction 
 
Decision-Making in Paediatric Oncology 
When children are diagnosed with cancer, families and physicians face the cumbersome task 
of making urgent and difficult treatment decisions. In the paediatric setting, decision-making 
process includes multiple steps and at least three parties: the physician/nurse, the patient, and 
the parents: each with their own opinions, needs, and expectations1. They form a triadic 
constellation that must share the process and make a decision in the best interest of the child. 
Literature on shared decision-making emphasizes the following aspects: a) the involvement 
of at least two parties; b) sharing of information between the parties; c) consensus regarding 
the preferred treatment; and d) successfully achieving an agreement2,3. Shared decision-
making requires the involvement of all parties, with the child participating in a 
developmentally appropriate way4. However, neither the participation of the child nor the 
ability of parties to carry out their preferred role is guaranteed. For instance, Mack concluded 
that more than one-third of the parents held a passive role and that they were unsatisfied with 
the information they received5,6. Moreover, physicians often face several obstacles to 
communication such as time limitations and uncertainty about the patient’s current or 
projected condition7,8. Finally, despite recommendations by international guidelines to 
involve children9,10 several studies have noted that children’s participation is still low and that 
they are often shielded from difficult or bad information11-14. 
 
Factors Hindering the Decision-Making Process 
Forming a shared decision is not an easy process since all parties must overcome several 
difficulties. First, factors that inhibit parents include coping with the possible loss of their 
child and its consequences for the family15. Parents must overcome intra-familial conflicts, 
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may have unrealistic expectations regarding cure, and may deny that the cancer is terminal16. 
Parents’ limited understanding of the medical information and low family educational level 
also impair their ability to adequately take part in the decision-making process17.  
Second, physicians perceive a series of ethical challenges in making treatment decisions. 
These include weighing what the consequences of their actions would be, questioning the role 
of parents, and uncertainty as to how the child’s wishes should be considered7. Physician’s 
wishes to maintain some degree of hope may result in avoiding frank disclosure, thereby 
hindering decision-making. Furthermore, they face difficulties when asked “to provide 
uniquely tailored, culturally appropriate, holistic, comprehensive, coordinated, long-term care 
to all families”6,18,19. These concerns become more burdensome in light of the little 
formalized training that physicians receive in paediatric palliative care and in light of their 
reliance on learning through trial and error13,16,18. 
 
Study Purpose 
Available literature illustrates the need to shift the actual decision-making towards a process 
that empowers every involved person to occupy their preferred role. To know more about 
how shared decision-making in these situations occurs and how children are involved, more 
studies are needed. This research gap was addressed in this study carried out with physicians 
working in Swiss Pediatric Oncology Group (SPOG) centres and parents of children suffering 
from cancer. Study participants were questioned about their attitudes towards the child’s 
participation in the decision-making processes, their satisfaction with the process, and the 
actual involvement of the child. The study posed the following research questions: What are 
parents’ and physicians’ attitudes and orientation regarding inclusion of children in their 
cancer treatment decisions? What are their opinions on several aspects of shared decision-
making and do they differ? Which factors determine children’s actual involvement? 
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Methods 
 
Study Design 
Eight of the nine SPOG centres in Switzerland participated in this multicentre mixed methods 
project. The qualitative part of the project included interviews with children, their parents, 
and physicians. The results from the qualitative interviews have been reported elsewhere20-23. 
In addition, a quantitative collection of information using closed-ended surveys took place at 
the participating SPOG centres. In this quantitative part, children were not included. In this 
paper, we report the results of the quantitative surveys completed by parents and physicians. 
Distribution of the surveys began in November 2012 and was carried out until April 2015. 
Ethical approval was obtained from the responsible ethics committees for each SPOG centre. 
This inevitably meant that data could not be collected at all centres at the same time. The 
surveys were completed on a rolling basis according to when we received the ethics approval. 
The first centre began distributing the surveys and collecting them in November 2012 and the 
last one in June 2013. All centres ceased data collection in April 2015. 
 
Study Population 
Parents and treating physicians were included in the quantitative part of the project, if the 
respective child (a) was less than 18 years of age and (b) had a cancer diagnosis and received 
cancer treatment in one of the participating SPOG centres. The views of the paediatric 
patients were not gathered because we could not be sure that young children (less than twelve 
years) could understand and complete the study survey correctly. However, some variables 
captured children’s views indirectly through the parents or the physicians evaluation of the 
child’s view (e.g. “How satisfied was your child with decision-making?”; “Please evaluate 
your child’s suffering due to the disease”). 
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Data Collection 
Before starting data collection, the research team visited the respective SPOG centres to 
introduce the study, its methodology, and study tool to the physicians, as well as to the data 
manager (where possible). The purpose of this visit was to explain the recruitment process so 
that data collection would be as uniform as possible within each centre and between different 
centres. Study materials with codes for physician and parent were labelled for each patient by 
the researchers and delivered to the participating centres. The data manager or the responsible 
contact person for the centre kept a note on which participant received which code. To ensure 
confidentiality, the researchers did not have access to participants’ identifiable information. 
The study team requested each physician at the participating centre to complete one survey 
for every patient he or she treated. This meant that the physicians completed multiple 
surveys; however, each was for a unique patient case. They were also asked to approach the 
parents for each patient for whom they filled out a survey. The treating physician thus 
informed the parents about the study and provided the parents the study information 
documents: informed consent, a survey, and refusal card. Based on their preference, the 
parents could either return the survey to the hospital in a sealed envelope or post it using the 
self-addressed stamped envelope provided. Since parents completed the survey within a short 
time span of a few weeks after they were approached by their child’s treating physician, we 
expect that within one dyad perspective, the point along the child’s disease trajectory (e.g. 
diagnosis, relapse) would not have differed greatly. By emphasizing that parents have the 
opportunity to refuse to participate and by handing over a refusal card, the study team 
ensured that no undue pressure was placed on parents, given their difficult situation. 
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Study Sample 
A total of 229 surveys were completed and returned (138 by twenty treating physicians; 
ninety-one by parents) during the data collection period. These 229 responses represented 
151 unique children cases. From the 151 children, dyad-perspective (of parent and physician) 
was captured for seventy-eight children. For seventy-three children, only one perspective was 
available: sixty from the treating physician and thirteen children from a parent. We cannot 
confidently estimate the number of patients who sought treatment at the participating SPOG 
centres during the study period as this data is not obtainable for the research team. However, 
twenty of the twenty-eight physicians at the participating SPOG centres participated in the 
study. Since 138 surveys were completed by the twenty physicians, we expect that 138 
parents received a survey. From those parents who have received a survey, a completed 
survey was sent to the research team in 66 per cent of the cases. We received a total of eleven 
refusals from the parents. 
 
Study Questionnaire 
The study tool focused on the inclusion of children in the overall treatment decision-making. 
Several aspects and items of the detailed questionnaire were developed from the research 
team’s knowledge in the field and input from collaborating physicians. The survey was 
designed to gather the following data: a) demographics information; b) the amount of 
information given to the parents and whether the patient was present at this time; c) the 
capacity of the patient to understand disease-related information; d) decision-making and 
satisfaction with decision-making within the triadic system of child, parent, and physician; 
and e) current and preferred role of parents within decision-making. Questions concerning 
roles in decision-making were adapted and revised from Mack and colleagues. The 
questionnaire consisted of items with categorical responses or Likert scales. It was pilot 
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tested in August 2012 in one SPOG centre. A few adaptations were made that did not change 
the questionnaire’s overall purpose. 
 
Statistical Analyses 
A research assistant entered all completed surveys into SPSS 22 and another checked for 
correctness of data entry. Statistical analyses were performed using SPSS 22 (SPSS Inc, 
Chicago, IL). For analyses described below, reported p values are two-sided and statistical 
significance level was set at p < .05. 
To understand the general age at which children are considered capable of understanding 
different treatments and related consequences, physicians’ evaluations of the age from which 
the majority of children were considered able to understand various information related to 
their illness and capable of making related decisions were assessed descriptively. To be able 
to determine this age, we first counted how many children at a given age were considered 
capable versus how many children of the same age were not. Second, we examined the age at 
which these frequencies shifted from “more children were deemed not capable” to “more 
children were deemed capable.” This shift represented the “turning point” that we describe in 
this paper. 
Moreover, we compared physicians’ and parents’ perspectives on the decision-making 
process, on children’s characteristics, and on disease-related features. Using the seventy-eight 
dyad-perspectives a Wilcoxon signed-rank test was carried out to evaluate differences 
between physicians’ and parents’ responses to the following seven variables: suffering of the 
child, prognosis of child’s cancer, capacity of the patient to understand disease-related 
information, past and expected treatment duration, satisfaction with decision-making, current 
and preferred role of parents in decision-making, and amount of information given to the 
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parents. Additionally, using the parental perspective, we compared parents’ current and 
preferred role in decision-making in order to evaluate whether they hold the role they wanted. 
Finally, we evaluated factors associated with the actual involvement of the child in the shared 
decision-making process using generalized linear mixed model (GLMM). Categorical 
responses regarding the involved parties in decision-making (question: “who was involved in 
decision-making?”) were dichotomized into “with child” and “without child.” This binary 
variable was the dependent variable. Based on a priori theoretical considerations, four 
predictor variables were included: age of the child, gender of the child, cancer prognosis, and 
physician’s professional experience as a paediatric oncologist. Since children receiving care 
from a particular physician and/or centre might have similar data, the analysis was adjusted 
for clustering within physicians and SPOG centres. The GLMM analysis included the 138 
cases that were completed by twenty physicians. 
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Results 
 
Demographic Characteristics of the Sample 
Of the children, 62 per cent were male. Parents were between eighteen and fifty-nine years 
old, and most of them were mothers (80 per cent; two missing values). Physicians were 
between thirty-five and fifty-eight years old, with a small majority (56 per cent) being female 
(two missing values). Other demographic information of patients, parents, and physicians is 
presented in table 1. 
 
Table 1. Descriptive statistics of children and study population 
Children (n=151)1 Parents (n=91) Physician (n=20) 
Age (M; SD) 8.05 (4.85) Age (M; SD) 39.16 (7.23) Age (M; SD) 43.56 (6.28) 
Gender (male) 62% Gender (male) 16% Gender (male) 44% 
Prognosis  
(M; SD) 
1.63 (0.93) 
Nr. children  
(M; SD) 
2.22 (0.93) 
Experience     
(<8 years) 
50% 
Suffering 
(M; SD) 
2.49 (1.00) Religious (yes) 54% 
Religious    
(yes) 
39% 
Prev. Treatment  
(<6 months) 
63% 
Marital Status 
(married) 
82%   
Exp. Treatment  
(<12 months) 
31% 
Relationship with 
the child (father) 
16%   
Note. Prev. = Previous; Exp. = Expected. 
1 Information about children was obtained from physicians and parents. Due to minor discrepancies between parents and 
physician, we evaluated age and gender for the ninety-one cases from parents and the remainder from physicians. Prognosis, 
suffering, previous treatment, and expected treatment were evaluated by the physicians in all cases, except for thirteen cases 
for whom we did not have the physician survey. Prognosis was measured by a five-point Likert item ranging from 0 
(“extremely good”) to 4 (“very bad”); suffering from 0 (“a great deal”) to 4 (“not at all”). 
 
According to the twelve categories (I–XII) of the International Classification of Childhood 
Cancer (ICCC), the most frequent diagnoses were as follows: leukaemia (ICCC-I; 49.7 per 
cent), central nervous system neoplasms (ICCC-III; 18.5 per cent), malignant bone tumours 
(ICCC-VIII, 7.9 per cent), and lymphomas and reticuloendothelial neoplasms (ICCC-II, 6.6 
per cent). Two diagnoses were not represented in our sample: retinoblastoma (ICCC-V) and 
hepatic tumours (ICCC-VII). Compared to the Swiss Childhood Cancer Registry (SCCR), 
leukaemia was over-represented (49.7 per cent vs 33 per cent) and central nervous system 
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neoplasms were comparable (18.5 per cent vs 19.6 per cent) (Swiss Childhood Cancer 
Registry 2016). Patients’ ages were overall comparable to SCCR (in brackets): 0–4 years 
34.8 per cent (36 per cent), 5–9 years 26.2 per cent (21.5 per cent), 10–14 years 27.5 per cent 
(22.7 per cent), and 15–20 years 11.4 per cent (19.8 per cent; note: SCCR includes 
adolescents up to twenty years of age). 
 
Physicians’ Evaluations of Children’s Understanding and Capacity 
With regards to understanding diagnosis, only one out of four children who were five years of 
age were deemed capable, three out of eight children who were six years of age were 
considered capable, and the same goes for seven out of thirteen children who were seven 
years old, and seven out of nine for children eight years old. Accordingly, the turning point 
was reached between six and seven years of age (table 2).  
 
Table 2. Turning points1 of children’s competency evaluations by physicians (n=138) 
Variable  Age (years) 
Understanding diagnosis  6.5 
Understanding prognosis  9.0 
Understanding cancer cause  9.5 
Understanding response to treatment  6.0 
Making treatment decisions  11.5 
Making decisions to be included in CT  11.5 
Note. CT = clinical trial. 
1 From this age physicians considered the majority of children at a given age capable of understanding/ 
decision-making. 
 
Therefore, physicians judged understanding of response to treatment and understanding 
diagnosis to be easiest and thus deemed the majority of children older than six years to be 
capable of these two tasks. Understanding of cancer cause and prognosis was reported more 
positively for those children who were nine years and older. The capacity to make treatment-
related decisions was evaluated as most challenging with the age limit for these choices being 
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above eleven and a half years. Because of lower numbers we do not present the evaluations 
of the parents. 
 
Factors Influencing Decision-Making Process 
With regard to the provision of information the results highlight that for all six aspects of 
information provision (diagnosis, prognosis, treatment options, cancer cause, response to 
treatment, and clinical trial inclusion) parents’ and physicians’ perceptions differed 
significantly (table 3). Compared to physicians, parents rated the amount of information that 
was given to them by the physicians as being less satisfactory. 
Second, concerning children’s understanding of disease-related information, results indicate 
that parents evaluated children’s ability to understand diagnosis and prognosis higher than 
how it was evaluated by the physicians. Parents thus had a more capable image of their 
children (table 3). Regarding the characteristics of disease, parents’ and physicians’ ratings 
of the suffering of a child as well as the expected treatment duration differed significantly. 
Parents assessed the disease of their child as worse (higher suffering, longer duration) than 
how physicians evaluated the disease. Finally, concerning satisfaction with involvement in the 
decision-making process, parents rated a child’s satisfaction with the actual decision-making 
as higher than the physician (table 3). 
 
Parents’ Preferred and Current Role in Decision-Making 
Study results present that parents held a less active role than they actually wanted, Z = –
3.080, p = 0.002. Of the parents who reported both their current and preferred role, 64 per 
cent reported that their current roles matched their preferred role; 8 per cent reported a more 
active role, and 28 per cent a less active role. In order to further examine this difference in 
current and preferred roles, an exploratory GLMM analysis was performed addressing the 
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question of what determines parents’ less active role. This analysis did not reveal any 
predictors. 
 
 
 
Characteristics of Children Involved in Decision-Making 
Only forty-four (out of 137) children were involved in decision-making. They belonged to 
these age groups: three out of fifty children from zero to four years, six out of thirty-six 
Table 3. Wilcoxon signed-rank test comparing physicians’ and parents’ perceptions on elements 
related to decision-making (dyad-perspective n=78) 
Variable  PH=PA PH>PA PA>PH z p 
1. Provision of information 
Information Diagnosisa (n=62) 48 13 1 -3.116i .008
j 
Information Prognosisa (n=63) 39 20 4 .3.563i .000
j 
Information Treat. Optionsa (n=62) 43 16 3 -3.065i .006
j 
Information Cancer Causea (n=62) 27 22 13 -2.178i .029
j 
Information Response to Treat.a (n=62) 44 16 2 -2.840i .010
j 
Information Inclusion CTa (n=56) 41 14 1 -3.231i .005
j 
2. Children’s understanding of disease related information 
Understanding Diagnosisb (n=67) 27 13 27 -2.202h .028j 
Understanding Prognosisb (n=63) 29 11 23 -2.497h .026j 
3. Children’s competency to make treatment related decisions 
Competency Treatment Decisionsb (n=66) 33 15 18 -.553h .580
j 
Competency CT Decisionsb (n=64) 31 15 18 -1.295h .390
j 
4. Characteristics of disease 
Prognosisc (n=61) 20 21 20 -.162h .872j 
Suffering of the Childd (n=62) 27 10 25 -2.830h .010j 
Expected Treat. Duratione (n=67) 45 5 17 -2.802i .015j 
5. Satisfaction of involved parties 
Satisfaction Childf (n=33) 12 6 15 -2.538h .011 
Satisfaction Parentf (n=62) 23 15 24 -1.711h .087 
Satisfaction Physicianf (59) 34 9 16 -1.224h .221 
6. Shared decision-making      
Shared Decision-makingb (n=65) 16 20 29 -1.239i .215 
Preferred Role of Parentsg (n=65) 29 22 14 -1.171h .242 
Note. CT = clinical trial; Treat. = treatment; PH=PA = physicians and parents rated equally; PH>PA = physicians rated 
higher than parents; PA>PH = parents rated higher than physicians. 
afive-point Likert item ranging from “full information” to “no information”; bfive-point Likert item ranging from 
“absolutely agree” to “strongly disagree”, cfive-point Likert-item ranging from “excellent” to “very bad”; dfive-point Likert-
item ranging from “severe” to “no suffering”; efour-point Likert-item: “less than one year”, “between one and two years”, 
“between two and four years”, “more than four years”; ffive-point Likert-item ranging from “very satisfied” to “not 
satisfied”; gseven-point Likert-item ranging from “I prefer to make the decision with no input from the physician” to “I 
prefer that the physician makes the decision with no input from me”; hbased on negative ranks; ibased on positive ranks; 
jsince the overall-hypothesis was tested through multiple comparisons and to control for the increased likelihood of a type I 
error, p-values were adjusted applying Bonferroni-Holm correction. 
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children from five to nine years, twenty-three out of thirty-eight children from ten to fourteen 
years, and twelve out of thirteen from fifteen to seventeen years. The findings from the 
GLMM reveal that a patient’s age and gender significantly predicted whether the child was 
involved or not (table 4). In particular, the older a child, the more likely was his or her 
involvement. Also, girls were more likely to be involved than boys. To illustrate, an 
additional year in age resulted in higher odds of being involved by a factor of 1.7; for a girl 
instead of a boy, the odds increase by a factor of 3.7. An exploratory independent samples t-
test (t(76) = 2.079, p = .041, d = .048) revealed that parents evaluated girls’ capacity (M = 
1.95, SD = 1.58) to make treatment decisions higher than boys’ capacity (M = 2.75, SD = 
1.43). 
 
Table 4. GLMM of involvement of the child in decision-making (n=137) 
 B SE t P 
Odds 
Ratio 
95% CI for Odds Ratio 
Lower              Upper 
Intercept -4.406 1.531 -2.878 .005    
Age of Patient .498 .058 8.569 .000 1.646 1.467 1.846 
Female gender of Patient 1.296 .610 2.129 .035 3.656 1.096 12.193 
Physician’s Experience -.602 .415 -1.450 .166 .548 .228 1.317 
Prognosis of Disease -.301 .243 -1.235 .219 .740 .457 1.198 
Note. The dependent variable in this analysis is the involvement of the child so that 0 = no and 1 = yes. Results 
were adjusted for physician and centre clustering. 
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Discussion 
 
By providing findings on children’s actual involvement in decision-making, on parents’ and 
physicians’ evaluations of children’s capacity to understand disease-related information and 
make treatment-related decisions, and on parents’ roles in shared decision-making, this study 
presents new data contributing to the limited literature to date in shared decision-making in 
paediatric oncology, particularly in the Swiss paediatric oncology setting. The findings 
suggest appropriate and feasible ways to facilitate shared decision-making in paediatric 
oncology for all stakeholders. The study is unique as it highlights the dyad perspective on the 
same case. 
Results from our dyad perspective first highlight that in comparison to physicians, parents 
rated the amount of information (on diagnosis, prognosis etc.) that they received as less 
satisfactory. Since studies have shown that most parents want to be informed honestly and 
frequently with respect to poor prognosis, this deficit in communication is likely to reduce 
parental satisfaction with decision-making6,19,23,24. For example, one study reported that the 
main reason for conflicts between physicians and parents was the latter’s overly optimistic 
assessment of their child’s prognosis25. In addition, parents perceived the fate of their 
children (i.e. treatment duration, suffering) as worse than how physicians perceived it. They 
thus felt that their children were suffering more and that the treatment seemed to be a long-
lasting process. This divergence in the perception of information received could be because 
physicians avoided full disclosure to maintain hope. Although hope is a strong emotional 
motive, it may not produce the desired outcome in light of the value placed by the family on 
proper and adequate information in such situations6,18,26. On the contrary, full disclosure of 
prognosis is not only recommended by international guidelines27 but can promote parental 
hope and peace of mind19. Other explanations for this difference are that information was not 
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sufficiently tailored to the parents’ need, due to ineffective consent documents as well as 
difficulties associated with understanding complex information in a stressful situation with 
limited time28. There is thus a need to assess whether information provided is actually 
understood by the family17 and a need for mechanisms to ensure clear communication 
between the healthcare providers and the family29. 
Second, parents held a more positive view of children’s capacities as they rated the child’s 
capacity to understand diagnosis and prognosis information higher than the physicians. This 
could be because they deemed their children more capable, perceived inclusion as being 
helpful, or were simply hopeful. Parent’s more positive view raises the question whether 
physicians underestimate children’s capacities or parents overestimate their children’s 
abilities or whether the view of parents and physicians depend on factors not related to the 
child (e.g. the time when information was received, educational level of the parent, gender). 
Exploring the reasons behind parental and professional assessment of child’s capacity is a 
fruitful area of investigation that is lagging presently29. 
Third, as expected our study findings point out that the likelihood of children’s involvement 
in decision-making increases with age. While Hinds concluded that children between ten and 
twenty years of age are capable of participating in end-of-life decisions, in our sample only 
69 per cent of this age group were involved, even though decisions considered in our study 
were not of this type and could be seen as being less cumbersome26. The qualitative findings 
from this project reveal that children and adolescents valued being involved in their treatment 
decisions20,23. Therefore, stronger involvement of children in light of their increasing age is 
recommendable for two reasons: age is highly correlated with the development of a child and 
involving children is internationally recommended4,27,30. Furthermore, guidelines highlight 
that children’s level of understanding is often underestimated and that adolescents are aware 
of failed treatments31,32. Besides guidelines’ recommendations and physicians’ facilitation of 
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children’s involvement in decision-making, parents have the responsibility to make their 
children’s voices heard. However, this parental ability can be limited, for example, by the 
burden of coping with their child’s disease15 and exclusion of children from medical 
discussions because they wish to protect their child33. Related to inclusion of a paediatric 
patient, an interesting finding of our study is that girls were more likely to be involved even 
when there was neither age nor prognosis difference between boys and girls. An explanation 
from our exploratory analysis is that participating parents considered girls more capable of 
making treatment decisions than boys. Future research should carefully examine this finding. 
Finally, similar to results from a study carried out in the United States, our study found that 
only 64 per cent of the parents held their preferred role, with 28 per cent holding a less active 
role and 8 per cent a more active role5. It should be noted that there was no difference 
between parents’ and physicians’ evaluation of the parents’ preferred role in decision-
making. That means that participating physicians in our sample perceived the parental 
preferences correctly but the realization of preferred roles was hindered. This is concerning 
since a study pointed out that holding a less active role was associated with lower evaluation 
of communication quality5. One reason for parents’ less active roles could be that physicians 
were critical of the parental roles, namely parents holding too much decisional authority, and 
therefore restricted parents’ participation7. In the face of their child’s disease, parents often 
want to gather further expert opinions28, and it could be that parents did not receive enough 
time to make a decision in light of the time constraints in clinical practice34. It is important to 
take parental preferences into account and to conduct research on decision-making because 
this can influence practice in paediatric oncology35. Thus, barriers that hinder shared 
decision-making and individual-level factors that affect such processes need further 
evaluation to close this gap between perceived and current parental roles. 
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Limitations 
The limitations of this study include the different time range during which data was collected 
in the eight participating centres. One centre refused participation, but we do not believe that 
parents and physicians in that centre would have provided a significantly different response. 
Second, physicians carried out survey dissemination to the families. We can neither ascertain 
the number of families to whom the study was explained and study materials distributed nor 
the number of families who refused to participate. The response rate calculated in the 
methods section is limited to the number of surveys completed by the physicians which 
composed our known denominator. Third, 80 per cent of the participating parents were 
mothers. Since mothers are more likely to carry out the main responsibility for their child 
during these situations, it is a legitimate over-representation. Fourth, from the 151 children, 
the dyad-perspective was captured for only 78. Correspondingly, for 48 per cent of the 
children, only one perspective was available, and thus comparative analysis could not be 
performed for all children cases. However, the number of dyad-perspectives is sufficient to 
derive statements about differences between physicians and parents. Finally, as our aim was 
to gather information about children who had cancer, we did not differentiate their disease 
trajectory. Therefore, this information was not gathered in our survey, and there could be an 
effect on the results of the child’s point along the disease trajectory. Given that participating 
parent and the physician completed their surveys on the same child (dyad-perspective) within 
a few weeks, it is not very likely that the point along the disease trajectory differed 
significantly within a dyad. 
 
Conclusion 
Our study provides both valuable insights into the decision-making of physicians and parents, 
and information to improve the decision-making process. It reveals the need for healthcare 
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providers to ensure that information provision is clear and correctly understood by the family. 
They should not take for granted that the information they relate to the family is perceived the 
way it is intended. That a girl patient is more likely to be involved in decision-making than a 
boy patient of the same age cautions both physician and parents to evaluate their perception 
of a child’s capacity so that a capable male child is not denied participation. Additionally, our 
results note that physicians fail to ensure the preferred role of the parents. Measures to ensure 
that parents are enabled to enact their preferred roles in decision-making will be valuable to 
ensure good communication and the family’s satisfaction with healthcare. Finally, our 
findings can be applied beyond paediatric oncology to the general aim of facilitating the 
optimal participation of parents and paediatric patients in shared decision-making. 
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Abstract 
 
Purpose: This study examined the provision of palliative care and related decision-making in 
Swiss pediatric oncology settings. The aim was to determine if and when children who died 
from cancer received palliative care, whether there were differences by cancer diagnosis, and 
inclusion of children in decision-making regarding palliative care. 
Methods: Using a standardized data extraction form, a retrospective review of medical 
records of deceased pediatric patients was conducted. The form captured information on 
demographics, diagnosis, relapse(s), treatments, decision-making during palliative care, and 
circumstances surrounding a child’s death. 
Results: For 170 patients, there was information on whether the child received palliative care.  
Among those, 38 cases (22%) did not receive palliative care. For 16 patients, palliative care 
began at diagnosis. The mean duration of palliative care was 145 days (Mdn = 89.5, SD = 
183.4). Decision to begin palliative care was discussed solely with parent(s) in 60.9% of the 
cases. In 39.1% the child was involved. These children were 13.6 years of age (SD = 4.6), 
whereas those not included were 7.16 years old (SD = 3.9). Leukemia patients were less likely 
to receive palliative care than the overall sample and patients with CNS neoplasms received 
palliative care for a longer time than other patients. 
Conclusions: There are still high numbers of late or non-referrals and even children older 
than 12 years where not involved in decision-making regarding palliative care. These results 
do not align with international organizational guidelines which recommend that palliative care 
should begin at diagnosis. 
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Introduction 
 
Since the early 2000’s, pediatric palliative care guidelines have carefully distinguished 
palliative and hospice care, and ultimately recommended an integrative model for concurrent 
administration of curative treatment and palliative care1-4. This integrated model starts at 
diagnosis and continues throughout the illness trajectory, irrespective of the outcome5,6. It 
focuses not only on symptom management of the child, but also on the social, psychological, 
and spiritual well-being of both the child and the family1,5. However, palliative care (PC) for 
children is frequently deemed infeasible within the clinical practice for many reasons, 
including disagreement with the definition of PC as psychological and social support may 
already be part of the curative treatment1. It thus appears that the traditional understanding of 
PC, namely a dualistic model of curative and palliative, predominates in clinical care7-9, and, 
accordingly, a chasm between guidelines’ recommendations and actual clinical practice 
exists. 
Although several studies highlight general improvement in the early implementation of 
PC10,11, PC still does not always begin at the time of diagnosis of a life-threatening disease as 
recommended by existing guidelines. For instance, a Canadian study found that pediatric 
oncology patients did not receive PC at diagnosis, but most were referred during the course of 
their illness9. A survey of pediatricians in the U.S. concluded that children with life-limiting 
illness are referred to PC late, that is, at the end of their illness trajectory when no other 
curative options exist7. One study revealed an average time of 461 days after being diagnosed 
with cancer for pediatric patients to be referred to PC9. Similarly, a nationwide retrospective 
medical records review of pediatric oncology in Sweden found that the transition to non-
curative care took place between the last day of life to over four years before death, with a 
median of 60 days8. The large range was attributed to varying types of cancer, as children 
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with leukemia were treated curatively until very close to death, while those with brain and 
solid tumors received PC earlier. An Australian study reported an average duration of 
69.4 days of PC provision12.  Lastly, a U.S. study found that the time between PC consultation 
and death ranged from 1 to 96 days (median 18 days)13. Reasons for late referrals are many: 
misconception of PC as not belonging to cure-oriented therapy14, thus referring to PC only 
when no curative treatment exists; an uncertain prognosis compounded with families’ refusal 
to acknowledge the incurable condition15 and fear that the family may feel abandoned by 
primary caregiver if PC is discussed16; and physicians’ difficulties with objectivity and 
uneasiness in diminishing hope14. 
Closely related to the issue of provision of palliative care for children is the question of their 
inclusion in such decisions. In Switzerland, there is no age at which children become legally 
competent to make decisions (Art 16. Swiss Civil Code). In the literature and in international 
guidelines, children’s participation is recommended along with provision of information 
adapted to their personality, cognitive ability, maturity, and age2-5,17. Coyne and colleagues17 
found that healthcare professionals strongly supported a transparent approach to information 
sharing. However, parents wished to protect their children from burdensome information to 
maintain hope, and children trusted their parents to act as their advocates17,18.  Several other 
studies underline the involvement of the patient and his or her parent in palliative cases19-22. 
In sum, it is evident that a sizable fraction of children and their families still do not benefit 
from holistic and quality of life enhancing PC at early stages of the illness and data 
concerning children’s inclusion in decision-making (DM) regarding PC is lacking. This study 
examined provision of PC in Swiss Pediatric Oncology Group (SPOG) settings to determine 
if and when children who died from cancer received PC, whether there were differences by 
cancer diagnosis, and inclusion of children in their DM process. We chose to raise these 
questions in the Swiss settings in response to our previous nation-wide project on treatment 
DM and inclusion of children in these decisions20,22-24. During the course of our interviews in 
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the previous project with children, their parents, and corresponding physicians as well as 
survey of parents and physicians, we were unable to obtain data on palliative cases mostly due 
to hesitancy to discuss this issue with patients and their families.  Therefore, we choose to 
exclusively examine PC in this setting using a retrospective study design. 
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Methods 
 
Seven of the nine SPOG-centers in Switzerland participated in this study because they had 
collaborated with the researchers on the previous project. Using a standardized data extraction 
form, a retrospective review of medical records of deceased pediatric patients was conducted. 
All responsible ethics committees approved this study. The list of children who comprised our 
study cohort was provided by the Swiss Childhood Cancer Registry (SCCR). Please see figure 
1 for inclusion and exclusion criteria. 
 
Figure 1. Inclusion and exclusion criteria 
 
 
Data Collection 
The data extraction form captured the following information: a) demographics, b) type and 
date of diagnosis, as well as number and dates of relapse(s), c) type of treatment(s), d) DM 
during PC, and e) circumstances surrounding the death of the child.  These items were 
developed based on the research team’s knowledge in the field and discussions with 
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collaborating physicians. Not all information was available in the medical records for all 
cases. In such cases, the researchers had the opportunity to consult the collaborating 
physicians. However, several missing values remained, which caused different sample sizes 
for some analyses. For example, the exact date when PC was initiated was not always 
available and consequently the duration of PC could not be calculated for these cases. The 
medical records were read carefully by four researchers who extracted the data. To ensure 
consistency of data collection, the first five extractions were discussed among the researchers; 
these discussions continued throughout the data collection period.  Data was collected on-site 
from July 2015 to July 2016 and to ensure anonymity, an alphanumeric code was created for 
each child based on a predefined algorithm. 
  
Data Analyses  
All extracted data were entered into SPSS.22 by a research assistant and verified by another 
researcher for accuracy. Statistical analyses were performed using SPSS.22 (SPSS Inc, 
Chicago, IL). For analyses described below, reported P values are 2-sided and statistical 
significance level was set at P < .05. The variable of interest, PC, was identified either by an 
explicit reference to “palliative care” or when the records’ content on treatment implied that 
PC was started, for example: curative treatment was stopped and quality of life was envisaged 
via best supportive care. The variable, “Provision of PC” indicates that children received PC 
(as per our interpretation of the medical records) characterized by a focus on quality of life 
and a supportive intent as compared to previous curative treatment with a focus on life 
prolongation and a restorative intent. The variable, “transition to PC” marks the point where it 
was clear from the medical records that curative treatment was no longer viable and thus, a 
PC was chosen. 
After performing descriptive analyses, we divided our sample into three diagnosis-based 
subgroups (leukemia, CNS neoplasms, and other diagnoses) which were compared using 
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analysis of variance and Chi-square test of independence. Besides the quantitative analysis, 
content analysis was used in order to qualitatively analyze the discussions between medical 
professionals and the family25.  
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Results 
 
The average age of the sample (N=193) at diagnosis was 7.2 years and 55.4% were male 
(table 1). All 12 diagnosis groups of International Classification of Childhood Cancer 3 
(ICCC3) were represented in our sample: CNS neoplasms (III) 34.2%, Leukemias (I) 27.5%, 
Neuroblastoma & other peripheral nervous cell tumours (IV) 11.9%, Malignant bone tumours 
(VIII) 8.3%, Lymphomas & reticuloendothelial neoplasms (II) 6.2%, Soft tissue & other 
extraosseous sarcomas (IX) 6.2%, and the remaining six formed 5.7%. 
 
Table 1. Demographics of children by SPOG-center (N=193) 
Center 
Mean age at diagnosis 
(Mdn, SD) 
Mean age at palliative 
care begin b 
(Mdn, SD) 
Sex 
(male) 
Center 1 7.5 (7.0, 5.0) 9.6 (8.0, 4.8) 68.4% 
Center 2 6.8 (6.0, 5.2) 7.8 (7.0, 5.0) 56.6% 
Center 3 8.2 (8.0, 5.3) 11.5 (13.0, 4.7) 63.6% 
Center 4 6.5 (6.0, 3.5) 9.6 (9.0, 4.1) 35.3% 
Center 5 9.3 (10.0, 4.3) 11.55 (13.0, 4.5) 58.8% 
Center 6 6.0c 12.7 c 100% 
Center 7 6.8 (6.0, 5.5) 10.0 (10.0, 5.4) 46.1% 
Total 7.2 (6.0; 5.1) 9.5 (9.0, 5.1) 55.4% 
a In order to preserve anonymity we do not provide absolute numbers for each center;           
b palliative care time variable data available for 130 cases; c Due to the small number of 
children median and standard deviation were not reported.  
 
When Did Palliative Care Begin?    
For 170 patients, data was available on whether a child received PC. Of these, 77.7% (n=132) 
received PC and 22.3% (n=38) did not with the rationale being: in five cases, PC was 
discussed, but the child died before it could be started; in 25 cases, the child died before PC 
could be discussed; in four cases, the family opted for continuation of curative treatment even 
after physicians recommended PC; and in one case, parents refused both further curative 
treatment and PC. For three cases, there was no rationale documented in the medical records.  
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Of the 132 cases who received PC, information on when PC was started was available in all 
but one case. We found that PC began at diagnosis in 16 cases (12.1%) because of poor 
prognosis, and at progression after diagnosis in 28 cases (21.2%). In the remaining 88 cases, 
PC started at first relapse or later (66.7%; figure 2); for six children PC started after a second 
cancer diagnosis. 
 
Figure 2. When did palliative care begin 
 
 
Duration of Palliative Care 
Duration of PC was computed using the start date of PC and time of death, which were 
available in 104 out of the 132 cases (79%).  Of these children, 11.5% received PC equal to or 
less than one week, 19.3% between one week and one month, 21.1% between one month and 
three months, 22.1% between three and six months, and 26% more than six months. The mean 
duration of PC was almost five months, or 146.6 days (Mdn = 89.5, SD = 182.7, range: 2 - 
1111 days). For six children (5.8%), PC began the day before their death. 
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Decision-Making Regarding Palliative Care 
Information on who was present at palliative care DM was found for 115 cases and on 
children’s involvement for 113 cases. Decision to begin PC was discussed solely with both 
parents or with one parent in 60.9% of the cases (70 out of 115), with both or one parent and 
the child in 34.8% of the cases (40 out of 115), and first with the parents and afterwards with 
the child in 4.3% of the cases (5 out of 115). Children who were included in DM were on 
average 13.6 years of age (SD = 4.6), whereas children that were not included were on 
average 7.16 years of age (SD = 3.9; table 2). 
 
Table 2. Involvement of children (n =113) 
Age Not involved (n=70) Involved (n=43) 
0 2 0 
1 1 0 
2 4 0 
3 4 1 
4 6 0 
5 12 2 
6 7 2 
7 6 1 
8 4 1 
9 5 2 
10 5 1 
11 2 2 
12 1 0 
13 6 4 
14 1 6 
15 1 5 
16 1 4 
17 2 5 
18 0 6 
19 0 1 
 
Although the participating SPOG-centers used different names (e.g. ethical committee, 
dialogue ethic), all centers generally employed discussion of ethically relevant and 
challenging issues, if indicated. Information on whether ethics relevant discussion took place 
was available for 175 cases.  In 61 cases an ethical discussion involving different professions 
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was conducted (excluding family members), and for the remaining 114 cases, no information 
on ethical discussions was found. 
Using the written statements in the medical records where information was given on 
discussions between medical professionals and family members, we categorized them into 
types of decisions and if children were included in these decisions (table 3). This resulted in 
eight types of decisions, ranging from refusing a discussion to shared DM. Most of the 
decisions were described as a one-time act. 
 
Table 3. Results from the content analysis – decision making regarding PC 
Type of 
decisions 
In which only parents were involved In which child were involved 
Parents refuse 
discussion 
(n=1) 
“(The transition) was discussed among the 
medical staff, parents refused to discuss 
it.” 
- 
Parents want 
physician to 
make the 
decision  
(n=1) 
“She (the mother) expresses the desire 
that in the case of further progression of 
the disease, she does not want to make 
that decision (to continue or stop curative 
treatment). She wants the physicians to 
make that choice...” 
- 
Withheld 
information 
from the child  
(n=5; 
children’s 
ages; 9, 16, 
11, 7, 10) 
 “The parents asked the physicians not to 
explicitly inform the child about the 
situation, and their request was 
respected.” 
- 
Patient is 
aware of 
situation 
 (n=6) 
- “Patient was also aware of the bad 
prognosis and was living his life 
in the present, without making 
any project in the long term.” 
Family 
express wish 
for palliative 
care  
(n=11) 
(n=5) 
“In light of these facts (chance of survival 
or cure very low) parents themselves 
suggested the shift towards best quality of 
life, symptom control and palliation (…), 
physicians agreed that this makes sense.” 
(n=6) 
“Family decided to receive 
palliative therapy at home, wish 
on the part of patient and family.” 
 
Agreement 
with 
physician’s 
decision 
(n=16) 
(n=10)  
“After diagnosing third relapse: 
discussion with parents; given the 
progression of a third relapse the parents 
were informed that there is no curative 
option available; Parents agreed to 
palliative care.” 
 
(n=6)  
“Palliative treatment was 
recommended to parents and 
patient; Parents and patient 
agreed” 
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Parents 
informed 
about decision 
made by the 
physicians   
(n=30) 
(n=22) 
“Because of huge suffering and the low 
likelihood to cure the patient: palliative 
therapy in order to achieve freedom from 
pain without loss of vigilance; parents 
were informed about the consensus at the 
same day.”  
(n=8)  
“They (parents and patient) were 
informed “openly and in detail” 
about infaust prognosis in case of 
progression under chemotherapy; 
from now on: palliative treatment 
with focus on symptom 
management and QoL” 
Shared 
decision 
making 
 (n=48) 
(n=28) 
“After several discussions, the parents and 
the physicians decided to stop the 
chemotherapy treatment that had been 
initially intended and to begin the comfort 
care.” 
 
(n=20) 
“The child and his family were 
told that the chances of cure were 
almost inexistent … After several 
days, the child and his family 
chose to follow the combined 
treatment (radiotherapy and 
chemotherapy through bone, with 
palliative goal).” 
 
Diagnostic groups and palliative care 
Three diagnosis-based subgroups described in the literature on paediatric cancer patients8,26,27 
were created: (1) leukaemia patients, (2) CNS neoplasms patients, and (3) patients with other 
diagnoses. These groups were compared with respect to whether a child received PC.  The 
relation between whether PC was received and the diagnostic groups was significant, Χ2 = 
30.9 (2, N = 170), p = .000, indicating that diagnostic group has an impact on whether a child 
receives PC. Post hoc tests (Bonferroni correction was applied) illustrated that patients who 
died from leukemia were less likely to receive PC (p = .000), and patients with other 
diagnoses were more likely to receive PC (p = .008) than the overall sample.  There was no 
significant result for patients with CNS neoplasms.   
Furthermore, analysis of variance between the three diagnostic groups was conducted for 
further variables related to PC, revealing that there were significant effects of diagnostic 
groups on both initiation and duration of PC (table 4). 
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Table 4. Summary of ANOVAs with respect to palliative care 
Variable  
   M (N) 
df F ω2 p 
Leukemia CNS Others 
Begin of PCb * 5.22 (23) 3.00 (47) 4.18 (61) 2 9.290 .11 .000 
Duration of PC in daysa ** 81 (22) 224 (38) 113 (44) 2 6.112 .09  .003 
Note. PC = palliative care; CNS = CNS neoplasms; Begin of PC represents an ordinal variable that corresponds to the 
nine ordered categories shown in figure 2. a Welch ANOVA (an adjusted omega squared and Games-Howell post-hoc 
test were used); b One-way ANOVA (Tukey post-hoc test was used).  
 PC started later for both leukemia patients (M = 5.2, SD = 1.6) and patients with other diagnoses (M = 4.2, SD = 2.2) as 
compared to patients with CNS neoplasms (M = 3.0, SD = 2.2). The former two did not differ significantly.  Patients 
with CNS neoplasms (M = 223.8, SD = 236.4) received PC for a longer time than both patients with leukemia (M = 81.4, 
SD = 138.6) and with other diagnoses (M = 112.5, SD = 117.6). The latter two did not differ significantly. 
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Discussion 
 
The integrated model of PC recommends that it commence alongside curative treatment5,6, 
thus ensuring that all children with life-threatening diseases benefit from this approach 
irrespective of prognosis. First, in our study sample, one out of eight children received PC at 
the time of diagnosis due to poor prognosis. For the remaining cases, there was a transition to 
PC with the realization that a curative intent would be ineffective. These results support the 
findings of Johnston and colleagues9 that most patients received PC but these referrals seldom 
occurred within a month of diagnosis. Unlike other studies10,11, we have no previous 
nationwide study to compare whether PC provision has improved in the country. However, 
recent investigations into PC in pediatric oncology do indicate that it is an important topic of 
national interest20-22,28,29. Second, 15% of our sample received PC for a week or less because 
PC was implemented very late or at the end of the illness trajectory7. Third, our results also 
indicate that the mean duration of PC of 145 days was longer than in analogous studies 
performed in Sweden8, Australia12, and the U.S.13 The longer PC duration may indicate earlier 
integration of PC in our sample, but can also be attributed to methodological differences (e.g. 
different definitions of when PC started), cultural perceptions of when a condition cannot be 
cured anymore (e.g. prognosis smaller than 10% versus 5%), or the composition of the 
sample.   
Because discussing PC is sometimes associated with loss of hope and abandonment by the 
healthcare provider16, it might be a strong argument for physicians to not call some of their 
efforts towards relieving pain and supportive care as PC and to use a less distressing term. 
There may be hesitations to discuss PC by explicitly mentioning the term (and consequently 
not recording it as such) even when it occurred or the term was avoided because supportive 
care and symptom management are generally considered parts of oncological treatment. 
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Given physicians’ tendency to avoid the term and families’ discomfort when PC is 
suggested16, it might be advantageous to use a term that is less threatening in this context, 
such as best supportive care. It has to be noted that, if this term was used (or any other term), 
it must be unambiguously defined to avoid conceptual confusion. Further, it should be clearly 
explained to families to avoid any misunderstanding associated with the terminology and, 
consequently, to help them better accept the initiation of PC at diagnosis. However, studies 
have shown benefits of providing PC consultation and including a PC specialist11,13, such as 
identifying the need of medication changes. Finally, irrespective of the terms used, this 
particular type of care has to be compassionate, individually tailored to the needs of the child 
and the family, and holistic embracing multiple domains of care such as physical, 
psychological, social, and spiritual care. Providing adequate PC also includes 
developmentally appropriate preparation for death.  
Comparisons of diagnostic groups suggest that leukemia patients began PC later than CNS 
neoplasms patients and patients with other diagnoses did, their duration of PC was shorter 
than that of CNS neoplasms patients, and they were less likely to receive PC than the overall 
sample. Also, the PC duration of patients with CNS neoplasms was significantly longer than 
for patients with other diagnoses, and the latter were more likely to receive PC than the 
overall sample. These findings relate to the Swedish study8 in which children with 
hematological malignancies received curative treatment closer to death and transitioned later 
than children suffering from brain tumors. One explanation could be the higher survival rate 
of children suffering from leukemia compared to children with other types of cancer30-32. 
Additionally, successful curative treatment protocols are available in leukemia relapses using 
different treatment modalities, such as conventional chemotherapy, high-dose chemotherapy, 
allogenic hematopoietic stem cell transplantation, and many different experimental drugs. 
Therefore, there may be greater hesitation by the healthcare provider to recommend PC at 
diagnosis, as well as higher expectations of maintaining hope in leukemia cases14,16, whereas 
Chapter 3  Palliative Care in Swiss Pediatric Oncology 
 
79 
 
for CNS neoplasms patients, comparably bad prognoses might prompt the physician to begin 
PC earlier. 
Although we did not collect data on the quality of communication and information provided, 
it was evident that parents and, in some cases, children were involved in the DM process 
(either actively in shared DM or passively in “informative” DM) and information was thereby 
given to them. Given the information in the medical records, shared DM appeared to be the 
most frequently used approach to DM in our study. While this reflects only the physicians’ 
perspectives and families may have perceived the DM process differently, this finding is in 
line with the calls for such a DM process in pediatric healthcare17,33-35. At the same time, 
contrary to the suggestion that clear and appropriate information provision is helpful for 
young patients5,17,36, in five cases, it was explicitly stated that information was withheld from 
the patient per their parents’ wishes. The WHO and pediatric association guidelines 
recommend inclusion of children in their DM2-4, which was not the case for all children in our 
sample.  Specific to Switzerland is the issue of capacity, as most children aged 14, and many 
aged 12 are considered competent37,38 and therefore legally have the right to be included in 
their DM. With respect to DM and PC, Whitney and colleagues propose that in situations 
where cure is unlikely and PC services are the best option, the physician should take the lead 
in decision making39. That is, they should exercise decisional priority by identifying the single 
best course of action and should explain to the parents (and child) that there is no curative 
treatment left and thus, quality of life becomes the new focal point. However, decisional 
authority, that is the nondelegable right of the parents to decide, remains with the parents and, 
as the child matures, decisions should be increasingly shared with the child. 
This study has several limitations. The findings are limited to the quality of information 
available in the medical records. Not all information was available, resulting in missing values 
for several variables, which, in turn, resulted in different sample sizes for some of the 
analyses. It is also possible that the extracting researchers could not find the information in 
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the medical records or that the information they were looking for, e.g. PC, was a term that was 
not used by the physicians unless it was absolutely clear that the case was end-of-life.  
However, sample sizes were sufficiently big to apply inferential statistics. Furthermore, the 
quality of information can vary across centers and individual health staff members.  As the 
medical records were written in French, German, or Italian and translated into English by our 
team, we cannot exclude linguistic differences which could affect interpretation of the data. 
During the time covered by our analysis (2008  2014), the pediatric team involved in PC 
may have changed, resulting in variations in the information documented in medical records 
over time. Finally, the views of the families and children themselves are not directly 
represented, as the information in the records is solely noted by medical staff and is their 
impression of the communication between physicians and family. It is necessary to 
understand the views of family members as well to obtain a better picture of how provision of 
PC and DM surrounding it took place. Therefore, further studies are necessary to fully capture 
the intricacies of PC for children with cancer and inclusion of children in such delicate DM.  
Limited evidence exists on this issue in Switzerland, and considering the limitations of a 
retrospective study that used medical records, prospective studies are needed to further 
strengthen research in this field. In addition to more research, the medical team and the family 
may benefit from the introduction of a standardized form for the recording PC discussions and 
decision-making. Such standardization may also improve communication within the team as 
well as with the family and, thereby, facilitate shared DM.  
In conclusion, the data on PC in the Swiss pediatric oncology settings presented in this study 
underline that only a very small proportion of the children received PC at diagnosis and for 
most children palliative care began late in the illness trajectory. These results on the timing of 
PC do not align with international organizational guidelines which recommend an integrated 
approach. However, integrated PC has been shown to be beneficial for children10,11,40 and 
therefore, must be envisaged. Additionally, since it is not only the right of children to be 
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involved in decisions that affect them, but also a need of a child23, the possibility of including 
them in DM must be considered. Furthermore, our findings from the medical records could 
help discuss the usage of the terms best supportive care and PC, which as shown from our 
data collection, seems to be a term mostly understood as the opposite of curative care. Finally, 
reasons for not including children older than 12 years need to be further examined, especially 
for the Swiss context in which capacity of judgement is not strictly defined based on age of 
maturity and minor patients between 12 and 18 years are mostly expected to be capable of 
judgement.   
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Abstract 
 
Lived experiences of childhood cancer patients and their families have been described as 
interrupted and as a loss of normal life. Apart from symptoms due to the cancer disease, 
families continuously experience burden of treatment. Since coping capacities are unique to 
each individual, we captured variables that offer objective measures of treatment burden, with 
a particular focus on the disruptive effects of treatment on families’ lives.  
Our sample was comprised by 193 children that died of cancer. Medical records were 
extracted retrospectively. Quantitative data was statistically analysed with respect to variables 
related to treatment burden.  
Deceased children with cancer and their families faced a significant burden of treatment. 
Results revealed that deceased leukemia patients had a higher number of inpatient stays, 
spent more time in the hospital both during their illness and during the last month of their life, 
and were more likely to die in the hospital when compared to deceased patients with CNS 
neoplasms and with other diagnoses.  
Our findings highlight the disruptive effects of treatment that are likely to have a great impact 
on families’ daily life, that go beyond exclusively focusing on side effects, and that needs to 
be taken into account by the treating staff. 
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Introduction 
 
Worldwide, approximately 200.000 children are diagnosed with cancer each year, among 
them 50.000 from high-income countries with a survival rate around 80%1. Living with a life-
threatening disease like cancer represents a burdensome and difficult time for both the 
pediatric patient and the family2. 
 
The Cancer Experience for Children and their Families 
A cancer diagnosis marks an abrupt break in life. Lived experiences of children with cancer 
and their families have been described as an interrupted one with limited opportunities to 
engage in leisure activities and difficulties in sustaining existing friendships3-5. Cancer 
diagnosis of a child is often described as a loss of normal family life2,6,7. Moreover, children 
diagnosed with cancer experience being isolated from friends and family members 8,9, which 
may have negative consequences on their well-being10-12.  
The interruptive effect of cancer on the everyday life of the child as well as his or her family 
can be attributed to the treatment procedures, their corresponding appointments, and waiting 
times4. In a qualitative study, children evaluated the latter as an even more significant stressor 
than the treatment itself because during waiting times they feel alone and anxious about what 
will follow13. Other studies show that children experience treatment procedures as highly 
stressful and their situation as one of having no choice but to undergo treatment5,14. In light of 
the changes that a cancer diagnosis brings, families seek to maintain as much of their former 
life as possible4,15. It is thus recommended that the inpatient stays of a child should be limited 
to what is necessary by drawing on outpatient visits and provision of care at home16,17. In 
support of this recommendation, a study found that when chemotherapy treatment was 
provided at home versus in the hospital, children had more opportunities to engage in normal 
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activities, parents were financially less burdened and saved time, and families’ overall life 
was minimally disrupted18.    
In cases where children died due to cancer, studies found that most parents not only plan for 
their child’s death, but they also favor their home as the location for death as well as for end-
of-life care19-21. Besides the explicit parental wish that the child dies at home, various other 
determinants of place of death for children dying due to cancer have been identified, for 
example, diagnosis, length of last hospital admission, ethnicity, gender, or a child’s age22-24. 
However, a systematic literature review found no compelling evidence that families opt home 
as the place of death25. 
 
The Burden of (Cancer) Treatment      
Apart from symptoms due to the underlying cancer disease, families continuously experience 
burden due to the treatment(s) that the child must undergo. Burden of treatment is different 
from burden of illness. The latter expression rather refers to the physical and psychological 
effects caused by the illness26. The former points not only to the treatment side effects but to 
the burden which is associated with the treatment of an illness27; and “encompasses (among 
other things) the disruptive effects that treatment has on working lives (for example, having 
to repeatedly go to clinics for tests) and on social lives (for example, having to curtail 
activities because of treatment side effects)”28. Moreover, according to a literature review on 
the different conceptualizations of burden of treatment, the latter is in its nature dynamic, 
comprises both subjective and objective dimensions and distinguishes between antecedents 
and consequences of burden27. Finally, burden of treatment theory refers to the importance of 
relational networks when facing treatment because these “collective agents” are able to 
provide more resources than the individual patient29. 
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Even though burden of treatment is unavoidable, it can function as an indicator for the quality 
of care provided or managed by the health care team28. A better understanding of burden of 
treatment may facilitate an improved understanding of the family’s situation and preferences 
which, in turn, is a prerequisite for a minimal disruptive medicine that reduces patients’, 
families’, and caregivers’ overall burden26.  
 
Study Purpose 
Although it is understood that childhood cancer entails high burden of treatment as well as 
high burden of illness, there is a lack of studies that allow complete understanding of burden 
of treatment for children with cancer and their families. Our empirical work seeks to assess 
different indicators of burden of treatment for children who died of cancer through a study 
carried out in Swiss Pediatric Oncology Group (SPOG) centers. Since coping capacities are 
unique to each individual, we captured variables that offer objective measures of burden of 
treatment, namely time periods and count information, with a particular focus on the 
disruptive effects of treatment on families’ lives. Examples of such variables include the 
number and duration of a child’s inpatient stays which, among others, cause the above 
mentioned disruptive effects on families’ daily lives. We retrospectively extracted these 
variables from medical records of children who died due to childhood cancer. This paper 
addresses two research questions: (a) a data based description of what the actual burden of 
treatment for childhood cancer patients who died of the illness and their families is in 
Switzerland, and (b) whether burden of treatment differs by different types of cancer. 
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Methods 
 
Study Design 
In Switzerland, there are nine SPOG-centers. We collected data from seven of them based on 
prior research collaboration. A retrospective review of medical records of pediatric oncology 
patients who died between 1 January 2008 and 31 December 2014 was conducted. Ethical 
approval was obtained from the responsible ethics committees in Switzerland.  
       
Study Population 
We extracted information from medical records of children who met the following inclusion 
criteria: the child (a) was diagnosed with cancer and received treatment in one of the 
participating SPOG centers, (b) was less than or equal to 18 years of age at diagnosis, and (c) 
died of cancer or treatment-related complications. We obtained information on which 
children died at each participating SPOG center from the Swiss Childhood Cancer Registry 
(SCCR). This information enabled us to exclusively search for children that met the inclusion 
criteria (note: SCCR includes information on both living and deceased pediatric oncology 
cases and reports data on adolescents up to 20 years of age). This study confined their 
analysis to children who died due to childhood cancer in response to our previous project on 
children’s inclusion in treatment-related decision-making in which we were unable to recruit 
palliative cases due to hesitancy to bring up this issue within discussions with families30-33. 
Therefore, to examine decision-making regarding palliative care we decided to exclusively 
analyze medical records of deceased children.  
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Data Extraction Form 
A data extraction form was designed to gather data on the following aspects from the medical 
records: a) demographics, b) diagnosis and relapse(s), c) treatments received, d) decision-
making in the course of treatment, and e) death of the child. Items were developed from the 
research team’s knowledge in the field and based on discussions with collaborating 
physicians. The extraction form consisted of items with categorical responses (e.g. center, 
sex, diagnosis), continuous variables (e.g. age, number of inpatient stays, time being 
inpatient), and open-ended items (e.g. Please note any information about the transition from 
curative to palliative phase). The data extraction form was used as a digital version (i.e. 
Microsoft Word document).  
 
Data Collection 
Before starting data collection, we contacted the collaborating physician of the respective 
SPOG-center in order to be referred to the SPOG-center’s data manager who is responsible 
for research-related data requests. The data manager created access to the archive, organized 
working spaces, and remained at our disposal for further questions. Most medical records 
were available in paper form. In cases of already digitalized records, we extracted the 
relevant information from the digital records. Four research assistants gathered relevant data 
from the medical records using the extraction form. Data was collected center by center and 
on-site between July 2015 and July 2016. Researchers discussed the first five extractions 
aiming for standardization of extracting and continuously discussed their extractions, when 
needed. Each child was anonymized through a participant code at the time of extraction. This 
code was created based on a predefined algorithm. 
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Study Sample 
Based on the list that was provided by SCCR 201 children died during the study period and 
were treated in one of the participating SPOG-centers. For seven cases, in consultation with 
collaborating oncologists the research team decided that the diagnosis was non-cancer and 
therefore excluded them, and one child was over the age of 18 years at diagnosis. After 
excluding these eight cases, a final sample of 193 cases remained. 
 
Statistical Analyses 
A research assistant entered all extracted records into SPSS.22 (SPSS Inc, Chicago, IL) and 
another randomly checked 15% of the data for correctness of data entry. Statistical analyses 
were performed using SPSS.22 (SPSS Inc, Chicago, IL). Since not every item of the 
extraction form was always contained in all medical records or could be found, sample sizes 
for some variables were less than the total number of data collected (N = 193). Information 
on palliative care and transition to palliative care are discussed in another paper. Related to 
the goal of this project, children’s and families’ burden of treatment was measured using the 
following seven variables: (a) number of inpatient stays, that is, the sum of all inpatient stays 
a child went through (n = 162); (b) total time being inpatient representing the durations of all 
inpatient stays (n=162); (c) duration of illness, which was defined as the time between 
diagnosis and death of the patient, thereby capturing the total time span a child had lived with 
illness (n = 185; This definition intends to capture both active treatment and in-remission 
time spans with the underlying rationale that even in periods when the child was in remission 
families’ daily life was still somehow affected by the illness, for example by regular follow-
up appointments, uncertainty because of possible relapses, or long-term effects on physical 
and psychological health.); (d) inpatient-proportion was computed using b and c (n = 154), 
for example, a patient was hospitalized 30 days and the entire duration of illness was 180 
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days, the percentage equals 16.7%; and (e) days being inpatient during the last month of a 
child’s life, that is, burden through hospitalizations in the last month of their lives (n = 157). 
Finally, we analyzed (f) where a child died, namely at home or in the hospital (n = 161), and 
(g) who was present at death (n = 119).  
In a first step, variables were analyzed descriptively. In a second step, we compared three 
diagnosis-based subgroups within our sample of deceased childhood cancer patients, namely 
leukemia patients, CNS neoplasms patients, and patients with other diagnoses employing 
analysis of variance and Chi-square test of independence. For the analyses, reported P values 
are 2-sided and statistical significance level was set at P < .05. 
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Results 
 
Characteristics of the Sample 
Fifty-five percent (107 of 193) of the deceased children were male. Mean age at diagnosis 
was 7.2 years, ranging from 0 to 17 years of age. Of the 12 categories (I-XII) of International 
Classification of Childhood Cancer 3 (ICCC), the most frequent diagnoses were as follows: 
CNS neoplasms (ICCC-III, 34.2%) and leukemia (ICCC-I, 27.5%). The other ten categories 
were also represented in our sample, and we collapsed the least six as “others” (table 1). 
  
 
 
 
 
 
As expected, compared to the SCCR, a national dataset that includes all children diagnosed 
with cancer 34, due to the different mortality rates, leukemia was underrepresented in our 
sample of deceased children (27.5% vs 33.6%), whereas CNS neoplasms (34.2% vs 22.9%) 
and neuroblastomas were overrepresented (11.9% vs 6.1%). Patients’ age was overall 
comparable to SCCR (in bracket): 0-4 years 37.8% (35.4%), 5-9 years 26.9% (21.3%), 10-14 
years 24.4% (22.7%), and 15-18 years 10.9% (20.6%). 
In most of the cases (77.3%; 140 out of 181 children) cancer treatment protocols were 
followed at diagnosis. In more than half of the cases (54.4%; 99 out of 182) other hospitals 
Table 1: Sample characteristics (N = 193) 
Demographics 
Mean (Mdn, SD) 
Percentage 
Sex (male) 55.4% 
Age at diagnosis 7.2 (6.0; 5.1) 
Age at death (n = 179)  9.8 (9.0; 5.2) 
Main diagnostic groups according to ICCC Percentage 
CNS neoplasms (III) 34.2% 
Leukemias (I) 27.5% 
Neuroblastoma & other peripheral nervous cell tumours (IV) 11.9% 
Malignant bone tumours (VIII) 8.3% 
Lymphomas & reticuloendothelial neoplasms (II) 6.2% 
Soft tissue & other extraosseous  sarcomas (IX) 6.2% 
Others  5.7% 
Note. ICCC = International Classification of Childhood Cancer 3  
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were consulted for further support or advice. More than three quarter of the children received 
palliative care (77.6%, 132 out of 170, palliative care is defined here as opposed to curative 
care, i.e. palliative care means here a supportive care approach that was taken once it was 
agreed that the treatment goal was not anymore curative). This finding means that almost one 
quarter of the deceased children died during supposedly curative care and did not go through 
a phase where it was transparent that they were dying and during which they received only 
supportive palliative care (22.4%, 38 out of 170). Among them, 9 children died due to 
unexpected complications or side effects of the treatment. 
 
Burden of Treatment 
Our analysis focused on variables indicating deceased children’s burden of treatment (table 
2). On average, children from our sample had 13 inpatient stays during their illness course, 
which amounted to 117 days in the hospital. During the last month of their lives, the deceased 
children were hospitalized for an average of 10 days.  
 
Table 2: Variables indicating burden of treatment 
Variable 
Median (M, SD) 
Percentage 
Nr. of inpatient stays (n = 162) 12.0 (13.0, 9.2) 
Days being inpatient (n= 162) 102.5 (117.3, 92.8) 
Illness duration in months (n = 185)  19.0 (30.6, 34.2) 
Inpatient days/ last month of life (n = 157) 5.0 (10.0, 10.8) 
Inpatient-proportion in percent (n = 154) 15.0 (26.0, 24.8) 
Child died at home (n = 161) 43.5% 
Parents were present at death (n = 119) 96.6% 
 
Overall, the majority of the children did not die at home: 55.9% died in the hospital (90 out of 
161) and 0.6% (1 out of 161) in a supportive care center. Still, a relatively large minority of 
43.5% of the children died at home (70 out of 161). Looking only at those children who 
received palliative care (and for whom we were able to gather information on location of 
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death), the numbers change as follows: 53.7% died at home (66 out of 123), 46.3% in the 
hospital (57 out of 123). At the time of death, in almost all of the cases parents were present 
except for 4 cases. 
Figure 1 provides detailed information on burden of treatment, that is, number of inpatient 
days, time spent in inpatient care, and illness duration. First, deceased children’s burden due 
to the number of inpatient stays ranges from 1 to 39 stays with almost one third of them 
having more than 16 inpatient stays. Additionally, one in ten children was admitted to the 
hospital more than 25 times during the entire illness period (figure 1). Second, concerning 
inpatient time, ranging from 2 to 581 days, one in six children lived in the hospital for 6 
months or more (figure 1). Also two-fifths of the sample had between 3 and 6 months of 
inpatient stays. Third, the overall duration of illness ranged from 1 day to 5582 days 
(equaling around 183 months or 15 years, respectively), with more than one third of the 
children undergoing treatment for less than one year and almost one in five children for more 
than 4 years.   
 
Figure 1: Inpatient stays and illness duration 
 
     Note. w = week; m = month; y = year. 
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To further understand the burden of treatment in our sample, we computed the percentage of 
time spent in the hospital during the entire duration of illness. The results show that almost 
one third of our deceased children sample spent less than 10% of their time during their entire 
illness duration in the hospital and more than one quarter between 10% and 20%. Almost one 
in eight children spent more than half of their illness duration in the hospital (figure 2). 
Furthermore, 29% of the children were hospitalized between one and ten days during the last 
month of their life, and one in ten children was hospitalized the entire last month of his or her 
life (figure 2). Moreover, an exploratory independent samples t-test revealed that children 
who died during curative treatment spent significantly more days in the hospital (n = 24, M = 
16.8, SD = 11.7) than children who died during palliative care (n = 112, M = 8.2 days, SD = 
9.7), t (134) = -3.779, p = 0.000.   
 Figure 2: Inpatient-proportion and days being inpatient during last month 
 
 
     Note. d = day; m = month. 
 
Burden of Treatment: Comparisons among Diagnostic Groups  
Based on the twelve diagnostic categories of ICCC of our sample, we reclassified them into 
those who died with: a) leukemias (27.5%), b) CNS neoplasms (34.2%), and c) other 
diagnoses (38.3%). Leukemia and CNS neoplasms were chosen to represent individual 
groups because they formed the two biggest groups in our sample and were already used in 
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studies on pediatric oncology 22,23,35. Since summing up the remaining ten categories of ICCC 
resulted in a comparably big subgroup, they were grouped into the residual category “other 
diagnoses”. Hereinafter, this diagnosis variable is referred to as “three diagnostic groups”. 
Subsequently, analysis of variance (table 3) and Chi-Square test of independence were 
conducted for variables related to children’s burden of treatment.  
 
Table 3: Summary of ANOVAs 
Variable  
M (N) 
df F ω2 p 
Leukemia CNS Others 
Nr. of inpatient staysb 14.3 (44) 8.2 (50) 15.8 (68) 2 11.818 .12 .000 
Days being inpatienta 155.8 (44) 85 (50) 116 (68) 2 7.461 .05 .001 
Illness duration in daysb 857.4 (50) 933 (64) 986 (71) 2 0.220 - .802 
Inpatient-proportion in percentb 36.7 (41) 21.9 (49) 22.3 (64) 2 5.510 .06 .005 
Inpatient days/ last month of life b 15.8 (46) 6.6 (49) 8.4 (62) 2 11.035 .11 .000 
Note. CNS = CNS neoplasms; df = degrees of freedom (between); F denotes the F statistic used with ANOVAs;           
ω2 denotes the effect size omega squared, an adjusted omega squared was used for Welch ANOVA; p = p-value; 
Depending on homogeneity of variance, Welch ANOVA or One-way ANOVA was used. a Welch ANOVA; b One-way 
ANOVA. 
 
 Analysis of variance revealed that there were significant effects of the diagnostic groups on 
the deceased children’s number of inpatient stays, the days being inpatient, the inpatient-
proportion, and inpatient days during the last month of life. Post hoc comparisons for the four 
significant results were conducted in order to see which diagnostic group or groups differed 
from one another. 
First, with respect to the number of inpatient stays, a post hoc Tukey test showed that both 
leukemia patients (M = 14.3, SD = 9.0) and patients with other diagnoses (M = 15.8, SD = 
9.0) had significantly more inpatient stays than those patients with CNS neoplasms (M = 
8.16, SD = 7.9). There was no significant difference between leukemia patients and patients 
with other diagnoses (figure 3). 
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Second, for days being inpatient, a post hoc Games-Howell test revealed that leukemia 
patients (M = 155.8, SD = 122.0) had significantly more days being inpatient than patients 
with CNS neoplasms (M = 84.5, SD = 88.9). No other pairwise post hoc comparison revealed 
a significant difference (figure 3). 
Third, concerning inpatient-proportion, a post hoc Tukey test showed that leukemia patients 
(M = 36.7%, SD = 26.4%) spent significantly more time of their overall illness duration in the 
hospital than both patients with CNS neoplasms (M = 21.9%, SD =  27.8%) and those with 
other diagnoses (M = 22.3%, SD = 19.0% ). The latter two did not differ significantly (figure 
3). 
 
Figure 3. Comparisons among diagnostic groups 
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Fourth, regarding days being inpatient during the last month of life, a post hoc Tukey test 
showed that leukemia patients (M = 15.8, SD = 10.9) were hospitalized for more days than 
both patients with CNS neoplasms (M = 6.6, SD = 9.8) and the remaining with other 
diagnoses (M = 8.4, SD = 9.7). The latter two did not differ significantly (figure 3). 
Finally, the relation between the place of death (at home or in the hospital) and the diagnostic 
groups was significant, Χ2 (2, N = 160) = 15.9, p = .000, V = .32, indicating that the 
diagnostic group has an impact on whether a child dies at home or in the hospital. Post hoc 
tests (Bonferroni correction was applied) revealed that leukemia patients (81.8%) were more 
likely to die in the hospital (p = .000) than the total sample (56.5%). There was no significant 
result for patients with CNS neoplasms or for patients with other diagnoses (figure 3). 
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Discussion 
 
Overall, assessing the treatment-related burden descriptively reveals that deceased children 
with cancer and their families face a significant number of inpatient stays and long 
hospitalizations. Undoubtedly, the many inpatient visits lead children to miss out on school 
and parents from work, changes in both familial and social relations, limited opportunities for 
leisure time activities, as well as a general physical and psychological strain. Such effects of 
childhood cancer are described as “rough spots”36-38. Since our sample was exclusively 
comprised of children who died due to cancer, they may have faced a higher burden of 
treatment. As a consequence, further research examining burden of treatment among children 
who survived is needed.  
 
Deceased Leukemia Childhood Cancer Patients: The Higher Burden of Treatment 
Specifically, deceased leukemia patients faced an almost double burden (number of inpatient 
stays and time being inpatient) compared to those patients with CNS neoplasms. It is evident 
that, as for children with other cancer diagnoses, leukemia patients’ quality of life is affected, 
by changed relationships with family members and friends and by decreased number of 
participation in social activities39,40. Furthermore, it is shown that leukemia patients must 
cope with a higher burden of disease, measured by patient-reported functioning than patients 
with CNS/solid tumors 41. Besides, our findings of more and overall longer inpatient stays for 
deceased patients with leukemia is particularly relevant, since burden of treatment for 
children with leukemia might be underestimated given the comparably good prognosis for 
this diagnostic group41 and leukemia being the most common type of childhood cancer. Such 
an underestimation might result from the so-called halo-effect, that is, the tendency to let one 
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key characteristic of a person or a situation (e.g. very good prognosis) outshine other 
characteristics (e.g. burden due to the disease and treatment)42.  
Regarding the percentage of time spent in the hospital during the entire duration of illness 
(inpatient-proportion) and the number of days being inpatient during the last month of life our 
findings reveal that our sample of leukemia patients spent more time in hospital than the 
other diagnostic groups, both during their entire illness and during the last month of their life. 
These results correspond to a study which reported longer last hospital stays for leukemia 
patients 23. One study found an association between more than 10 hospital days during the 
last month of life and lower quality of care ratings by physician43. Against the background of 
relationship between longer hospitalizations and quality of care, the highly interrupted daily 
life3,4, difficulties to maintain social relationships and accompanying isolation9,10,12, and 
affected familial relations6,9 especially apply to leukemia patients. Spending more time in the 
hospital not only decreases the odds of benefitting from protective factors, it also magnifies 
children’s major stressors, for example, those associated with treatment procedures, loss of 
control and the hospital environment14. In addition to the higher burden due to treatment 
found in our study, another revealed that hospitalized children were also burdened by more 
symptoms than outpatients44.  
Finally, compared to the overall sample leukemia patients were less likely to die at home. 
Similar results were reported in two US studies22,23. Low home death rates are not 
problematic per se as a literature review concluded that evidence is lacking for the notion that 
most families wish for death at home25. With respect to our results, it needs to be further 
examined why leukemia patients are less likely to die at home and relevant other factors that 
determine place of death, such as sex of the child or educational level of the mother24. If 
parents of deceased leukemia patients or the children themselves are less likely to prefer 
home as the place of death, for instance, because of a higher stress and strain of providing 
Chapter 4  Burden of Childhood Cancer Treatment  
103 
 
end-of-life care at home as compared to children with other cancer diagnoses, the lower 
proportion of death taking place at home can be attributed to parental or children’s wishes 
and are therefore justified. On the contrary, if they show the same preference for home as the 
place of death as other parents and children, the treating staff should facilitate the realization 
of these preferences. In the latter cases, realization of parental (or children’s) preferences is 
vital because parental adaptation after a child’s death is better when a child died at home and 
parents whose child died in the hospital reported higher ratings of depression45,46. However, 
lower home death rates for leukemia patients may have resulted from the fact that this 
diagnostic group was more likely to die because of therapy-related complications, but not due 
to progression of the disease which hinders the timely transition to palliative care at home 
23,47. In fact, it was shown that in cases of progressive cancer higher efforts were made to 
suggest home as the place of care and, if wanted, of death23. Lastly, in our sample 53% of the 
children who received palliative care died at home. This home death rate is comparable to 
home death rates reported in other studies from Brazil with 59%, Australia with 61%, and 
England with around 40%24,48,49.  
Although burden of treatment is a currently emerging field, it is still lacking specific research 
as well as theoretical development27,28. Our findings reflect antecedents of burden of 
treatment, namely treatment characteristics of children who died due to cancer. Being 
confronted with a higher burden of treatment, pediatric leukemia patients and their families 
are particularly vulnerable. For example, more hospitalizations mean more interruption of 
daily life, longer hospitalizations lead to a higher likelihood of changes in relational networks 
and more absence from work or school. These effects, in turn, negatively affect both 
antecedents (e.g. support by a social network) and consequences of burden of treatment (e.g. 
quality of life, adherence). From this perspective, it can be argued that a high burden of 
treatment is associated with less favorable health care outcomes26.  
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Burden of treatment theory argues that patients’ ability to participate in the provided 
treatment, termed “agency”, is dependent on social networks that support individual agents, 
termed “relationality”29. Furthermore, the authors identify a group of persons, not the 
individual patient, as the adequate unit of analysis29. When thinking about burden of 
treatment of pediatric cancer patients, both notions are particularly relevant because pediatric 
patients are highly dependent agents. They have to rely on their parents for mobility, 
finances, and participation in treatment-related decision-making. Additionally, the child’s 
cancer disease becomes a life-changing experience for the whole family, calling for family to 
be the unit of analysis. A higher burden of treatment for children who died of leukemia 
translates itself into a higher burden for the entire family unit. Therefore, health care 
professionals could aid in reducing the burden of treatment when they are better aware of the 
characteristics of leukemia treatment and by constantly applying this awareness to the entire 
family.  
           
Limitations 
This study has several limitations. First, the analysis of medical records is necessarily limited 
to both the available information in the records and to the quality of the information. Second, 
it is possible that the extracting research assistants may have overlooked relevant 
information. Both these factors may have contributed to missing values which, in turn, 
resulted in different sample sizes for some of the analyses. Researchers tried nevertheless to 
gather all relevant information by thoroughly extracting, and by asking the collaborating 
physicians for support. Third, since data collection took place at different centers, 
information in the records is not presented in a consistent manner which could have affected 
the extracted data. Fourth, medical records were written in French, German, and Italian and 
extracted in English. Accordingly, inter-extractor agreement with respect to linguistic 
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nuances could be limited. However, researchers discussed a set of extractions and continued 
discussing throughout time of data collection. Fifth, our sample of deceased children is 
subject to a selection bias. However, we think that our results on number and duration of 
inpatient stays can be transferred to some extent to the sample of children with cancer who 
would survive. 
Finally, retrospectively examining the duration and number of inpatient stays naturally does 
not capture the quality of these hospitalizations that could be indicated by the work of the 
psychosocial team, by the access to spiritual care or by the palliative approach within a 
hospital. Besides, exclusively focusing on the location of end-of-life care and of death does 
not obtain a complete picture of the quality of end-of-life care which requires considering 
additional factors such as the palliative concept of the respective ward, the parental 
preferences, demographic characteristics or collaboration between inpatient and outpatient 
settings. Generally, more time spent in the hospital does not necessarily indicate lower 
quality of life for the child. On the contrary, in some cases hospitalizations may be 
experienced positively. For example, an inpatient setting can evoke a feeling of certainty on 
the part of the family, allows psychosocial and spiritual care, facilitates certain activities and 
therapies that are not available at home, or provides relief for caregiving parents. Capturing 
these indicators of quality of care and quality of life cannot be achieved by a retrospective 
analysis of medical records, but necessitates a prospective qualitative study which addresses 
the experiences of the patient and the family. Nonetheless, as shown above current research 
seems to validate the view that inpatient stays represent burdensome experiences for the child 
and the family. Besides, it is self-evident that higher numbers of inpatient stays eo ipso lead 
to more disruptive effects on families’ daily lives with all consequences for social 
relationships, leisure activities, or psychological and physical well-being discussed above. 
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Therefore, interpreting number and duration of inpatient stays as indicators (not sole 
determinants) of burden due to treatment is legitimate. 
 
Conclusion 
Our findings reveal that deceased children with cancer and their families face a high burden 
of treatment. However, on average deceased pediatric leukemia patients and their families are 
burdened by more and longer inpatient stays, by a higher proportion of inpatient-stays, by 
spending more days in the hospital during the last month of the child’s life, and by a higher 
likelihood of the hospital as the location of death. Their comparably good prognosis may be 
causing an unintentional underestimation of their burden of treatment. Health care 
professionals (in both inpatient and outpatient settings) who are involved in the treatment of 
this especially vulnerable patient group should, if possible, mitigate burden of treatment and 
shape treatment regimes in close collaboration with the family aiming for a minimum of 
disruption and of changed daily life. That is, the treating staff not only should keep treatment 
throughout the course of the illness (including end-of-life) on an effective and necessary 
minimum, but also has to work towards understanding what kind of impact treatment and 
treatment-related aspects have on family’s and children’s daily lives26. Indicating burden of 
treatment, our findings enable physicians and nurses to better grasp and understand what is 
imposed upon the patient and the family, for example, in terms of inpatient stays and 
accompanying factors. Finally, burden of treatment was analyzed in this paper using 
objective variables extracted from medical records highlight the disruptive effects of 
treatment that are likely to have a great impact on their daily life and that go beyond 
exclusively focusing on side effects on the part of the child as indicators of treatment burden. 
Thus, it emphasizes the claim to think about burden of treatment from a family perspective.   
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Abstract 
  
Background: Health care providers’ perception of pediatric palliative care might negatively 
influence timely implementation. The aim of the study was to examine understanding of and 
attitudes towards pediatric palliative care from the perspective of health care providers 
working in pediatric oncology in Switzerland to promote the timely implementation of 
pediatric palliative care. 
Methods: Five mixed focus groups were conducted with 29 health care providers 
(oncologists, nurses, psychologists, and social workers) at five Swiss pediatric oncology 
group centers. The focus group interviews were analyzed using thematic coding. 
Results: Most participants associated pediatric palliative care with non-curative treatment. 
They regularly reported difficulties in addressing palliative care services to families due to 
the strong stigma surrounding this term. They also thought that the notion of palliative care is 
very much linked to a policy context, and difficult to reconcile with children’s everyday life. 
To overcome these obstacles many participants used synonyms such as comfort or supportive 
care. A few providers insisted on the need of using palliative care and reported the 
importance of positive “word of mouth”. 
Conclusions: The use of synonyms might be a pragmatic approach to overcome initial 
barriers to the implementation of palliative care in pediatrics. However, this tactic might 
ultimately prove to be ineffective as these terms might acquire the same negative 
connotations as palliative care. Positive word-of-mouth by satisfied families and healthcare 
providers might be a more sustainable way to advocate for pediatric palliative care than 
replacing it with a euphemistic term.  
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Background 
 
Since its introduction in 1975 the term palliative care (PC) has been subject to 
fluctuations in meaning1-5. For almost two decades the term has been used 
interchangeably with hospice, end-of-life or terminal care3. In 1990 the World Health 
Organization (WHO) shifted away from the “end-of-life” mindset by stating that 
palliative care is applicable earlier in the course of illness, in conjunction with 
anticancer treatment. This definition was further amended in 2002 when PC was 
uncoupled from prognosis and the target population was broadened to include patients 
facing a life-threatening condition2,5. 
The current gold standard approach in PC, as defined by the World Health 
Organization (WHO), consists of the concurrent administration of curative treatment 
and PC with attention to patients’ physical, psychological, social, and spiritual needs. 
The definition provided by the WHO6 is said to be a philosophical, rather than a 
dictionary definition7 as it does not just report what “palliative” literally means (“the 
alleviation of suffering”), but invokes certain values (e.g. patient-centeredness, holism 
and multidisciplinarity) that are aimed to guide action and improve practice1,8. The 
principal aim of PC is to maintain the quality and the meaningfulness of life for both 
patients and their families. Unlike hospice care, PC is not limited to terminal care, but 
is appropriate for patients in all disease stages6. 
Within pediatrics and in pediatric oncology the early implementation of PC has been 
widely endorsed9,10 as it has been associated with improved survival and quality of life11-
17. According to the “Cancer Pain Relief and Palliative Care in Children” document18, 
pain management for children should start at diagnosis and continue throughout the 
course of illness alongside curative treatment. Despite these recommendations, patterns 
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of late referral continue to persist in pediatric oncology16. As a result, many children – 
like many adult patients – do not benefit from pediatric palliative care (PPC) or at least 
not in a timely manner19. Clinical reality appears thus to lag behind the paradigm shift 
made within PPC guidelines19-21. This suboptimal integration of PPC leads to a paradox: 
if the early introduction of PPC is beneficial to the child’s and family’s well-being, then 
why is there such reluctance to implement this principle in medical practice22? 
Studies exploring barriers to PC have focused mainly on PC in adult healthcare23-31. 
Given that the group of pediatric patients with PC needs is  considerably smaller 
compared to the adult patient group, fewer studies, with some noteworthy exceptions, 
have focused on barriers to PC in pediatrics20,32-34 and evidence specific for pediatric 
oncology is rather limited35. Of these studies, the majority have used quantitative 
methods and/or focused on the perspective of a single type of pediatric healthcare 
provider. In all these studies family and patient reluctance to accept PPC  is  often  cited 
as an important (perceived) barrier to early integration13,32,36 and related to 
misconceptions of PPC goals due to its equation with death and dying37. 
Still, a recent survey study on pediatric cancer patients’ and parents’ attitudes toward 
early integration of PPC in oncology seems to debunk the myth that parents and children 
are not ready to integrate PPC13. Interestingly, the study found that for the majority of 
children and parents who participated in the study, the term “palliative care” was 
unknown. In the survey, the researchers described the PPC team as “a group of clinicians 
with expertise in symptom management and a goal of improving quality of life”. These 
findings suggest that patients’ and parents’ attitudes toward PPC integration is 
influenced by the way in which PPC is explained28 and that (in) adequate understand- 
ing of PPC by healthcare providers may bias families’ attitudes and decisions towards 
the integration of PPC. 
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In Switzerland the knowledge gap regarding palliative care among lay people is still 
great38 and awareness of children’s unique PPC needs is scant compared to other countries 
like the UK39. Those who are familiar with the notion of palliative care associate it with a 
type of care that focuses on quality of life when faced with an incurable illness. A recent 
retrospective analysis of medical records of deceased pediatric patients has shown that 
late and non-referrals are still very common in the Swiss oncology setting and that a 
dualistic model of curative and palliative care continues to prevail40. Since health care 
providers’ perception of PPC might influence that of parents and children, the present 
study aimed to examine the understanding of and attitudes towards PPC in Switzerland 
from the perspectives of health care providers working in pediatric oncology centers. 
In order to gain a richer, more detailed account of staff members’ attitudes toward 
PPC and to identify possible socio-cultural factors that influence their perceptions, 
we conducted focus group discussions with various stakeholders in the field of 
pediatric oncology: oncologists, nurses, psychologists, and social workers. The 
study goal is particularly important given that health care providers might 
unwittingly associate PPC with end-of-life care even if they claim to support the 
early introduction of PPC32. Thanks to their interactive nature, focus groups 
provide access to data that might be less easily obtained through surveys or 
individual interviews as some thoughts can only be probed within a group 
context41. Furthermore, in order to develop appropriate interventions that im- prove 
PPC provision within the field of pediatric oncology, it is important to listen to 
different care providers, especially in the Swiss context where PPC is usually 
provided by the primary oncology team rather than by PPC specialists. Since 
divergence of opinions on PPC is not uncommon among team members and might 
lead to an inconsistent message about PPC in interaction with families42, we 
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intentionally used a mixed focus group approach. Finally, it is increasingly 
recognized that qualitative insights play an important role in closing the policy- 
implementation gap43-45, this is particularly relevant for the PPC context where 
(conceptual) implementation barriers continue to persist despite the development of 
educational programs, PC’s increased focus on quality of life (rather than on death) 
and its overall beneficial outcomes. 
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Methods 
 
This study is part of a larger project on end-of-life decision-making in pediatric 
oncology where (a) surveys were carried  out with  physicians  and parents  and b) 
interviews were conducted with children suffering from childhood cancer, their parents, 
and physicians; and (c) a retrospective data collection from medical records was 
performed40,46-48. For this qualitative part of the study, mixed focus groups were 
conducted with health care providers at five of the nine Swiss pediatric oncology group 
centers (SPOG): three out of six centers in the German-speaking part of Switzerland, 
and both of the two centers in the French-speaking part. The remaining four SPOG-
centers decided not to participate in the focus groups due to lack of time. Approvals 
were obtained from the respective cantonal research ethics committees.1 
For each SPOG a reference person was identified who helped with participant 
recruitment and focus group scheduling. The reference person informed all members 
about the overall aim of the focus groups and their confidential nature. Upon consent of 
the participants, the recruiter then gave the research team a list of team members who 
had expressed interest to participate. Each of these persons received the participant 
information sheet from a member of the research  team  via email, immediately after 
recruitment and then again (as a reminder) some days before the actual date  of  the 
focus group discussion to give participants enough time to read over the participant 
sheet.  The research team sent a request to all participants to find a common time to 
carry out the focus group discussions.  Since initial recruitment happened with the 
mediation of a reference person it was difficult to establish how many persons refused 
to participate (mainly because of lack of time). 
Focus groups were carried out by the first and second author between August 2016 and 
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June 2017 at the SPOG centers at a time agreed upon by all participants. At the time of 
the interviews, the first author was a postdoctoral researcher with a background in 
philosophy and ethics. The second author was a doctoral student with a back- ground in 
psychology and ethics. Both researchers had experience with conducting interviews. The 
total number of participants for each discussion varied between 4 and 8 healthcare 
providers. Oral informed consent was sought from all participants prior to the start of the 
focus group and registered upon consent. From an ethical point of view, for minimal risk 
research involving interviews studies with health care professionals whose data 
(transcripts or questionnaires) are anonymized, oral consent and active participation are 
ethically considered sufficient and proportionate. Furthermore, in Switzerland interviews 
with health care professionals (not patients) are outside of the human research act and do 
not require ethics commit- tee approval. To make sure that our experts were clearly 
informed, at the beginning of the discussion, the moderator briefly restated the purpose 
of the overall project, their role in the project and allowed participants to ask questions. 
A semi-structured interview guide framed each focus group discussion. The guide was 
built on the data obtained from a retrospective review of medical records of children who 
died at the SPOGs between 2008 and 201440 and on the experiences of the research 
team during prior phases of the overall project. In order to fine-tune the questions the 
interview guide was evaluated by a collaborator working at a SPOG. Questions 
included information about (a) the participants’ personal understanding of PPC, (b) 
the institutional attitude towards PPC, (c) discussions and communication processes 
with parents and children regarding PPC, (d) perceived obstacles to the implementation 
of PPC and (e) institutional referral practices. Questions on topics (c) to (e) were 
discussed with reference to a specific recent case that the team encountered.  Most of 
the data presented in this paper derives from the questions related to topics (a), (b) and 
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(d) as they deal with conceptual barriers. The other topics will be analyzed in a future 
manuscript. 
The five focus groups lasted between 90 and 120 min. One team member was the 
moderator; another team member was the co-moderator who took notes, kept track 
of time, and helped in asking follow up questions. To facilitate qualitative 
analysis, all the discussions were tape-recorded and transcribed verbatim in the 
language of the interview (German or French). Transcripts were returned to 
participants for revision. The 5 focus group transcripts were checked for accuracy 
by three researchers and transferred into the qualitative analysis software 
MaxQDA (version 12) to support the analysis process49. Three authors in- 
dependently analyzed the transcribed data by reading the interviews several times. 
After a close line-by-line analysis of the transcripts, provisional categories were 
identified by each of the three researchers. In a next step – to ensure consistency in 
the analysis of the data – the three team members discussed their respective 
categories and reached an agreement about the coding scheme and superordinate 
themes across the different focus groups were developed. In a final step, the first 
author reviewed the group level thematic taxonomy through the eyes of each 
individual participant to see which themes represented and did not represent the 
individual’s account. For this purpose, everything a single participant said was, 
first, marked in a specific colour and then re-read and compared to the themes 
discussed by the group as a whole. In this way, both differences and 
commonalities among participants were identified together with the overall 
context that triggered their claims. This step was important given that the focus 
groups were mixed and we wanted to do justice to the concerns of each individual 
and provider type. Saturation of data was reached after the 5 focus groups. 
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Results 
 
A total of 29 persons (working at 5 different SPOG centers) participated in this study: 14 
nurses (among which 2 nurses specialized in the field of PPC), 10 physicians, 4 psycho-
oncologists/psychiatrists, and 1 social worker (see Table 1). 
 
 
 
 
 
 
 
 
Analysis with regard to the conceptual understanding of PPC by pediatric oncology 
care providers identified 2 major themes (and several subthemes): (1) Definitions of 
PPC and (2) Conceptual barriers, their causes & possible solutions. To improve 
clarity, the themes and their respective subthemes are presented in Fig. 1. 
To illustrate the reported results, representative quotes were taken from the various 
interviews using pseudonyms for the participants as well as the center. All quotes were 
translated from German and French into English, and translations were checked for  
accuracy by two authors. Quotes will be  presented  in  tables so that all three 
perspectives on a particular topic are easier to compare and also  to  provide  an  insight  
into the richness of experiences and opinions gathered. 
 
 
Table 1. Participants characteristics (N = 29) 
All participants N (Percentage) / Mean (SD) 
Gender (women) 21 (72.4%) 
Experience in years 14.9 (8.9) 
Professions 
Experience in years 
Means (SD) 
Gender in percent 
(women) 
Nurses (n = 14) 16.3 (9.8) 92.9% 
Physicians (n = 10) 16.1 (8.4) 30% 
Psycho-oncologists / Psychiatrist (n = 4) 7.5 (4.1) 100% 
Social worker (n = 1) 12 100% 
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Figure1. Themes 
 
 
Definitions of PPC 
Philosophical definitions of PPC 
There was overall consensus on the common principles and values of PPC. In fact, most 
participants listed features that are essential to the gold standard of PPC: a family 
centred and active approach to care, offered by a multidisciplinary team and 
incorporating physical, psychological, social and spiritual needs to ensure the best 
possible quality of life throughout the illness trajectory (see Table 2.1, section a). 
In addition to these definitions that describe what PPC is or should be, many 
participants also provided “ex-negativo” definitions, that is, they used expressions to 
describe what PPC is not (see Table  2.1, section b). Most  providers  insisted  on  the  
fact  that  PPC  is not the same as end-of-life care  or  care  provided when death is 
imminent.  However,  at  the  same  time the majority of  the  participants  insisted  on  
the  fact that within the Swiss oncology context, it is best to  provide PC when there is 
no response to curative treatment. Among them many believed that understanding 
palliative care as  non-curative  care  was  crucial in order for the team “to  know  where  
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they  stand” and to be able to communicate  with  the  parents  in a clear and honest way 
(see Table 2.1., section b,  ii). Despite this shift, various  participants  insisted   that 
this is not an abrupt one, but a   gradual process which allows everyone involved to 
accept the fact that the child is dying. There was one participant who explicitly disagreed 
with the description that PC starts when there is no hope for cure. Within this regard it is 
important to highlight that participants were aware of the existence of other, often 
contradictory, definitions of PC (see Table 2.1, section c). Although most participants 
agreed that the provision of PPC is closely connected to the absence of cure, this 
rather broad understanding of PPC raised important challenges when implemented 
in practice. 
Operational definitions and operationalization of PPC 
Many participants acknowledged that clear guidance was missing on an operational 
level (see Table 2.2) and that this led to divergence of opinions among team members, 
especially with regard to the question of when to introduce palliative care. A physician 
reported (speaker 5, center 1): «There is always, or very very often, a moment when – I 
do not know how many times I have nurses heard saying: “but why do they 
[physicians] continue?”». Nurses recounted that they sometimes have the feeling that 
physicians push the boundaries too far and implement PPC too late. A nurse (speaker 
4, center 1) reported how upset she was when she forbade a young patient to eat the 
sausage of which he was so fond, while knowing that he might only live for another 3 
months: «We are the ones who enforce the  [food]  prohibition  (…) that’s maybe why 
we start asking ourselves questions more quickly». 
On the other hand, nurses acknowledged that they do not always have the same 
medical information as the doctors, and that this can create divergence. They thus 
noted that it is important to sit together so that everybody is on the same page. Some 
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participants expressed the concern that these disagreements might be due to confusion 
about the meaning of PPC: «Sometimes there is no agreement because the definitions 
are unclear» (nurse, speaker 4, center 5). 
 
Table 2. Definitions of pediatric palliative care 
1. Philosophical definitions 
                         
a) Positive 
definitions 
i.) PPC is gold standard (WHO) 
For me palliative care means comfort care, holistic care, it means taking care of the 
child and his/her family in a physical and psychological sense; total care of the 
entire family. (Nurse, speaker 2, center 1) 
 
It really means «not to abandon» … to provide palliative care is something very 
active, to stand by all the life projects until the very last second. (Nurse, speaker 1 
with PPC specialization, center 2)   
 
The most important thing is really the quality of life and (...) to create a network 
for families, for the whole family (...) and important is also to collaborate and also 
to have a multidisciplinary team. (Nurse, speaker 3, center 3) 
 
For me it is important that the persons who cared for the patient before do not just 
disappear and leave the patient alone (…) but that the contact remains until the end 
and even beyond the end, ideally. (Physician, speaker 1, center 5) 
 
                                    
b) Ex-negativo 
definitions 
 
i.) PPC is not end-of-life care 
To me it is quite clear that palliative care is something for the child (…) within a 
comfort approach and with the aim of increasing the child’s quality of life. But it 
does not necessarily imply the imminent end-of-life. (Nurse, speaker 4, center 2) 
 
End-of-life care that starts normally during the last four weeks, but PPC starts of 
course much earlier. (Physician, speaker 1, center 4) 
 
ii) PPC is not curative treatment 
PPC is the total care of a pediatric patient from the moment one knows that the 
oncological disease is incurable. (Physician, speaker 5, center 1) 
 
In some other areas of PC it is different – in the case of a chronic condition the 
child cannot be cured anyway. In oncology, however, we always start with a 
curative treatment, but then there are situations (…) in which we say: we cannot 
cure the child (…) and then there is a switch to palliative therapy, which can take a 
long time, but then we know that the child will die of either of the illness or the 
treatment. (Physician, speaker 1, center 3) 
 
The shift from curative to palliative, I think that in Switzerland that is very 
different from the UK where palliative care teams are integrated from the time of 
diagnosis (…) until there is still hope for a cure, that they will find a treatment. 
Here in Switzerland they will not consider them patients palliative. (Nurse, 
speaker 2 with PPC specialization, center 2). 
 
iii.) PPC is not an abrupt shift  
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It’s true that from a medical point of view there is never an abrupt shift from a 
curative to a palliative approach, there is always a transition phase (…) often the 
family and the patient, but maybe physicians too need such a transition time before 
coming to terms with the fact that the child will not heal. It’s not something on/off. 
(Physician, speaker 5, center 1) 
 
The decision-making regarding the shift from curative to palliative treatment, is a 
process (…) in which one goes back and forth, in which one is not fully certain … 
it is not a fixed point in time. (Psycho-oncologist, speaker 5, center 4) 
 
                                 
c) Definitional 
problems 
i.) Disagreement on the meaning of PPC 
I do not agree. For me curative and palliative are not in opposition, or consecutive, 
they are often rather concurrent, especially in the case of our patient group 
pediatric oncology where once the one aspect then the other can be more 
important. (Physician, speaker 3, center 4) 
 
ii.) Acknowledgement of various definitions 
I believe that you can understand many different things under palliative care and 
that is precisely the problem. (Physician, speaker 2, center 4) 
2. Operational definitions of PPC 
 i.) Uncertain timing due to definition 
The shift from curative to palliative is not that clear. From when can we say that a 
person is in palliative care? In practice this passage is not so clear to me. On the 
other hand what palliative care stands for I think is very clear here to professionals 
in the hospital] (Social assistant, speaker 2, center 2) 
 
ii.) team discussions due to unclear definition 
I still find it really difficult to say that now a patient is palliative or not. (…) I 
really notice - that nurses and doctors often have a different view on the whole. 
Sometimes we do not immediately find a consensus. Maybe the concepts are not 
clear (…) I remember the last big roundtable we had over a difficult case in order 
to all have the same understanding and to bring in ideas in order to know: “what 
next”? (Nurse, speaker 4, center 5) 
 
It PPC] was introduced quite late in the service (…) in some situations the 
children felt more and more uncomfortable, they had a poor quality of life and the 
nurses were the ones who shouted; "Help! " (…) (Nurse, speaker 2, center 1). 
 
The individuality within the team, the different values, the different attitudes 
towards life, are often not explicitly made (…) what remains unsaid can create 
barriers (…) it can lead to fractions or different fronts, without it being made 
explicit (Psycho-oncologist, speaker 5, center 4) 
 
iii) need to overcome conflicts 
Consensus is absolutely necessary (…) you have to try to find it. Which way do 
you want to go, how do you want to go there? (…) perhaps you need to get 
together two or three times. Even if you want to avoid conflicts (…) you have to 
face them (Physician, speaker 1, center 5). 
 
Conceptual barriers, their causes and possible solutions 
Conceptual barriers among parents and professionals 
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Many participants – across the different provider types – were convinced that parents are 
reluctant to start PPC be- cause they associate it with “death and dying”, “loss of hope”, 
and “giving up” (see Table 3.1, section a). According to a social assistant (speaker 2, 
center 2) the stigma sur- rounding PC is so substantial that «the term “palliative” is the 
biggest enemy» when addressing families. Some participants acknowledged that they 
also often “struggle” with the concept and have difficulty accepting the next phase in the 
child’s illness course (see Table 3.1, section b). 
The perceived causes of conceptual barriers 
Some participants acknowledged that their own attitudes towards PPC might 
negatively influence those of families’ and further compromise timely 
implementation of PPC (see Table 3.2, section a). 
Another important barrier that was cited (mainly by nurses) for the wrongful association 
between PPC and death was that PPC is still implemented relatively late in the  course of 
the illness, in response to a bad prognosis or when children’s quality of life becomes 
very poor (see Table 3.2, section b). On the other hand, some participants seemed to be 
concerned that introducing PPC too early; at the time of diagnosis – as set out by the 
WHO guidelines – risks diluting the meaning of PPC (see Table 3.2, section c). If PPC is 
uncoupled from the actual dying process and the non-curative phase, then «we are all in 
a palliative situation» (physician, speaker 3, center 2) insofar we all will die 1 day and 
this will cause confusion. Some were concerned that by uncoupling PC from dying, one 
risks marginalizing an important component of PPC, namely bereavement care. «There 
is little notion (…) in oncology of bereavement care which is an essential part of 
palliative care» (Nurse, speaker 2, center 1). Others reported that all-round care is 
provided from the moment the patient enters the hospital, and wondered what difference 
introducing PPC earlier would really make (see Table 3.2, section c). 
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As well as issues related to the timing of PPC, participants also argued that the notion 
of PPC is very much linked to an institutional, political and professional context, but 
that this PC philosophy is difficult to reconcile with children’s every day life: «In the 
child’s personal context what does that mean, palliative care?» (physician, speaker 3, 
center 2) Various participants associated PC with adult, and in particular elderly, care 
and emphasized that also on the policy level PC was rarely addressed with regard to 
children (see Table 3.2, section d). 
A final cause has to do with the cultural and religious background of patients and their 
families. When parents’ background significantly differed from traditional Swiss 
culture, participants frequently reported difficulties with introducing and providing 
PPC. In many cases, it was the presence of pain which finally convinced the parents to 
implement PPC, but this was often at a rather late stage (see Table 3.2, section e). 
 
Table 3. Perceived conceptual barriers and their causes 
1. Perceived conceptual barriers 
a) Among 
parents 
 
i.) PPC equals death, giving up, loss of hope 
There are parents where you have the feeling that they do not consent to the 
palliative care process because they think: «I am giving up on my child». 
(Psycho-oncologist, speaker 4, center 3) 
 
For many families ʺpalliativeʺ means ʺdeath, whereas palliative care does not 
mean that you will die. (Nurse, speaker 2, center 1) 
 
The difficulty may be to address the issue of death, but it is also like (…) if we 
abandon all efforts. For parents this is hard, because they perceive it as "we 
give up” and it does not meet their expectations. (Psycho-oncologist, speaker 7, 
center 2) 
 
The last case was a patient who medically speaking was in very bad shape (…) 
the mother fought with all her strength against the slow change of treatment 
course from curative to palliative. She had the impression that we were 
denying the boy the chance to heal. (Physician, speaker 7, center 5) 
b) Among HC 
professionals 
 
i.) Struggle to accept a next phase 
There is much work to do regarding the wording; many things belong to us, to 
the caregivers, our difficulty to accept that we pass from a curative to a 
palliative phase. (Psycho-oncologist, speaker 7, center 2) 
 
The concept of PPC]I s one thing, it is a bit the rational part, like safeguards 
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and structures it offers support, orientation and security. On the other hand, you 
have the attitude of the department…how team members actually experience 
palliative care (…), what we live (Psychologist, speaker 5, center 4) 
2. Perceived causes 
a) Reluctance 
among 
professionals 
 
i) HC professionals’ fear of PPC 
If there is no pain yet or something that leads to palliative care (…) I feel it as 
an obstacle myself. We are afraid of pronouncing the word and at the same time 
we do not know how to tell it differently. (Physicians, speaker 5, center 2) 
a) Late referral 
practice 
 
i) PPC as the grim reaper 
We only talk about PPC at the last minute; it's like we sign the child’s death 
warrant (…). So maybe if we were introduced before, it PPC] would not have 
the same effect on the family (Nurse with PPC specialization, speaker 1, center 
2) 
 
If we take the definition of palliative care, and ask ourselves whether death is 
probable, unavoidable within “six months”, so the speak (…) then I think we do 
not anticipate the situation enough and then all of a sudden it declines very 
quickly most of the time. (Nurse, speaker 1, center 1) 
b) Diluted 
meaning of 
PPC due to 
integrative 
approach of 
WHO 
 
i) No clear distinction leads to confusion 
It’s very hard to have a discussion and to state “not everything is lost yet” and 
at the same time mention “palliative care”. (Physician, speaker 5, center 2) 
 
ii) Total care is always already provided  
Holistic care is there already (…) that’s why there is confusion, I think. But ok, 
that is the WHO definition. Comprehensive care is present throughout the 
illness course, whether it is in the palliative or curative phase. (Nurse with PPC 
specialization, speaker 1, center 2) 
 
The concept [PPC] disturbs me (…) I think we have been providing medical 
care in a humane way for centuries and I do not think (…) care has to be 
renamed (…) the patients must receive best supportive care from to beginning 
until the end of life. (Physician, speaker 7, center 5) 
 
What would be the added value, which is currently missing, if one would 
integrate it PPC from the diagnosis onward? (…) there is already a total care 
approach (…) I think there is not necessarily an advantage. (Physician, speaker 
3, center 2) 
c) Institutional 
meaning of 
PPC  
i.) The term PPC is not related to the life-world of children 
I think the word ʺpalliativeʺ (…) is inadequate in pediatrics because if we place 
a person of 50 or 60 years old in palliative care, we know that the person will 
die at an age close to the natural age of death with a palliative care treatment of 
10-20 years depending on the type of illness. In the case of a child (…) we will 
not be reach the natural limit. (Nurse, speaker 4, center 1) 
 
We knew that talking about palliative care might constitute a barrier to certain 
families, but for the public health sector who finances us, it was a must (…) we 
needed to call ourselves the service] ʺpalliativeʺ. (Nurse with PPC 
specialization, speaker 1, center 2) 
An important topic is the difference between the life-world of adults and the 
life-world of children (…) when one in Switzerland talks about palliative care 
or about its political or infrastructural aspects then one has to be aware that the 
child is not taken into consideration. (Physician, speaker 2, center 4) 
d) Religious & 
cultural 
Something that makes it difficult to address palliative care is that 80% of the 
immigrant population comes from far away (…) and have many different 
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differences cultural backgrounds (…) What does palliative care mean for a Swiss person, 
but also in the broader sense in the world. Culturally speaking, what does it 
PPC] mean? (Nurse, speaker 4, center 1) 
 
Suggested strategies to overcome the conceptual barriers  
The participants provided several strategies to help overcome the conceptual barriers. 
Some of them suggested introducing PPC earlier so that this type of care would be part 
of the “landscape” and not be considered to be the “grim reaper” (Nurse, speaker 1 with 
PPC specialization, center 2). Timely implementation of PPC was believed to promote 
a more natural transition and take away the a priori negative connotation of PPC (see 
Table 4.1, section a). Several healthcare providers suggested rebranding PPC by using a 
synonym which is more easily understood and less stigmatized, such as comfort care, 
best supportive care or “accompagnement”2 as these words do not directly relate to death 
and dying. They believed that these more commonly used terms better expressed the 
caring goal of PPC (see Table 4.1, section b). 
A few participants, however, insisted on the importance of using “palliative care” 
because they feared that the use of a euphemism would not really help overcoming the 
stigma associated with the word. They further emphasized that it was healthcare 
providers’ task to pro- mote the values of PPC among policymakers and the general 
public. The use of the term “palliative care” was also said to be crucial to give a clear 
indication of the patient’s overall treatment and care goals and thus to have a common 
language and understanding within the team (see Table 4.1, section c). 
A few participants also reported about the importance of “word of mouth”: families who 
are satisfied about PPC can help overcoming the taboo surrounding this type of care 
and become PPC advocates (see Table 4.1, section d). 
Finally some care providers highlighted the importance of having an external specialized 
PPC team as this could offer an additional perspective on the situation and provide 
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support to the primary team, who might be too emotionally involved to start PPC in a 
timely manner. On the other hand, in some centres, concerns were raised about whether 
different teams could successfully work together (see Table 4.1, section e). 
 
Table 4. Strategies to overcome conceptual barriers 
1. Strategies to overcome conceptual barriers 
 
a) Early 
implementation 
of PPC 
i) Timely introduction 
Perhaps the fact of intervening sooner would create less fear. When people 
hear “palliative care” they immediately think: “Ah that means: death”. (Nurse, 
speaker 8, center 2) 
b) The use of 
synonyms 
ii) Euphemisms 
I like the term “accompagnement” in these situations (…) it means “being 
with” (…) “palliative” evokes, in my opinion, something a priori negative and 
I do not feel comfortable using it. (Nurse, speaker 3, center 1) 
 
For me, more than using this word PPC], it's more about contextualizing it 
together with the parents and the child. I think that the child and the parents 
have a different view on the situation. We must try to make them understand 
that knowing that a disease incurable does not mean stop giving care, but 
entails a different way of caregiving (…) one should use the word “comfort 
care", for me that is more appropriate (Nurse with PPC specialization, center 
2) 
c) Explicit use of 
the term PPC 
 
i) De-bunk the stigma 
We need a common language (…) You have to call a cat ʺa catʺ (…) among 
the general public there is maybe a kind of ʺmystificationʺ of palliative care, in 
the sense of palliative equals death, but it is our task as professionals to finally 
inform the public on the federal level and the rest. (Nurse, speaker 1, center 1) 
 
ii) Bring clarification to family & team 
The concept (…) should bring clarification to the treatment team and the 
patient. Therefore I actually understand palliative care as non-curative care. 
That is a crucial point for me, which I then need to discuss with the parents so 
that we know where we stand. (Physician, speaker 2, center 4) 
We on the nursing level use the word (…). We say: «the doctors have talked 
with the parents, we are in a palliative care situation now». I think for us this 
word signifies a change of attitude in the perception of the type of care we will 
provide. (Nurse, speaker 4, center 2) 
d) “Word of 
mouth” 
i) Family satisfaction 
We deprive ourselves a little of the opportunity to give them a chance (…) In 
see the family room I see how much families speak to each other. Every time a 
family has really benefitted and been satisfied, well, this information goes 
around. Families speak a lot among them (Social assistant, speaker 2, center 
2) 
e) Support of 
specialized 
PPC team 
i.) Benefits of specialist PPC team 
I think we would benefit to have a systematic support external PPC service] 
(…) to bring a bit of order in the discussion, in the ideas, in the emotions when 
preparing to pass from curative to palliative care. (Nurse, Speaker 3, center 1) 
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ii.) Drawbacks of specialist PPC team 
There are different models in Switzerland and in the world, also in pediatrics, 
on this subject matter, with some hospitals having specialized teams in the 
background (…) I think that it is not desirable (…) there are not so many cases 
in oncology (…) it would be an exaggeration to have such a team (…) it would 
also create certain problems. (Physician, speaker 1, center 4) 
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Discussion 
 
Early PPC is encouraged by various international oncology organizations as it has been 
associated with improved symptom management and quality of life of both children and 
their families21. Still, to date, many patients who could benefit from PPC services do not 
receive them, or at least not in a timely manner50. Conceptual confusion has been 
identified as an important barrier to adequate implementation of PPC. Given the 
influential role of healthcare professionals on families’ decisions, this study offers a 
unique insight into the personal understanding of and attitudes towards PPC among 
various types of pediatric oncology providers. There is only a small body of literature 
on barriers to PC in pediatrics and most of the existing studies have used 
quantitative research methods. However, in order to better understand the “paradox” 
in PPC – the persistence of late and non- referrals despite PC’s beneficial impact – 
qualitative research might be more appropriate as it enables a more complex insight 
into people’s opinions and motivations. 
The study results show that most participants recognized the important value of PPC 
and had good knowledge of its core principles and objectives. The interesting 
finding is that although they clearly distinguished PPC from end-of-life or terminal 
care, many of them – across the various provider types – insisted that, within the 
pediatric oncology context, PPC is best provided when curative treatment is no  
longer an option. Thus, although the WHO guidelines embrace an integrative 
approach from the time of diagnosis, most participants defined the target group for 
PPC in a much more restrictive sense. However, they also emphasized that the 
transition from curative to PPC is not abrupt, but is actually a rather gradual process 
during which both families and healthcare providers slowly but steadily become 
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aware of the need to redirect the care provision.  Understanding PPC as non-curative 
was considered necessary to generate this change in attitude. Some participants 
expressed the concern that “mixing” the two care approaches might cause confusion 
among both family and staff members and thus be counter-productive. 
While most participants supported PPC principles, they were worried about the lack of 
guidance on implementing them within clinical practice. Timely integration of PPC 
continued to pose a problem on the operational level and led to conflicts among the team 
members. Due to their daily contact with patients and families at the bedside, participants 
believed that nurses are more pro-active than physicians in encouraging PPC. Various 
interviewees recognized their own personal difficulties with the transition of treatment 
goals and welcomed the intervention of a specialized PPC team to lessen the burden. 
However, not all participants were in favour of such a specialized PPC team.  Some 
believed that the primary oncology team could offer all the necessary PPC and seemed 
to be concerned about possible interpersonal conflicts. Research has shown that such 
conflicts are not unusual as the non-hierarchical structure of PPC tends to challenge the 
traditional hierarchical culture of the medical system51,52.  
Confirming the results of previous studies22,24,26,30,31,53, participants regularly reported 
difficulties in addressing PPC services to families due to the strong (perceived) stigma 
surrounding this word. To overcome this obstacle many participants adopted a 
euphemistic term, such as comfort care, supportive care or accompagnement2. This 
finding confronts us with the following paradox: given that the definition of PPC has 
evolved considerably over the last decades and its ascribed (formal) meaning in the 
guidelines is highly beneficent (“improvement of life quality”), why then is the lay 
meaning still overly negative1,2,22? Prior studies suggest that negative attitudes towards 
PPC among patients and families are often influenced by staff members’ own negative 
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image of PPC25,32,33,36. Some of our participants seemed to confirm these findings and 
this might confirm the idea that like many Western societies, Swiss society is still death-
denying. Still we believe that given the centrality of death and dying in the Swiss public 
debate, it is difficult to maintain that this topic is still taboo.  Hence, it is crucial to better 
understand care providers’ own perception of PPC to comprehend their aversion of the 
term palliative care. Our results show that various participants personally disliked the 
term “palliative care”  not, or at least not primarily, because of its strong association 
with death or dying (many of them, in fact, were in favour of understanding PC as non-
curative!) but be- cause they considered it to be a concept that is incompatible with 
children’s everyday life. In this context, it is interesting to reflect further on the meaning 
of the terms, “support”, “comfort” and “accompagnement”.  They are all words that are 
widely used in daily life to describe a willingness to be with others, to stand by someone, 
to be present54. This ordinariness stands in sharp contrast with the term “palliative care” 
which was perceived by the providers as being too policy-loaded. This finding is worth 
exploring more fully as it can provide novel insights into the conceptual barriers 
impeding implementation of PPC and thus be used to frame the design and analysis of 
future empirical studies on this topic. Although we cannot address this topic extensively 
here, we should keep in mind that both on an institutional level and in the public debate, 
PC is often discussed and promoted as a life- and choice-affirming alternative to 
euthanasia and physician  assisted  suicide as PC intends neither to hasten nor postpone 
death and patient preferences are heavily promoted in the WHO definition of PC6,55. 
This means that PC is often debated within  a context of autonomy  and choice in  which 
planning towards and acceptance of death are actively encouraged. This may explain 
why some participants considered the concept of PC to be out of touch with children’s 
perspective. By using synonyms such as com- fort, support and “accompagnement” they 
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might have wanted to reinforce PC’s original aim of being close to patients and families 
in care and affection. 
Some participants were skeptical about rebranding PPC. They insisted on endorsing the 
term and debunk- ing its negative meanings by introducing PPC earlier. In this way 
families will be less scared to revise the treatment goals the moment their child is not 
doing well.  Other participants, however, critized this integrative approach. They argued 
that holistic care is provided at the time of diagnosis and wondered what the added value 
would be of introducing PPC at the start of the illness trajectory. In line with other 
studies, the question that we have to ask is: if PPC is no longer a special type of care, but 
becomes part of the medical “mainstream”, independent of any advanced prognosis, then 
does it not become too de-coupled from death2?  Some  authors are concerned that in 
order to improve acceptance, PPC guidelines have become death-sensitive and risk 
marginalizing those for whom PC was developed in the first place: dying children and 
their bereaved families56-59. A few participants seemed to share this worry when they 
reflected on the limited bereavement care possibilities in pediatric oncology. 
A small number of participants addressed the possibility of rebranding PPC by relying 
on positive word-of-mouth. Studies have shown that word-of-mouth communication 
might have a great influence on the healthcare behaviour of the general public, 
especially in our current era of internet-based communication and the in- creasing use of 
social media60. 
A last concern expressed by the participants was the interaction with patients and 
families from a different, non-Swiss cultural and religious background. At present, there 
is little or no research on how ethnic and religious minorities perceive and understand 
PC definitions61. 
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Limitations 
First, because of the mixed focus group approach and the possible power differences that 
go along with it, it is possible that not all participants freely expressed their views on the 
subject matter, so some issues might have been left unsaid. Furthermore, the familiarity 
among the participants (most of them were part of the same team) might have resulted in 
taken-for granted “party-line” attitudes regarding PPC62. However, we intentionally used 
such an approach to mirror the actual “natural” group dynamics in the Swiss SPOGs 
where PPC is usually provided by the primary oncology team, which includes nurses, 
psychologists, psycho-oncologists etc. in addition to physicians. This inter professionalism 
might have allowed the production of in- sights that could have been less accessible in 
single provider type groups. Moreover, the moderators encouraged all participants to 
engage actively during the debate. Finally, the advantage of using an acquaintance group 
was that participants could provide more details regarding certain events or experiences 
and challenge the statements of other participants if they did not correspond to the actual 
hospital practice62. Second, given the specific Swiss pediatric oncology context, findings 
are not generalizable to other contexts abroad with specialist PPC teams and a different 
healthcare system. Third, since the focus group data collection was part of a bigger 
project that has been running since 2012, a few of the study participants knew the re- 
search project and the team already. Thus, we cannot exclude that the responses of some 
participants might have been influenced by their perception of the overall goal of the 
project. Finally, because most of our participants were women, our findings might be 
gender biased.  However, since the workforce in both the pediatric and palliative care 
context is predominantly female, our sample does reflect the setting that we wanted to 
examine. 
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Conclusion 
Despite important changes in the formal definition of PPC, it has still a overly negative 
connotation in the minds of many parents and healthcare providers. To counter this 
trend, calls have been made to initiate PPC at diagnosis and if necessary, rebrand the 
term PPC as supportive or comfort care. Many participants in this study seemed critical 
about the “from diagnosis onward” directive and clearly associated PPC with non-
curative treatment. To most of them, the adequate timing of PPC remained a major 
challenge. Although the philosophical definition of PPC leaves room for patient 
individuality, it complicates clinical practice as it does not provide clear protocols. More 
referral tools are needed to help oncologists to identify children and families with 
palliative care needs. Further, although PPC has increasingly profiled it- self as being 
concerned with the patient’s quality of life (rather than with death) this shift has not 
overcome all stigmas. Therefore, perhaps the conceptual obstacle to PPC is not so much 
death itself, but the way in which PC is discussed on both a policy level and in public 
debates, that is, in terms of choice, autonomy and personal development. This 
interpretation could find support in the fact that our participants considered the term 
“palliative care” to be out of touch with the child’s perspective and preferred to use 
synonyms that are closer to PC’s original aims: to offer support to patients and families 
in pain, anger, sadness and laughter without any normative expectations. Other well-
designed empirical studies are needed to further explore these findings. Still, although 
the use of these alternative terms might be a useful and pragmatic approach to 
overcoming the initial stigma30, in the end, it might be ineffective as these words might 
gradually acquire the same negative connotations as PC as long as there is no change in 
the public discourse on dying. The best way to counter this trend may be to promote (on- 
and offline) positive word-of-mouth63 among satisfied families and health care 
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providers. By sharing their stories, families and healthcare providers could become the 
true ambassadors of PPC. More research is needed on how healthcare professionals can 
use online word-of-mouth on social media for PPC advocacy. Also, further efforts 
should be pursued to develop PPC educational and training programs for healthcare staff 
(including conscious self-reflection). Finally, critical reflection is needed on the possible 
practical and conceptual shortcomings in PPC guidelines themselves, in order to better 
support PPC healthcare providers. 
 
 
Endnotes 
 
1 Switzerland is a federal state which is divided into 26 cantons. Each canton has its own 
cantonal constitution, approved by the federal parliament. For the current study, we obtained 
the approval of 4 research ethics committees.  
2 It is difficult to adequately translate the French word “accompagnement” in English since it 
is deeply indebted into the Francophone culture. The notion emphasizes patients’ 
embeddedness in society, rather than putting the focus on their individuality. The best 
translation would maybe be “accompanying”, “to be a companion”.  
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Abstract 
 
Palliative care (PC) aims to improve quality of life for patients and their families. The World 
Health Organization and American Academy of Pediatrics recommend that PC starts at 
diagnosis for children with cancer. This systematic review describes studies that reported PC 
timing in the pediatric oncology population. The following databases were searched: 
PubMed, Web of Science, CINAHL, and PsycInfo databases. Studies that reported time of 
PC initiation were independently screened and reviewed by 2 researchers. Studies describing 
pilot initiatives, published prior to 1998, not written in English, or providing no empirical 
time information on PC were excluded. Extracted data included sample characteristics and 
timing of PC discussion and initiation. Of 1120 identified citations, 16 articles met the 
inclusion criteria and comprised the study cohort. Overall, 54.5% of pediatric oncology 
patients received any palliative service prior to death. Data revealed PC discussion does not 
occur until late in the illness trajectory, and PC does not begin until close to time of death. 
Despite efforts to spur earlier initiation, many pediatric oncology patients do not receive any 
palliative care service, and those who do, predominantly receive it near the time of death. 
Delays occur both at first PC discussion and at PC initiation. Efforts for early PC integration 
must recognize the complex determinants of PC utilization across the illness timeline.  
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Introduction 
 
The World Health Organization (WHO) released a seminal report, titled Cancer Pain Relief 
and Palliative Care in Children, in which it recommended that palliative care (PC) for 
children with cancer ought to begin at diagnosis, irrespective of prognosis1. Other 
international health organizations – the American Academy of Pediatrics (AAP)2, Institute of 
Medicine (IOM)3, European Association for Palliative Care (EAPC)4, and the Royal College 
of Paediatrics and Child Health (RCPCH)5 – have all since adopted a similar 
recommendation6. These calls for earlier PC are grounded in evidence of an unmet need: the 
high illness burden and degree of suffering are well established among children with cancer7. 
Additionally, numerous studies have demonstrated that the tight prognostic limits of hospice 
– a type of PC reserved for the end‐of‐life – are incompatible with the full spectrum of 
physical, psychological, social, and spiritual needs8-10. PC presents an effective solution as 
both children with cancer and their parents report significantly enhanced quality of life from 
PC involvement11,12.  
With the improvements in medical therapy for pediatric oncology patients13, children now 
survive for longer periods and require extended PC, making pediatric PC an increasingly 
important area of research14,15. Recent studies have investigated related ethical issues: how 
and when children should be involved in decision‐making16-19 and what disparities exist in 
PC access20,21. Moreover, various studies have demonstrated PC for children with cancer is 
initiated late in the illness trajectory22-24, indicating a discrepancy between the normative 
recommendation for early integration and referral practices in pediatric oncology. Yet, no 
systematic review of the timing of PC initiation has been conducted to compile this growing 
body of literature. 
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Understanding the current state of PC timing is necessary to inform efforts to expand PC 
access, increase the time that children benefit from PC, and better support pediatric 
oncologists. As such, the purpose of this study was to systematically review literature 
describing the current timing practices of PC initiation in children with cancer. The two key 
events involved in the start of PC are the initial discussion with or without specialist 
consultation and the first instance of palliative service provided. If PC services started close 
to time of death, it is important to know if discussion occurred early and PC was deemed 
unnecessary, or if discussion also occurred late. Knowing the specific timing of these events 
will identify where in the care continuum barriers may lie. Thus, this review sought to answer 
a guiding questions: a) what time elapses between cancer diagnosis and PC discussion or 
consult; b) how long before death does PC discussion occur; c) what is the PC duration 
received before death, and d) what proportion of children receive PC. 
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Methods 
 
Search methodology 
This systematic review of literature on the timing of PC in pediatric oncology patients was 
performed in accordance with the Preferred Reporting Items for Systematic reviews and 
Meta‐Analysis (PRISMA) guidelines25. Details of the systematic review protocol were 
registered on the PROSPERO International Prospective Register of Systematic Reviews 
(CRD42018108557). We searched PubMed, Web of Science, CINAHL, and PsycInfo for 
publications between 1 January 1998 and 15 December 2017, examined the citations of 
included articles for relevant additions, and solicited additional citations through discussion 
with topic experts. The year 1998 was selected as the beginning date because the WHO 
declared in this year that PC for children with cancer ought to begin at the time of diagnosis1. 
The WHO declaration altered the paradigm of PC initiation, so practices prior to this date 
may not be comparable. We developed the following Boolean search phrase based on 
controlled vocabulary results from the Medical Subject Headings (MeSH) terms database: 
(Palliative OR Hospice OR End‐of‐Life) AND (Pediatric* OR Child* OR Adolescent* OR 
Teen*) AND (Cancer OR Oncology OR Tumor* OR Neoplas*) AND (Duration OR Start* 
OR Time death OR Timing death OR Begin OR Began OR Time referr* OR Timing referr*). 
The terms “hospice” and “end‐oflife” care were included in our search because researchers 
and healthcare staff commonly equate them with PC, but care was taken during screening and 
full‐text review to ensure the reported data reflected the first iteration of PC. If the patients in 
the included study had not previously received PC, then that study was included because the 
described hospice or EOL care also represented the first time PC was provided. Our search 
yielded a total of 1220 titles and abstracts across all 4 databases (Table 1). 
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Exclusion criteria 
We defined the following a priori exclusion criteria: a) results published after the 1998 
starting date of our search, but based on data collected from patients prior to the 1998 WHO 
recommendation; b) neonates because the type, presentation, and management of neonate 
cancer differs from those of older children19, c) case studies because these describe 
exceptional medical situations and would skew our review; d) pilot initiatives that report 
results of a focused trial to encourage earlier PC consultation without pretrial data; e) no 
empirical data relevant to at least one of the primary study questions; and f) articles written in 
a language other than English. 
 
Search results and data extraction 
After duplicates were eliminated, two reviewers independently screened the article titles and 
abstracts to identify relevant articles. Of the 1137 unique citations identified, 1086 were 
published in English; titles and abstracts were independently screened by two authors, and 31 
were selected for full-text review, in addition to three articles identified from reference lists 
and expert consultation; 16 remained after full-text review and comprised the full study 
cohort (Figure 1). The authors independently collected the necessary data using a purpose‐
Table 1. Search terms and search results on timing of pediatric palliative care 
  Matches 
No. Search terms PubMed CINAHL PsycINFO Web of Science 
1 
Palliative OR Hospice OR End 
of Life 
121.923 41.833 28.926 136.362 
2 
Pediatric* OR Child* OR 
Adolescent* OR Teen* 
2.104.073 414.163 631.834 1.529.829 
3 
Cancer OR Oncology OR 
Tumor* OR Neoplas* 
2.585.401 268.727 76.791 2.552.665 
4 
Duration OR Start* OR Time 
death OR Timing death OR 
Begin OR Began OR Time 
referr* OR Timing referr* 
822.311 103.473 185.668 1.810.823 
5 1 And 2 And 3 And 4 704 55 81 380 
Note. Date of last search: 12th of August 2018 
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built Microsoft Excel extraction form: publication information, sample characteristics, and 
timing information from each of the articles. The two sets of extracted data were compared to 
validate the accuracy, and disagreements were resolved by discussion and input of a third 
investigator. 
 
 
Figure 1. PRISMA flowchart for inclusion of studies 
 
 
 
 
Analysis 
All evaluated outcomes were included in meta-analysis, including three timeframes – time 
from diagnosis to first PC discussion, first discussion to death, duration of PC provided and 
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proportion who received PC. A study was included in meta‐analysis if it reported mean with 
standard deviation or median with arithmetic range or interquartile range (IQR). For studies 
that only reported median and range, mean and standard deviation were calculated based on 
algorithms presented by Hozo et al26. All time data were converted into days. Data integration 
was conducted using Hedges-Olkin weighting models for inverse variance27. Random effect 
models were fitted by applying restricted maximum likelihood estimation, and Forest plots 
were constructed to visualize the results. All statistical procedures were executed with the 
metafor package in R‐statistical software28. In cases of significant homogeneity and 
sufficient number of studies, Lipsey‐Wilson moderator analyses were performed to examine 
study (sample country [US/non‐US], publication year, terminology [PC‐only/non‐PC], 
and sample size) and clinical characteristics (principle diagnostic group [solid tumor/blood 
cancer]) as potential reasons for variability29. A two‐sided P‐value ≤0.05 was considered 
significant for all analyses. 
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Results 
 
Characteristics of studies describing PC initiation 
Of the 1137 identified studies, 16 studies were included in our review. Mean sample size was 
237.2 (standard deviation = 294.5) patients and ranged from 17 to 1208 patients. Included 
data describes 3796 pediatric cancer patients, including 1438 solid tumor and 1231 
hematologic cancer patients. Fifteen articles performed a retrospective medical review of 
records to study the timing of PC initiation, and one study was a prospective observation 
across six institutions (Table 2)30. Metrics in eight studies were representative of the pediatric 
oncology population, while the remaining examined subsets of this target population. Timing 
was a primary outcome in all 16 studies. While all studies used the phrase “palliative care,
” it is important to note that six studies also used end‐of‐life (k = 4) or hospice (k = 2) 
care interchangeably with palliative care.  
The 16 included studies were published between 2002 and 2018. The median publication year 
was 2014, indicating that half of the studies were published in the last 4 years. Most studies 
(k = 9) reported timing of PC in North America, four in Europe, two in Asia, and one in 
Australia. However, there was little diversity in World Bank income classification: 15 
included from high‐income countries and one from an upper-middle‐income country. 
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Table 2. Study characteristics of publications included in review (n = 16) 
Year Authors 
Country 
of data 
collection 
Study method 
Sample 
size 
Represents 
Population 
Terms 
used for 
palliative 
care 
Study 
period 
2002 De Graves et al31 Australia 
Retrospective 
review 
17 Yes 
Palliative 
care 
1999-
1999 
2005 Bradshaw et al32 USA 
Retrospective 
review 
145 No 
End of 
life 
2000-
2001 
2008 Menon et al33 Malaysia 
Retrospective 
review 
247 No 
Palliative 
care 
2001-
2007 
2011 Tzuh-Tang et al34 Taiwan 
Retrospective 
review 
1208 No Hospice 
2001-
2006 
2011 Feudtner et al30 
USA & 
Canada 
Prospective 
data collection 
102a Yes 
Palliative 
care 
2008-
2008 
2012 Johnston et al23 Canada 
Retrospective 
review 
273 Yes 
Palliative 
care 
2006-
2009 
2013 Jalmsell et al22 Sweden 
Retrospective 
review 
95 Yes 
End of 
life 
2007-
2009 
2013 Thienprayoonet al35 USA 
Retrospective 
review 
114 No Hospice 
2006-
2010 
2014 Vallero et al36 Italy 
Retrospective 
review 
39 No 
Palliative 
therapy 
2005-
2011 
2015 Levine et al37 USA 
Retrospective 
review 
277 No 
End of 
life 
2001-
2005 
2015 Vern-Gross et al38 USA 
Retrospective 
review 
134 Yes 
Palliative 
care 
2001-
2005 
2016 Levine et al39 USA 
Retrospective 
Review 
615 No 
Palliative 
care 
2007-
2014 
2016 Ullrich et al40 USA 
Retrospective 
review 
147 No 
Palliative 
care 
2004-
2012 
2017 Ananth et al41 USA 
Retrospective 
review 
125 Yes 
Palliative 
care 
2010-
2014 
2017 Hoell et al42 Germany 
Retrospective 
Review 
65 No 
End of 
life 
2009-
2016 
2018 Rost et al43 
Switzer-
land 
Retrospective 
review 
193 Yes 
Palliative 
care 
2008-
2014 
Representation of the target population is defined as whether the metrics reported by the study estimate the pediatric oncology 
population. 
aNumber of cancer patients isolated from n = 515 cohort. 
 
 
Time from diagnosis to PC discussion 
Time from diagnosis to first PC discussion was reported in three studies, which included 485 
pediatric oncology patients (Figure 2). In our random effects model, the weighted mean time 
to PC consult was 509.6 (standard error (SE) [95% confidence interval (CI)]: 37.6 [435.9‐
583.4]) days. PC discussion did not occur at diagnosis as recommended by WHO and AAP 
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guidelines (P < 0.0001). Test for heterogeneity suggested large variation in effect sizes within 
these studies (Q[2] = 11.7, P = 0.003), and Higgins I2 statistic demonstrated 78.9% of 
variability is not attributable to sampling error. There was an insufficient number of studies 
for moderator analysis. 
 
Time from PC discussion to death 
Six studies, including 1571 patients, reported time from PC discussion to death with a 
weighted mean length of 85.6 (SE [95% CI]: 18.3 [49.8‐121.3]) days. Of note, this number 
is significantly smaller than the mean time from diagnosis to PC discussion, indicating that 
PC is discussed late in the illness timeline. An additional study reported median time was less 
than 37 days, but this study could not be included in our descriptive analysis because it did 
not report a measure of variation.30 In the two studies that reported both time from diagnosis 
to PC discussion and PC discussion to death, time from PC discussion to death was 
comparatively short, comprising 25.4% and 3.6% of the total illness duration23,40. 
Heterogeneity was significant for this outcome (Q[5] = 1547.6, P < 0.0001), and Higgins I2 
statistic was 99.8%, suggesting much of the variability across studies was due to the 
heterogeneity. However, the role of individual moderators in this variation could not be 
investigated due to the small number of studies. 
 
Duration of PC 
Time from formal PC initiation to death was reported in six studies, including 814 patients. 
One additional study reported a mean PC duration of 69.4 days, but did not report a measure 
of variation and could not be integrated in our duration model31. In the random effects model 
for PC duration, mean duration was 57.8 (SE [95% CI]: 19.9 [18.80‐96.8]) days. Two 
studies quantified both time from PC discussion to death and PC duration: Levine et al 
reported 144.2 and 56.3 days, respectively, while Vern‐Gross and colleagues stated 64 and 
Chapter 6  Palliative Care Initiation in Pediatric Oncology Patients 
152 
 
31 days37,38. Taken together, these findings reveal initial PC discussion does not often result 
in prompt PC initiation. Effect sizes varied across studies (Q[5] = 134.8, P < 0.0001), and 
97.8% of variability came from a source other than sampling error. Again, moderator 
analyses could not be conducted due to the small number of studies. 
 
Figure 2. Timing and duration of palliative care provided to children with cancer 
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Proportion with PC 
The weighted mean percentage of patients who received PC prior to death was 54.5% (SE 
[95% CI]: 8.2% [38.5%‐70.5%]) across 12 studies and 3467 patients. Higgins I2 statistic 
was 99.2%; test of heterogeneity was significant (Q[11] = 2230, P < 0.0001), and moderator 
analysis was conducted to investigate the effects of methodological and sample 
characteristics.  
In mixed‐effects models for moderator variables, increasing sample size was associated 
with a decline in proportion receiving PC (Q[1] = 6.1, P = 0.01). Mean PC proportions in US 
vs non‐US studies were 56.0 vs 53.0 (Q[1] = 0.03, P = 0.86); PC proportion has not 
changed significantly over time (Q[1] = 1.4, P = 0.24). Studies exclusively using the PC 
terminology reported a mean provision fraction of 54.2%, compared to 55.1% in studies that 
also used EOL or hospice terminology (Q[1] = 0.003, P = 0.96). In subgroup analysis by 
malignancy type, weighted proportion was 39.9% (95% CI: 12.0%‐67.9%) in studies with 
predominantly hematological malignancies, 54.7% (29.7%‐79.6%) in those with mostly 
solid tumor patients, and 66.5% (27.1%‐100.0%) for studies in which principle cancer type 
could not be identified. Despite the variation, cancer type was not significant on moderator 
analysis (Q[2] = 1.3, P = 0.53) (Figure 3). 
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Figure 3. Proportion receiving palliative care in children with cancer 
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Discussion 
 
This systematic review summarizes the timing of PC services for pediatric oncology patients 
reported in 16 publications published between 2002 and 2018. No systematic review has been 
conducted on the timing of PC initiation for children with cancer, and the present study is the 
first to compile the growing literature on pediatric oncology PC practices. Comparing PC 
provision within studies and across publications, it is apparent that PC integration was 
delayed at two time points: first PC discussion occurs late in the illness trajectory, and there 
is a delay between the initial conversation and start of PC. The growing number of 
publications and pilot initiatives demonstrate genuine energy to embed PC into conventional 
healthcare and improve the timing of PC discussion37,44-46. However, the results of this study 
suggest that PC integration at diagnosis remains an unmet objective.  
Our finding that only 54.5% of pediatric oncology patients received any PC before death may 
suggest there are structural barriers that inhibit availability of PC. A multinational review of 
Children’s Oncology Group institutions, which serve more than 90% of pediatric oncology 
patients in the US, found only 60% of providers offer PC services47. Potential reasons for the 
absence of PC services include lack of coordination between oncology providers and 
palliative programs outside the hospital, restrictive reimbursement models, and ambiguous 
roles of members in the care team48. While previous studies established the deficiencies in 
hospital infrastructure and our results demonstrate the effects on timing of PC provision, the 
drivers that cause hospitals to offer pediatric PC are not well understood. Further research is 
recommended to identify socioeconomic and geographic disparities associated with lower 
pediatric PC provision. Such research would identify areas where PC is underutilized in 
children with cancer and guide interventions to increase PC provision.  
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Another proposed explanation in literature for the lack of timely PC provision is the shortage 
of clinicians capable to deliver PC to children with cancer49. In a survey of PC providers – 
physicians, nurses, and other staff members – one‐third of respondents cited insufficient 
training in PC as a barrier to earlier PC integration50. The limited exposure to targeted PC 
education in residency and fellowship means hospitals do not have staff with the training to 
meet the palliative needs of pediatric oncology patients51-53. Improvements have been made 
to increase training opportunities as the number of pediatric PC fellowships in the US have 
doubled since 201354. However, adequate workforce availability remains a priority to expand 
the number of institutions that can offer PC to children with cancer.  
Training in PC principles is not important solely for designated PC staff; communication by 
the primary oncologist has a critical role in initiating the first PC discussion with the patient 
and family. Physicians recognize the child’s poor prognosis, on average, almost twice as 
early as parents do and thus, are often given the task to communicate the bad news to parents, 
explain treatment complications, maintain hope, and calibrate parental expectations55. 
Physicians, however, do not consistently articulate this prognosis effectively to the family of 
children with cancer: parents are more likely than their treating oncologist to indicate the 
primary goal is cure56, and 61% of parents were more optimistic about their child’s odds of a 
cure than the physician was15. Physicians view broaching PC as a stressor and delay the 
conversation, focusing instead on treatment arrangements57,58.  
Formal training is associated with feeling comfortable to manage end‐of‐life issues, but 75% 
of pediatric oncologists have not had any formal end‐of‐life training59. This communication 
deficit may cause parents to be overly optimistic and encourage them to pursue aggressive 
treatment until the physician is certain of their child’s imminent death56. Communication 
skills trainings, supporting resources, and a team‐based approach have shown promise as a 
means to facilitate earlier advance care planning and PC referral60,61.  
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Multiple studies have cited conceptual confusion between PC and hospice or EOL care, as 
well as the stigma of hopelessness associated with PC, as significant obstacles to early PC 
discussions6,62-65. The International Classification of Disease coding system considers hospice 
and end‐of‐life care as synonymous with palliative care, and US clinicians are instructed to 
bill these services identically.66 There are even definitional inconsistencies between and 
among PC guidelines of what palliative care constitutes67. If parents equate PC with EOL 
support, then it is understandable they will oppose the suggestion of PC at diagnosis or soon 
after. Yet, the Patient Protection and Affordable Care Act Section 2302 “Concurrent Care for 
Children” recognizes the difference between PC and EOL care and guarantees coverage 
under Medicaid or the Children’s Health Insurance Program for concurrent hospice and 
curative care for all children under age 2168. Adoption of a new phrase without the same 
connotations of death may support physicians in patient discussions. While the use of new 
terminology in pediatric oncology has not been tested, a survey found that compared to 
“supportive care,” the phrase “palliative care” was associated with decreased hope and 
increased distress in adult oncology patients and their families69. Furthermore, in a survey of 
646 Canadian physicians, pediatric oncologists reported they would refer patients earlier if 
PC was renamed “supportive care”70. Additional research is warranted to devise methods to 
encourage earlier PC in the pediatric setting.  
In moderator analysis, larger studies reported lower rates of PC utilization, suggesting that 
small single‐institution studies may overestimate PC provision. Future research on the topic 
should consider sample size and setting when designing studies. Literature in which hospice 
or EOL terminology was used did not vary in results when compared to studies that only used 
PC terminology; this indicates that despite the connotational significance of terminology in 
the clinical setting, researchers frequently use these phrases interchangeably. We recommend 
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that researchers use caution to avoid confusion in reporting results and communicating 
findings to clinicians.  
Finally, US location, temporal trend, and cancer type were not moderators of PC utilization. 
However, there was notable difference in rates between blood cancer and solid tumor. 
Pediatric blood cancers tend to have higher survival rates than solid tumors71, which raises 
concerns that hematological cancer patients may receive more aggressive curative therapy 
until close to time of death. The low number of studies may explain why cancer type was not 
a significant co‐variate in our moderator analysis, but additional research is warranted to 
further investigate a possible difference by malignancy type. 
 
Limitations 
Our analyses coalesce data across multiple sites and countries, which increase our confidence 
that these findings reflect true practice. All included studies were retrospective medical 
records reviews or prospective collection, which enhances the comparability across studies 
and reduces the chance of measurement error. Additionally, 12 of our 16 studies had sample 
sizes with k > 100. As such, we could calculate robust estimations of true effects. There are 
also limitations to our study. Inherent to systematic reviews, all included data were already 
published and may be affected by publication bias. Second, studies primarily originated from 
research in well‐developed regions of the world. Research is needed outside of developed 
countries to better understand the state of PC access and availability for children with cancer 
worldwide.  
Sample size may partially explain the variation in PC timing observed in our results. Yet, 
there are other potential moderators that were not reported and could not be tested. Culturally 
determined understandings of when a condition is considered terminal (eg prognosis smaller 
than 10% vs 5%) may affect timing in different settings. Other demographic (eg income, 
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ethnicity), clinical (eg comorbid chronic conditions), and methodological (eg different 
definitions of when PC began) characteristics may also provide valuable context for the 
observed results and thus, warrant further study. Aside from these limitations, this study is 
the first systematic review on the timing of PC and sets a foundation for efforts to improve 
quality of life for children with cancer. 
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Conclusion 
 
Our results underscore that PC starts too late for children with cancer and are not in line with 
the recommended AAP, WHO, IOM, EAPC, and RCPCH guidelines1,2,4,5. Palliative care 
discussion does not occur until far into the illness, and PC does not start until much later. 
Each case is unique and must be evaluated using the caring physician’s best medical 
judgment and with respect to the patient and family, but holistically, there is much room for 
improvement regarding PC timing for this patient population. Effective, timely 
communication maintains patient quality of life and dovetails the transition to palliative care, 
while poor communication may lead to poor treatment planning and psychological harms for 
the child and family72. Reasons for delayed discussion and initiation include insufficient 
resources and infrastructure, lack of training, and negative connotations attached to PC.  
Findings in the present study regarding timings of PC discussion and initiation suggest 
pronounced obstacles across the PC lifecycle. As such, initiatives focused on specific referral 
points likely will not succeed. Programs designed to target PC timing must be robust and 
coordinated across the PC lifecycle to achieve effective improvement. Palliative care is 
central in pediatric oncology, and continued advocacy is 
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Abstract 
 
Objective: Palliative care for children is becoming an important subspecialty of healthcare. 
Although concurrent administration of curative and palliative care is recommended, timely 
referral to pediatric palliative care (PPC) services remains problematic. This literature review 
aims to identify barriers and recommendations for proper implementation of palliative care 
for children through the looking glass of PPC guidelines. 
Method: To identify studies on PPC guidelines, five databases were searched systematically 
between 1960 and 2015: Scopus, PubMed, PsycINFO, the Web of Science, and CINAHL. No 
restrictions were placed on the type of methodology employed in the studies. 
Results: Concerning barriers, most of the papers focused on gaps within medical practice and 
the lack of evidence-based research. Common recommendations therefore included: training 
and education of healthcare staff, formation of a multidisciplinary PPC team, research on the 
benefits of PPC, and raising awareness about PPC. A small number of publications reported 
on the absence of clear guidance in PPC documents regarding bereavement care, as well as 
on the difficulties and challenges involved in multidisciplinary care teams. 
Significance of results: Our results indicate that a critical assessment of both the research 
guidelines and medical practice is required in order to promote timely implementation of PPC 
for pediatric patients. 
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Introduction 
 
Medical improvements have led to longer survival of pediatric patients1,2. As a result, the 
number of children with life-limiting and life-threatening illnesses is increasing. This explains 
why pediatric palliative care (PPC) is becoming an important subspecialty within the setting of 
overall healthcare. The illness of a child alters family relationships, and family members often 
experience psychological and emotional distress as a result3. Therefore, PPC aims to care for 
children and their loved ones in a multidisciplinary fashion. It focuses not solely on pain and 
symptom management, but also on the social, psychological, and spiritual well-being of 
patients and their families. 
Palliative care developed first within adult cancer care. Its history is closely related to that of 
the hospice movement. For almost two decades, the terms “palliative care” and “hospice 
care” were used interchangeably, until the World Health Organization4 fostered a conceptual 
distinction between the two5. Unlike hospice care, palliative care was no longer identified 
with “end-of-life care,” but was “applicable earlier on in the course of illness, in conjunction 
with anticancer treatment”4¨. In 2002, the WHO promulgated a further amendment of the 
general definition of palliative care6. From then on, palliative care would be defined as an 
appropriate approach to care for anyone with a life-threatening condition irrespective of 
prognosis7. Other organizations have since adopted this broader understanding in their 
palliative care recommendations: the Institute of Medicine (IOM)8, the European Association 
for Palliative Care (EAPC)9 (the IMPaCCT standards), and the Royal College of Paediatrics 
and Child Health (RCPCH)10. 
The field of palliative care for children and neonates developed in the 1980s under the 
stimulus of palliative care for adults11. Still, it was mainly from the 1990s onward, with the 
formation of the Association for Children with Life-Threatening or Terminal Conditions and 
Their Families (ACT) (currently called “Together for Short Lives”) and ChiPPS (the 
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Children’s Project on Palliative and Hospices Services) that palliative care for children 
became more diffuse. “A Guide to the Development of Children’s Palliative Care Services”12 
was one of the first documents to define palliative care as a total approach to care for children 
and the family13. “Cancer Pain Relief and Palliative Care in Children”14 represented another 
significant milestone for the acceptance of PPC. This latter document states that pain 
management for children should begin at diagnosis and continue throughout the course of 
illness alongside curative treatment. Early integration of palliative care is highly beneficial 
for children with chronic and life-threatening conditions, as they often have complicated illness 
trajectories that come with a high degree of prognostic uncertainty15. This integrative model 
was soon also embraced by the American Academy of Pediatrics (AAP)11,16. 
Following the palliative guidelines (ACT, AAP, WHO), the current gold standard definition 
of PPC includes: (1) concurrent administration of curative and  palliative  treatment  from  
diagnosis onwards, (2) attention to the physical, psychological, social, and spiritual needs of 
patients and their families; (3) provision of services 24/7 at home, in the hospital, or in health 
community centers that should not stop with the child’s death; and (4) a team composed of at 
least physicians, nurses, psychologists, social workers, and family members. The main aim of 
PPC is to enhance the child’s quality of life rather than focusing on the quality of the dying 
process17. 
Although the number of palliative care facilities for children has grown, it still lags behind the 
number of those for adults18,19. However, even when they are available, the existing guidelines 
are not adequately implemented. Many children who could benefit from palliative care 
services in fact do not receive them, or at least not in a timely manner20-22. A significant 
difficulty in the United States has been that, until the introduction of the Patient Protection and 
Affordable Care Act in 2010, palliative care for pediatric patients was determined following 
hospice regulations for adults, meaning that disease-related treatments were not covered and 
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reimbursement was limited to the last six months of a patient’s life23. However, low referral 
rates have been reported in Canada22 and in Europe as well24,25. Since the number of children 
with life-threatening and life-limiting conditions is still on the rise, it is even more important 
to address the underlying reasons for these late or non-referrals. 
Various studies have identified barriers to palliative care in general26-28 and PPC in 
particular29,30, but mostly from the perspective of the patient, healthcare provider, or family 
member. None of these studies have documented these barriers through the looking glass of 
the PPC guidelines themselves. Therefore, our literature review had the following aims: to 
identify (empirical and theoretical) studies that discuss PPC guidelines in order to: (1) explore 
the development and evolution of these guidelines; (2) assess the barriers to their proper 
implementation; and (3) identify and address possible gaps in the guidelines. 
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Methods 
 
A systematic literature review was completed by searching the following online databases: 
Scopus, PubMed, PsycINFO, the Web of Science, and CI-NAHL (table 1). The following 
search terms were combined using Boolean logic: “Pediatric*,” “child*,” “adolescent*,” 
“palliati*,” “palliative care,” “hospice care,” “guidelines,” and “recommendations.” The 
inclusion criteria were: (1) published between 1960 and May of 2015 and (2) written in 
English or German. A 50-year publication window was chosen to capture earlier studies that 
most likely utilized a different conceptual framework than more recent works (in particular, 
since WHO4, AAP16, and WHO6) when discussing and assessing palliative pediatric 
guidelines. No restrictions were placed on type of methodology (quantitative, qualitative, 
mixed-methods, or theoretical). In addition, literature reviews, abstracts, comments, 
conference proceedings, dissertations, and books were excluded. 
 
Table 1. Search terms 
Nr Search terms 
                                        Matches 
    Scopus            PubMed            PsycINFO      Web of science          Cinahl 
1 
Pediatric* or 
child* or 
adolescent* 
2506694              3152041             215016         1057623                321967 
2 
Palliati* or 
palliative care or 
hospice care 
37253                  81110                  20077             35105                 25512 
3 
Guidelines or 
recommendations 
471012               398677              131292              26327                 93859 
4 1 AND 2 AND 3   324                     462                      65                    217                      138 
 
 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
framework31 was employed to organize the research (see figure 1), which resulted in 1,210 
papers. After removal of duplicates, 764 remained. During the first step of the review, three 
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researchers screened all 764 titles and abstracts. All articles that discussed pediatric palliative 
guidelines (in general or a particular subaspect like pain and symptom management, 
psychosocial, spiritual, cultural, or bereavement care) were included. With respect to 
guidelines, we intended to deal not only with nationally and internationally recognized ones 
from pediatric organizations, but also those developed within a hospital context. The 
guidelines themselves (those issued by the AAP, WHO, etc.), however, were not part of the 
review, having been assessed in another publication (blinded for peer review). Studies that 
dealt exclusively with neonatal and/or perinatal palliative guidelines were excluded. Papers 
discussing one specific type of pain management (e.g., a particular drug or palliative sedation) 
or psychological support (e.g., music therapy) were also excluded. Discrepancies between 
reviews were evaluated by a fourth reviewer, who determined which articles were potentially 
eligible based on the abstract. In total, 692 articles were excluded. 
 
Figure 1. Search process using a PRISMA systematic review of the literature 
 
The reference lists of the remaining 72 papers were checked to identify any additional 
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studies. Three papers were added through this process. The final sample thus included 75 
papers. During the next phase, the first author read the full-text versions of the articles. After 
evaluating each article, 21 were excluded because they (1) focused mainly on adult palliative 
care and only superficially on palliative care for children; (2) touched only implicitly on 
palliative care guidelines, addressing instead certain subaspects of PPC like decision making or 
the notion of a good death; or (3) focused in detail on certain pain medications. 
To assess the remaining 54 articles, a data extraction framework was created with the 
following information: year of publication, country of study, methodology, references to PPC 
guidelines, type of PPC, barriers to implementation of guidelines, and recommendations for 
overcoming these barriers. 
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Results 
 
Among the 54 papers included in our analysis, 29 were theoretical papers, that is, they 
proposed a theoretical framework of PPC or critically reviewed PPC models and practices. Of 
the remaining 25 studies, 10 employed quantitative methods, 10 qualitative methods, and 5 
mixed methods. Most of the papers (n 46) were published after the 2002 WHO amendment. 
Some 30 papers were from the United States, 7 from the United Kingdom, 7 from Canada, and 
the remaining ones from Australia, Italy, Germany, Switzerland, Israel, and Poland, and one 
from two countries. The most frequently cited guidelines were WHO14, AAP16, IOM8, and 
ACT (various editions between 1997 and 2013). Concerning the domains of PPC, 38 papers 
discussed palliative care in general. From the remaining 16 papers, 3 focused on two 
dimensions at the same time. The other 13 papers addressed one specific domain of PPC. 
End-of-life care was the main focus in a total of 21 papers, but only 4 of these dated from the 
most recent period, and 2 focused on bereavement care (table 2). 
 
Table 2. List of included studies 
Author, year, 
country 
Design  Participants  PPC Guidelines Domain of PPC Focus 
on 
EOL 
Ashby  et al. 
(1991), 
Australia 
Mixed method 
 
Interviews: 15 
HCP, 4 parents 
Questionnaires: 
10 HCS, 2 
parents  
None general Yes 
Baker et al. 
(2008) USA 
Theoretical  IOM 2003, AAP 
2000, WHO 
(1998) 
general No 
Bergstraesser 
et al. (2013), 
Swiss 
Qualitative  76 HCP IOM 2003 and 
ACT 2009 
general No 
Collins J. et al. 
(2002), 
Australia 
Theoretical   WHO 1998  psycho-social and 
physical care (pain 
management) 
No 
Corr et al. 
(1985), USA 
Theoretical   None general  No 
Dangel 
(2002), Poland 
Quantitative  41 HCP WHO 1998 and 
ACT 1997 
general  No 
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Danvers 
(2003), UK 
Mixed method 91 question. 
(parents + 
physicians); 
interviews (17 
parents, 3 
children) 7 
focus groups 
(parents), 7 
focus groups 
(Diana team), 
86 multi-agency 
professional 
questionnaires 
None general  Yes 
Davies et al. 
(2002), USA 
Theoretical  Chipps 1998 spiritual care No 
Di Gallo et al.  
(2006), Swiss 
Theoretical   None bereavement 
care/spiritual care 
Yes 
Downing 
(2015), UK 
Theoretical   WHO (2012: two 
step analgesic 
ladder) & ICPCN 
 physical care (pain 
management) 
No 
Eggly et al. 
(2011), USA 
Qualitative  56 parents; 70 
PICU 
physicians 
AAP 2000 bereavement care Yes 
Epelman 
(2012), Brazil 
Theoretical  Clinical practice 
guidelines for 
palliative care 
general  Yes 
Fernandez et 
al. (2011), 
Canada 
Theoretical  WHO 1998 pain and psycho-
social care 
No 
Feudtner et al. 
(2013), USA 
Quantitative  126 HCP AAP 2000 general No 
Foster et al. 
(2012), USA 
Qualitative  1 case study Clinical practice 
guidelines for 
palliative care 
spiritual care Yes 
Frager G. 
(1997), 
Canada 
Theoretical  None general (but emphasis 
on physician care/pain 
management 
No 
Freyer et al. 
(2006), USA 
Theoretical  None general Yes 
Gowan 
(2003), USA 
Theoretical   AAP 2000 physical care (pain 
management) 
Yes 
Heath (2009), 
Australia-
USA 
Qualitative  96 parents IOM 2003 general Yes 
Houlahan 
(2006), USA 
Quantitative   16 inpatient 
oncology 
nurses, 8 
fellows 
WHO 1998 -
IOM 2002 - 
JCAHO 2001) 
physical care (pain 
management) 
Yes 
Hubble et al. 
(2009), USA 
Theoretical  AAP 2000 general  No 
Janssen et al. 
(2004), 
Germany 
Theoretical  ACT 1997 general  Yes 
Jones et al. 
(2014), USA 
Theoretical  AAP 2000  - 
WHO 1998 
bereavement care No 
Kang et al.  
(2005), USA 
Theoretical  AAP 2000/WHO 
1996 (pain 
general No 
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ladder) 
Kang et al. 
(2014), USA 
Theoretical  AAP 2013 general No 
Kassam et al. 
(2013), 
Canada 
Quantitative   75 parents ; 48 
oncologists 
Clinical practice 
guidelines for 
palliative care 
general No 
Lee et al. 
(2008), USA 
Qualitative  29 HCP IOM 2003 bereavement care-
moral distress staff 
Yes 
Liben (1996), 
Canada 
Theoretical  None general Yes 
Mandac et al. 
(2014), USA 
Theoretical  AAP 2000, WHO 
1998 and clinical 
practice 
guidelines 
general No 
Matthews et 
al. (2006), UK 
Qualitative 39 cases ACT 2003 
(RCPCH) 
general Yes 
Maynard et al. 
(2014), UK 
Quantitative  26 families, 60 
hospice 
professionals 
and 53 HCP 
ACT 2009 
(RCPCH) 
physical care 
(symptom 
management) 
No 
McNamara et 
al. (2008), UK 
Theoretical  ACT 2005 
(RCPCH) 
general No 
Meyer et al. 
(2006), USA 
Qualitative  56 parents IOM 2003 general (focus on 
communication) 
Yes 
Mitchell et al. 
(2015), UK 
Qualitative  8 physicians and 
6 nurses PICU 
ACT 2013 ACP Yes 
Moody 
(2011), USA 
Theoretical   WHO 1996 - 
AAP 2000 
general No 
Perilongo et 
al. (2001), 
Italy 
Mixed method 13 cases  None general Yes 
Postovsky 
(2004), Israel 
Theoretical   AAP 2000 General (emphasis on 
DNR, palliative 
sedation, nutrition 
hydration, place of 
death)  
Yes 
Pritchard et al. 
(2011), 
Canada 
Theoretical   WHO 1998 general No 
Remke et al. 
(2007), USA 
Theoretical  WHO 1998  general (emphasis on 
socio-psychological 
and pain 
management) 
No 
Remke et al. 
(2012), USA 
Theoretical  None general No 
Rushton et al. 
(2006), USA 
Mixed method 100 HCP IOM 2003 general No 
Schmidt 
(2011), USA 
Theoretical  AAP 2000 and 
IOM 2003 
general No 
Shaw (2012), 
USA 
Theoretical  WHO 2012 pain and symptom 
management 
No 
Sheetz et al. 
(2012), USA 
Quantitative  65 parents AAP 2000 - IOM 
2003 
general No 
Shelton et al. 
(2011), USA 
Theoretical  AAP 2000  physical care (pain 
management) 
No 
Solomon et al. Quantitative  211 physicians, No physical care No 
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(2005), USA 116 house 
officers, 469 
nurses 
Steele et al. 
(2008a), 
Canada 
Qualitative  6 families, 4 
HCP 
ACT 2003 general (emphasis on 
respite care in hospice 
and on continuity of 
care) 
No 
Steele et al. 
(2008b), 
Canada 
Mixed method  16 HCP WHO - AAP 
2000- IOM 2003 
general (need 
research) 
No 
Stephenson 
(2000), USA 
Theoretical  AAP 2000 general Yes 
Tan et al. 
(2006), USA 
Quantitative 236 medical 
charts of 
deceased 
children 
AAP 2000 general (emphasis on 
spiritual and pain 
management) 
Yes 
Thompson et 
al. (2009), 
USA 
Quantitative  393 physicians IOM 2003 - AAP 
2000 
general  No 
Thompson et 
al. (2013), 
USA 
Qualitative  2 case studies WHO 1998 - 
IOM 2003 
general (emphasis on 
pain management) 
No 
Toce et al. 
(2003), USA 
Theoretical  AAP 2000 general No 
Twamley et. al 
(2014), UK 
Quantitative  132 HCP AAP 2000 ACT 
2009 - IOM 2003 
general No 
 
 
The Development of Pediatric Palliative Care Guidelines 
To explore the development of PPC guidelines, we divided the studies into four different 
periods to correspond with the publication of the most important documents in PPC. 
The 1980s and 1990s: The “Thirst” for Guidelines 
We assessed four studies (one mixed-methods and three theoretical studies) that dated from 
before the 1998 WHO and 2000 AAP guidelines32-35. These papers welcomed the increasing 
trend toward honest and open communication about dying as a result of the hospice 
movement for adults, but stressed that the death of children was harder to discuss. They also 
underlined the importance of comfort and quality of life within the hospice philosophy and the 
need to include children in this type of care. They already introduced some of the central tenets 
of palliative care for children: the need for (1) total or holistic care; (2) bereavement care for 
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patients, family, siblings, and staff; (3) adequate pain assessment and control; (4) an 
interdisciplinary care team;  and (5) continuity of care. Two studies focused exclusively on the 
needs of the dying child and did not make a clear conceptual distinction between hospice and 
palliative care33,34. Corr and Corr32 defined hospice care as a form of palliative care for both 
terminal and chronic conditions, but failed to explain the difference. Frager35 marked a kind of 
transition point, as this was the first paper among the four being discussed here to explicitly 
refer to an inclusive model of palliative care that should begin at diagnosis and be available 
not only for those with an imminently terminal condition, but also for individuals with a life-
threatening disease, independent of outcome. 
In the Direct Aftermath of Landmark Guidelines (1998 – 2002) 
We assessed five papers36-40 that were published shortly after or during the publication of 
internationally recognized palliative care guidelines6,12,16,41-43. Although most of them 
acknowledged the  crucial  role that guidelines play in promoting acceptance of the palliative 
care paradigm in pediatrics, some (empirical) studies raised the concern that these well-
intentioned guidelines would remain purely theoretical in the face of the lack of national 
palliative care programs for children40. Stephenson39 stated that hospice guidelines for adults 
(life expectancy of fewer than six months and no life-prolonging treatment) are too restrictive 
for pediatrics (due to difficulties involved with prognosis). Together with Collins36 and 
Dangel40, he embraced a total and integrative model (“from diagnosis onward”) of palliative 
care, but failed to make a clear distinction between palliative and hospice care. Dangel40 
insisted that prognosis at diagnosis should be poor in order to initiate PPC. Perilongo and 
colleagues38 equated palliative care with terminal care for the dying child. 
 
The First Decade of Pediatric Palliative Guidelines (2003 – 2009) 
The 23 papers dating from this period praised the increasing interest in palliative care within 
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pediatrics but underlined the limited availability of pediatric palliative services, as well as a 
lack of knowledge and specialized staff. Gowan44 and Thompson and  colleagues45 
highlighted  the  difference between palliative and hospice care. However, they noted that this 
adult model of end-of-life care is unrealistic for children with life-limiting and life-threatening 
conditions due to the restrictive policies regarding length and type of treatment (especially in 
the United States). In line with the guidelines, a growing number of articles underlined that, 
given the prognostic uncertainty, the pediatric population would benefit most from a holistic 
and integrative approach to care, that is, they insisted that palliative care should take place 
alongside curative treatment and begin at diagnosis44-50. This concurrent approach was also 
believed to improve the acceptance and thus implementation of palliative care guidelines for 
children47,49,50. At the same time, 12 of the 23 articles explicitly focused on PPC guidelines for 
end-of-life care44,46,50-59. Two of them51,55 discussed guidelines for end-of-life homecare in 
which pain and symptom control, good coordination, and continuity of care, together with a 
partnership approach with respect to the family, are central tenets. Several papers emphasized 
the importance of honest and open communication with family members regarding prognosis 
and death52,53,57,58,60. Rushton and colleagues61 addressed the problem of moral distress among 
healthcare staff due to competing professional ethical obligations and interdisciplinary 
conflicts. They proposed a facilitation model of education to support caregivers. Two papers 
offered guidelines for pain and symptom management54,60. Several (both empirical and 
theoretical) papers acknowledged the need to adapt guidelines to a child’s individual needs, 
depending on age, maturity, culture, and religion46,47,49,51,52. The empirical study authored by 
Steele and colleagues62,63 emphasized the need for more research on family experiences, pain 
management, and bereavement care in order to improve existing PPC guidelines. In the 
present sample, 12 of the 23 papers were empirical. Two qualitative studies by Heath et al.53 
and Meyer et al. 57 reported on parental satisfaction with end-of-life care and the need to 
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integrate their priorities (honest communication, emotional support, care coordination, 
integrity of parent– child relationships, and faith) to facilitate good PPC. Four other empirical 
studies focused instead on the experiences of pediatric healthcare personnel: two articles 
addressed the issue of moral distress61,64; two others concentrated on their preparation and 
training and concluded that, although staff members assessed themselves as knowledgeable; 
their awareness of the guidelines was limited45,59. The quantitative study of Thompson and 
colleagues45 also reported that, although half of their 303 physicians (all AAP members) 
would refer patients before the end of life, very few of them would refer them at diagnosis. 
Their findings showed that implementing PPC in practice might be problematic. The authors 
expressed the need for a more practical service-related definition of palliative care to avoid 
any connotation of hospice care. 
The Most Recent Period (2010 – 2015) 
The 22 studies that dated from 2010 to 2015 reported that PPC is increasingly recognized as a 
priority by policymakers and hospital staff. Three theoretical studies conducted in the United 
States7,65,66 referred to the 2010 change in federal legislation (the Affordable Care Act), which 
allowed for concurrent care (cure-related and palliative) for children until the age of 21. Still, 
despite recommendations and growing support worldwide, an important practice gap 
continued to exist between valued services and those that effectively  reach  the  family67-69. In 
some of the world’s most populous countries, PPC services are not readily available70, and 
even within the same country there might be important differences in terms of number of staff, 
level of funding, and education, depending on the region or state71. Various studies expressed 
the need for further research on PPC in order to assess financial benefits71; improve pain 
management70,72, show clinical benefits (improved quality of life and survival)73, define 
familial needs, identify moral distress in members of the healthcare team, and explore the use 
and implications of advance directives in a pediatric population7. Almost all of these papers 
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highlighted the importance of providing holistic care that addresses the needs of all involved 
parties. 
One qualitative study focused on spiritual care for patients and families74; five studies 
concentrated on bereavement care for the family during and after the child’s death7,73-76; and 
five studies took into account the needs of healthcare professionals67,70,73,76,77. In line with the 
guidelines, various papers indicated that holistic care requires an interdisciplinary 
approach70,73,74,76,78. Another core concept supported by most of these papers is the idea that 
palliative care should be integrated into the routine care of patients with life-limiting and life-
threatening conditions, from diagnosis onward, due to its beneficial impact on patients and 
families. Finally, two theoretical studies addressed the lack of and need for specific palliative 
care guidelines for adolescents79,80. 
 
Barriers to Adequate Implementation of PPC 
Most of the 54 papers discussed the barriers to adequate PPC implementation, which can be 
subcategorized into eight different types of obstacles (table 3). The most common barriers 
discussed in these papers were connected to policy, operational, healthcare staff, and research 
factors. Other frequently occurring barriers to effective delivery of palliative care to children 
were associated with the uniqueness of the pediatric context: uncertainty about prognosis and 
lifespan make it difficult to determine which children should receive palliative care and when 
to start it. This uncertainty undermines communications between providers and families, who 
are generally more optimistic about a child’s condition than the former and thus (perceived to 
be) hesitant about implementing palliative care in a timely fashion. Another insidious 
obstacle is the conceptual confusion between palliative and hospice care among both parents 
and healthcare providers. Interestingly enough, two recent papers73,81 reported that, even in the 
case of adequate knowledge of and support for PPC principles, healthcare staff unwittingly 
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associate palliative care with end-of-life care, highlighting society’s inexperience with 
childhood death. A limited number of manuscripts focused on conceptual and operational 
shortcomings within the guidelines (among others, see Bergstraesser et al.73; Jones et al.76). 
 
Table 3. Barriers to pediatric palliative care 
Barriers Related articles 
Policy factors – 
financial factors 
Lack of human, structural, 
financial resources and 
medication 
 
Bergstraessser et al. (2013); Collins et al. (2002); Dangel 
2002; Downing (2015); Feudtner (2013); Kassam et al. 
(2013); Levine et al. (2013); Perilongo et. al (2001); 
Pritchard et al. (2011); Stephenson (2000); Thompson 
(2009); Toce et al. (2003) 
Lack of reimbursement 
 
Baker et al. (2008); Gowan (2003); Mandac et al. (2014); 
Schmidt (2011); Stephenson (2000); Thompson (2009) 
Operational 
factors 
 
 
 
 
 
 
 
 
 
 
Healthcare staff 
Lack of time 
 
Baker et al. (2008); Davies (2002); Jones et al. 2014; 
Mitchell et al. (2015); Stephenson (2000); Toce et al. 
(2003) 
Lack of education – training 
- knowledge 
(communication skills, pain 
assessment and 
management) 
 
Baker et al. (2008); Bergstraessser et al. (2013); Collins 
et al. (2002); Dangel (2002); Downing (2015); Eggly 
(2011); Gowan (2003); Houlahan (2006); Jones et al. 
2014; Kassam et al. 2013; Levine et al. (2013); Liben 
(1996); Mandac et al. (2014); Mitchell et al. (2015); 
Moody (2011); Remke (2012); Rushton (2006); Schmidt 
(2011); Shaw (2012); Shelton et al. (2011); Solomon et 
al. (2005); Stephenson (2000); Thompson et al. (2013); 
Toce et al. (2003) 
Attitude 
 
Baker et al. (2008); Dangel 2002; Solomon et al. (2005); 
Thompson (2009); Thompson et al. (2013); Twamley et 
al. (2014) 
Moral distress – discomfort 
– grief  
 
Bergstraessser et al. (2013); Eggly (2011); Jones et al. 
2014; Lee et al. 2008; Liben (1996); Matthews et. al 
(2006); Pritchard et al. (2011); Rushton (2006); 
Thompson et al. (2009); Thompson et al. (2013) 
Family factors Fear of abandonment by 
oncology team 
Epelman (2012); Pritchard et al. (2011); Thompson 
(2000); Thompson et al. (2013); Twamley et al. (2014) 
Cultural and religious values 
 
Baker et al. (2008); Danvers (2003); Hubble et al. 
(2009); Mitchell et al. (2015) 
Misunderstanding of 
prognosis/treatment goals 
Moody (2011); Thompson (2009); Thompson et al. 
(2013) 
Societal factors Death/dying taboo 
 
Ashby (1991); Corr (1985); Liben (1996); Mitchell et al. 
(2015); Moody (2011); Stephenson (2000) 
Stigma/misunderstanding of 
PPC (hospice, give up etc.) 
 
Kang et al. (2014); Pritchard et al. (2011); Stephenson 
(2000); Thompson (2009); Toce et al. (2003); Twamley 
et al. (2014) 
Treatment/cure oriented 
 
Janssen et al. (2014); Kang et al. (2005); Remke (2012); 
Schmidt (2011); Stephenson (2000) 
Clinical factors  
 
(Uniqueness of 
PPC) 
Unpredictable disease 
trajectory and 
prognosis/Uncertainty when 
to start PPC 
Bergstraessser et al. (2013); Freyer et al. (2006); Mitchell 
et al. (2015); Moody (2011); Pritchard et al. (2011); 
Schmidt (2011); Steele et al. (2008a/b); Thompson 
(2009) 
Limited number/scattered Corr (1985); Danvers (2003); Mandac et al. (2014); 
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population/rarity of death Schmidt (2011); Stephenson (2000); Thompson (2009) 
Research 
factors 
Lack of evidence-based 
research 
Feudtner et al. (2013); Foster (2012); Kang et al. (2014); 
Lee et al. (2008); Mandac et al. (2014); Moody (2011); 
Remke (2012); Schmidt (2011); Shelton et al. (2011); 
Steel et al. (2008b); Stephenson (2000); Thompson et al. 
(2009) 
Guidelines 
factors 
 
Lack of clear standards for 
some core aspects of PPC: 
PPC team; bereavement 
care; holistic care 
Remke et al. (2012); Bergstraesser et al. (2013); Feudtner 
et al. (2013); Jones et al. (2014) 
Lack of clear referral criteria Bergstraesser et al. (2013); Thompson (2009) 
 
Recommendations to Overcome Barriers to Implementation of PPC 
Seven areas of improvement were presented in the papers to help get around the barriers to 
PPC implementation noted above (table 4). Training and education of healthcare staff (and 
parents) were the most frequently listed recommendations to overcome operational barriers, 
although there were few references to precise teaching and training methods. Various papers 
identified training in pain and symptom management necessary to assess and alleviate pain in 
a timely manner and to confute the myth of opioid addiction among children. Education about 
the principles of PPC was considered crucial to avoid any conceptual confusion between 
hospice and palliative care. In particular, the principle of early integration (from diagnosis 
onward) was frequently cited as a way to make palliative care more acceptable. The underlying 
idea was that, if palliative and curative treatments are implemented at the same time, gradual 
transition of goals can occur. For the same reason, many studies emphasized the need to seek 
for the support of the PPC team (or specialized nurse) at an early stage. They could function 
as a kind of “glue” between families and primary care staff. Several papers also insisted on 
the importance of open and honest communication about prognosis and death and the need for 
guidelines to prepare parents and siblings for the child’s death. Some articles spoke of the 
need for reflective practice among healthcare staff to address their (often unconscious) 
negative attitudes toward palliative care as end-of-life care. Four articles discussed advance 
care planning as a way to facilitate this process. Closely connected to this is the concern with 
Chapter 7  Aligning Guidelines and Medical Practice 
184 
 
structured bereavement care (during and after a child’s death) to support patients, families, 
and healthcare staff in their grief and moral distress. Two papers provided recommendations 
for spiritual care. Several insisted upon the need for evidence-based research in order to develop 
clear standards for various subfields of PPC. 
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Table 4. Recommendations for pediatric palliative care 
Recommendations  Related articles 
Team collaboration  
 
(PPC team, primary care 
team, parents and general 
practitioners ) 
 
PPC specialist support – 
integration in primary care 
team 
 
Ashby (1991); Bergstraesser et al. (2013): 
Epelman (2012); Foster et al. (2012); Freyer et al. 
(2006); Hubble et al. (2009); Mandac et al. 2014; 
Maynard et al. 2014; Moody (2011); Postovsky 
(2004); Pritchard et al. (2011); Rushton (2006); 
Toce et al. (2003) 
Training/education PPC principles 
 
Baker et al. (2008); Liben (1996); Dangel (2002); 
Danvers (2003); Downing (2015); Hubble et al. 
(2009); Kang et al. (2014); Kassam et al. (2013); 
Matthews et al. (2006); Mitchell et al. (2015); 
Schmidt (2011); Solomon et al. (2005); Steele et 
al. (2008a); Thompson et al. (2009); Toce et al. 
(2003) 
Pain and symptom 
management 
 
Liben (1996); Frager (1997); Danvers (2003); 
Downing (2015); Houlahan (2006); Mandac et al. 
(2014); Janssen et al. (2004); Solomon etval. 
(2005); Thompson et al. (2013) 
Communication skills 
 
Baker et al. (2008); Bergstraesser et al. (2013); 
Heath (2009); Hubble et al. (2009); Kang et al. 
(2005); Mandac et al. (2014); Meyer et al. (2006); 
Rushton (2006) 
Reflective practice 
 
Downing (2015); Kang et al. (2005); Solomon et 
al (2005); Twamley et al. (2014) 
Use of ACP  
 
Advanced care plan Baker et al. (2008); Mitchel et al. (2015); Tan et 
al. (2006); Toce et al. (2003) 
Awareness & advocacy 
 
Among PPC staff, families, 
policy makers and society at 
large 
Dangel (2002); Fernandez et al. (2011); Hubble et 
al. (2009); Perilongo et al. (2012); Steele et al. 
(2008a); Stephenson (2000); Toce et al. (2003) 
Bereavement care Structured guidelines 
 
Ashby (1991); Bergstraesser et al. (2013); Corr et 
al. (1985); Danvers (2003); Davies et al. (2002); 
Di Gallo et al. (2006); Eggly et al. (2011); 
Epelman (2012); Jones et al. (2014); Lee et al. 
(2008); Kang et al. (2005); Rushton (2006); 
Schmidt (2011) 
Spiritual care 
 
Specific guidelines Davies et al. (2002); Foster et al. (2012) 
Research 
 
Pain and symptom 
management 
 
Ashby (1991); Downing et al. (2015); Shelton et 
al. (2011); Steele et al. (2008b) 
Objective criteria to identify 
patients and families with 
PPC needs (referral paths) 
 
Bergstraesser (2013) 
Parents’ and physicians’ 
perceptions 
 
Steele et al. (2008b); Hubble (2009); Toce et al. 
(2003) 
Collaboration and 
communication among team 
members 
Mandac et al. (2014); Remke et al (2012); 
Rushton (2006) 
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Discussion 
 
In light of the increasing number of children with life-limiting and life-threatening 
conditions, national and international organizations have developed a holistic and integrative 
model to care for this group and their families, as well as to provide guidance for healthcare 
professionals. Although PPC is gaining momentum, there is still an important gap between 
the guidelines and their implementation into medical practice. Our literature review identified 
strategies on how to overcome this gap so that all children who are eligible for PPC services 
might receive them. From the 54 studies included in the review, we found that most have 
looked at this problem mainly from a policy, clinical, or societal point of view, while only a 
few have examined the practical and conceptual pitfalls inherent to the guidelines. Our 
review suggests that some PPC principles are not always easily translated within a medical 
setting  they are seen as too theoretical to be able to deal with the complexity of the different 
stages of illness. 
 
Some Trends throughout the Literature  
Upon exploring the development of guidelines, we have found several trends that highlight 
both the emerging and continuing challenges faced by PPC over the last six decades. First, 
the very limited number of studies before 1998 is an indication of the slow growth of PPC. At 
the same time, the literature from this time period expressed an increased interest within the 
medical field for practice guidelines that inform staff and parents about the management of 
chronically ill and dying children. From 2000 onward, there is a growing recognition of the 
important role that guidelines play in the further diffusion of PPC. This is testified to by the 
steady increase in the number of publications. With the development of specific PPC 
guidelines, the main concern is the lack of palliative care services due to the absence of 
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adequate policy support (such as health insurance or national strategies that permit broad 
access). Attention is further placed upon the differences in availability of PPC services both 
across and within countries. In the studies published from the late 2000s onward, however, 
his concern takes a different form. There is an uncomfortable awareness that, despite 
increased policy support and available services, PPC is not readily accessible to all the 
children who could benefit from them. 
Second, the inadequate implementation of PPC guidelines is mainly attributed to 
shortcomings within clinical practice and a lack of empirical research on PPC. This explains 
why recommendations concentrate primarily on educational and training programs for 
healthcare staff (including critical self-reflection), on the importance of multidisciplinarity (in 
particular, on the integration of PPC specialists into the primary care team to sustain the staff 
and guarantee seamless care without brusque transitions), and on the need for more evidence 
based research on the benefits of PPC. The latter concern is manifested in the increase in 
empirical research on the perceptions of parents and caregivers with regard to PPC from 2003 
onward. 
Third, the publications in the 2000s became more careful in respecting a clear conceptual 
distinction between hospice and palliative care. Although the hospice movement has been 
important to break the veil of silence surrounding death, these papers emphasize that this type 
of care should be redefined in function of the challenges posed by pediatric healthcare. They 
also underline that hospice care, due to its association with death, is still rife with stigma. 
Therefore, in line with the guidelines and motivated by the prognostic uncertainty within 
pediatrics and the family’s improved quality of life, they embrace the paradigm shift within 
palliative care from a strict dichotomous to an integrative approach. 
Finally, among the 54 included articles, 21 focus on end-of-life issues; however, only 4 of 
them date from the period between 2010 and 2015. Two of these four studies focus on 
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bereavement care in relation to the family and caregivers, and thus not directly on the death 
of the patients. This indicates that, for a long time, death and dying were considered to be 
central aspects of palliative care, whereas this connection has become less important recently. 
This finding is in line with those of other studies have highlighted the strained relationship 
between palliative care and the reality of death82-84. 
 
Some Missing Links and Prospects for the Future 
Despite being a core principle of PPC, only a small number of publications report on the 
absence of clear  guidance in PPC documents regarding bereavement care, the challenges of 
multidisciplinary care teams (e.g., hierarchy, competing values, communication), and training 
methods. More research needs to be done on bereavement care pathways85 and effective 
teamwork. Also, further study is needed of effective teaching and training methods in regard 
to palliative care86. 
Another difficulty is linked to providing palliative care “from diagnosis onward.” Although 
considered necessary to promote the acceptance of PPC, within medical practice it is often 
seen as unfeasible. Tools that can help physicians identify children and families with 
palliative care needs can be a way to address this concern and advance PPC. Some of these 
referral instruments are already under development87,88. 
Closely connected to the previous point, although PPC is not only meant for imminently 
dying patients, the question is whether the pendulum has not swung too far from end-of-life 
issues82. Palliative care has increasingly profiled itself as a more holistic medicine and as an 
alternative to the technical dehumanized medical tradition. This overall emphasis on quality 
of life and matters concerning the living might have contributed to the conceptual confusion 
around palliative care among both physicians and the lay public82. 
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Having considered all of this, a critical assessment of both the research guidelines and 
medical practice is indeed needed in order to improve the implementation and outcomes of 
PPC. 
 
Limitations 
For this systematic literature review, a total of 54 studies were assessed. Our results should be 
interpreted with caution, as articles in languages other than English and German have 
remained unexplored. Some studies relevant to the issue might have been overlooked as a 
result of the search terms chosen. Aside from these limitations, ours is one of the first studies 
to explore barriers and recommendations for proper implementation of palliative care from 
the perspective of PPC guidelines in order to overcome the gap between recommendations 
and practice. 
 
Conclusions 
The evolution of guidelines in PPC confronts us with a true paradox: while in the 1980s and 
1990s there was an increasing demand on the part of healthcare professionals to develop clear 
palliative care standards that would take into account the uniqueness of the pediatric 
population, two decades later there is a reluctance on the part of healthcare professionals to 
implement the model that was specifically developed in function of that population. Most 
studies address either the clinical gap or research gap to address this paradox. Accordingly, 
the recommendations found in a wide range of articles are related to the need to focus on 
training, education, and evidence-based guidelines. Future studies should continue to pursue 
empirical research on PPC and foster comprehensive educational and implementation 
programs that would make PPC an inextricable part of pediatric medicine. Aside from 
research on the perceptions of caregivers and parents about PPC, more research is needed 
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from the child’s perspective in order to gain better insight into their needs and preferences, 
and thus enhance PPC services. With some important exceptions89, the child’s perspective on 
PPC is missing. Finally, to better align guidelines and medical practice, studies should begin 
to focus on the conceptual and practical shortcomings of published PPC guidelines. 
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Abstract 
 
Conceptual confusion is a primary barrier to providing quality palliative care. This study aims 
to analyze pediatric palliative care guidelines from a conceptual perspective to facilitate a 
shared understanding of palliative care in pediatrics.  
Five online data bases were searched systematically, in addition to a Google search. Analysis 
focused on the language used to determine the domains of pediatric palliative care and on the 
composition of the pediatric palliative care team.  
Guidelines express consensus on four core domains: physical, psychological, social and 
spiritual care. However, conceptual vagueness exists with respect to the latter three as 
terminology is used inconsistently both within and across guidelines.  
An inconsistent use of terminology affects the quality of pediatric palliative care nursing in 
various ways. Therefore, a shared understanding and unambiguous language must be 
envisaged. Furthermore, although guidelines agree on the most prominent team members 
they do not clearly indicate how these occupational groups should collaborate.  
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Introduction 
 
Pediatric palliative care (PPC) seeks to care for pediatric patients, their families, and other 
significant persons using an interdisciplinary and holistic approach that focuses on several 
domains of care, such as psychological or spiritual care. Reduced child mortality rates and 
improved survival rates of pediatric patients with life-threatening diseases mean that there are 
more children who will need to access palliative care (PC), but only a fraction of these 
children actually receives PC 1. Several barriers to implementation and sufficient provision of 
PPC have been identified, such as, organizational and economic obstacles1.  
Various scholars have also focused on the problem of conceptual confusion and in particular, 
on the lack of a shared understanding of PC2-6. They argue that good PC provision 
necessitates such a common understanding. Unfortunately, PC is often misunderstood both 
inside and outside the professional health care setting4.  
Recent studies in the US, Northern Ireland, the UK, Bangladesh, and Canada indicate that PC 
is relatively unknown among parts of the public and that persons who are aware of it often 
have a mistaken idea of its nature7-11. This knowledge gap may result from the ambiguous 
terminology used by health care providers2. Studies show that many physicians and nurses 
still equate PC with hospice care or end-of-life care7, and those who know the difference, 
associate PC primarily with death and dying12. Another study shows that practitioners are 
often uncertain about how to translate PC in practice13. These misconceptions not only impact 
the lay understanding of PC, but also affect clinical practice in various ways, for example, 
whether and when patients are referred to PC.  
Hence, using the right terminology is crucial as it can influence both medical practice (e.g. 
reduced number of late or non-referrals), and policy-making (e.g. allocation of more 
resources as a result of awareness). The same vision is shared by the European Association 
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for PC (EAPC): “it is obvious that an effective European approach to quality PC demands an 
unambiguous use of terms, which implies, as a prerequisite, the mutual agreement on the 
definitions of these terms”3,p.280. However, such a shared language requires a common 
standard of care to refer to5. With respect to PPC, this means that international guidelines that 
determine clinical practice need to be unequivocal. Knowing the concept of PC and being 
able to demarcate it from hospice care is insufficient if guidelines remain ambiguous.  
Unlike the studies discussed above, this study’s rationale is to explore the conceptual 
consistency within and across international PPC guidelines. The focus was set on PPC 
guidelines because of the increasing number of children with life-threatening diseases and 
consequently, the increase in children who need access to PC. Furthermore, the study 
concentrates, in particular on two main principles of PPC: holism (the various domains of 
PPC care) and multidisciplinarity (the composition of the PPC team).  
Consequently, our analysis covers two main research questions: (a) the functions, namely 
which domains of care are part of the palliative approach in the pediatric setting; and (b) the 
composition of the PPC team, namely which professions are part of it. In particular, this 
article will analyze the language used in PPC guidelines by focusing on the definitions of the 
PPC domains and on the PPC team composition in order to identify both conceptual 
consensus and possible conceptual inconsistencies. Implications of inconsistencies for 
clinical practice in general and PPC nursing in particular will be discussed. Since pediatric 
nurses often spend significantly more time providing care for the child and the family than 
other members of the PPC team, the impact of guidelines’ conceptual confusion on clinical 
practice is highly relevant for them. An enhanced understanding of PPC will enable pediatric 
nurses to better identify, understand and meet the needs and wishes of children with life-
threatening diseases and to become more aware of their own crucial role within the PPC team 
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care14. The purpose of this analysis is to advance the development of such a clear PPC 
language to result in a shared understanding and, eventually, improved practice.  
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Methods 
 
Research Design 
A systematic literature search on both international and national guidelines on PPC was 
undertaken, resulting in 11 included documents. Subsequently, analysis of (a) guidelines’ 
language used to determine the core domains of PPC and (b) the composition of the PPC 
team was carried out, thereby addressing two PPC principles: multidisciplinarity and holism.  
 
Inclusion Criteria  
The following inclusion criteria were used: documents have to be a) on PPC (infants, 
children, and adolescents are subsequently referred to collectively as “children”), b) 
developed by a national or international PC organization or a national agency, c) normative in 
the sense of providing standards regarding PPC, and d) written in English or German.  
 
Exclusion Criteria  
Articles on PPC guidelines were excluded and analysed in a systematic literature review5. 
Further, guidelines dealing exclusively with one aspect of PPC (e.g. spiritual care) or 
addressing only one group of children (e.g. neonates) were excluded since the aim was to 
identify the core domains of PPC in general. Guidelines that focus exclusively on one group 
or one aspect naturally do not touch on the question which set of domains constitutes PPC. 
 
Search Strategy 
The literature search was comprised of two parts. First, employing the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) framework15, five online 
databases (Scopus, PubMed, PsycInfo, Web of Science, and CINAHL) were scanned, 
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combining search terms through Boolean algebra as follows: (Pediatric* or child* or 
adolescent*) AND (palliati* or palliative care or hospice care) AND (guidelines or 
recommendations). Second, a Google search was next performed using the above-mentioned 
search terms expanded by the inclusion of the term “guide” in the last parentheses: 
(guidelines or recommendations or guide). Scanning the five data bases resulted in 1206 
documents, and the Google search in 27. Subsequently, 413 out of 1206 (databases) and 10 
out of 27 (Google search) were identified as duplicates; 810 documents remained (Figure 1).  
 
Figure 1. Search process using PRISMA Systematic Review of Literature 
 
 
During the next phase, two researchers screened all 810 titles and abstracts (or introductions, 
respectively), resulting in 22 documents that were potentially eligible. The references of the 
latter were checked for additional documents. Through this process 1 document was added. 
In a final step, the first author read the full text of the resulting of 23 documents. Evaluating 
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these documents led to the exclusion of 12 documents because they (1) were not the latest 
version of a document, (2) focused mainly on adult PC and touched only superficially on 
PPC, (3) addressed only one sub-group of children, or (4) presented exclusively facts without 
suggestions on best practice. A final set of 11 guidelines published between 1998 and 2013 
fulfilled the inclusion criteria (table 1).  
 
Analysis 
The analysis was carried out in several steps. First, all domains and team members were 
extracted by reading one document at the time. The focus was set on how guidelines defined 
or outlined PPC, in particular which domains of care were considered constitutive for PPC, 
and on who was considered a member of the PPC team. Thereby, any domain of care that 
was used to define PPC was included in a list of all possible domains and any occupational 
group that was part of the PPC team was included in a list of all possible team members. Out 
of the eleven documents, 10 documents explicitly referred to domains of care that constitute 
PPC and eight to which occupational groups constitute the PPC team. 
Second, those domains that were used in all documents to define PPC were identified as core 
domains. For example, psychological care was considered a core domain because all 
guidelines referred to it when defining PPC. Furthermore, all occupational groups were 
ranked according to how often they were considered a part of the PPC team by the guidelines 
(list in a descending order). This step resulted in 4 core domains of PPC, namely, physical, 
psychological, social, and spiritual care and in a descending list of how often a specific 
occupational group was considered a member of the PPC team along with information on 
which documents referred to the respective occupational group. 
Third, both authors re-read and examined the guidelines, focusing on the comparison of the 
guidelines’ terminology with respect to the four core domains. This procedure allowed 
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determination of both consensus and inconsistencies across and within guidelines. In 
particular, analysis of the guidelines’ language used to designate domains of PPC employed 
the following categories of how two terms can interrelate: (a) distinction on different levels, 
(b) distinction on the same level, (c) used interchangeably, or (d) merged to one domain.   
The term “distinguished on different levels” refers to a subordination of one domain to 
another, for example emotional needs are subordinated to psychological needs.  The term “on 
the same level” points to two independent domains without one being subordinated to the 
other, for example psychological and physical needs are two independent core domains. 
“Interchangeably” means two terms are used as synonyms to designate the same domain of 
care, like for example social and psychosocial. A “merged domain” is characterized by two 
terms that are used jointly (at the same time), for example psychological-emotional care. 
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Results 
 
In total, 11 documents were analyzed, 3 from internationally recognized organizations (1 
from the World Health Organization, 2 from the EAPC Taskforce for PC in Children), 8 from 
organizations working on a national level, spanning seven North-American or European 
countries (USA, UK, Canada, Ireland, Scotland, Germany, Austria). 
 
Table 1.  List of included guidelines 
Document Self-description and purpose 
 WHO (1998) Guide to pain management in childhood cancer and PC in children 16 
 CHPCA (2006) Guide for standards of practice, service delivery, program and policies 17 
 IMPaCCT (2007) Defining and identifying standards of care 18 
 NHaPCO (2009) Guide for palliative and/or hospice programs providing care 19 
 EAPC (2009) Examination of the state-of-the-art and the need for PPC 1 
 DoHC (2009) Foundation for developing children’s PC services 20 
 ACT (2009) Guide to the development of children’s PC services 21 
 SCYPPEx (2012) Framework for the delivery of PC for children and young people 22 
 DHPV (2013) Principles for hospice and PC for children and adolescents 23 
 BfG (2013) Concept for hospice and PC for children 24 
 AAP (2013) Statement with principles for PPC 25 
Note. AAP = American Academy of Pediatrics; ACT = Association for Children's Palliative Care; BfG –  
Bundesministerium für Gesundheit, Austria; CHPCA = Canadian Hospice Palliative Care Association; DHPV = 
Deutscher Hospiz- und PalliativVerband e.V., Germany; DoHC = Department of Health & Children, Ireland; EAPC = 
European Association for Palliative Care; IMPaCCT = International Meeting for Palliative Care in Children; NHaPCO = 
National Hospice and Palliative Care Organization, USA; PC = Palliative care; SCYPPEx = Scottish Children and 
Young People’s Palliative Care Executive Group; WHO = World Health Organization. 
 
Core Domains of Pediatric Palliative Care 
All documents, except for one that does not list particular domains of care23, identify four 
core domains, namely physical, psychological, social and spiritual care. These domains are 
further discussed below and exemplified through quotes (table 2). Besides these four core 
domains, other domains were used to define PPC. However, none of these secondary domains 
was used by all guidelines. Practical care, which refers to activities of daily living and home-
based services, is considered a separate domain in three documents17,22,25. Other aspects of 
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PPC, such as loss, grief, bereavement, end-of-life care17, cultural care24, or developmental 
care17,19 are rarely considered separate domains of PPC. Analysis of language revealed that 
conceptual vagueness exists especially with regard to psychological, social, and spiritual care 
due to inconsistent terminology both within and across guidelines (table 2). 
 
Table 2. Examples of conceptual vagueness 
Domain Category Examples 
P
sy
ch
o
-l
o
g
ic
al
  
v
s.
  
E
m
o
ti
o
n
al
 
Distinction: same level 
“The PC team (…) address[es] the physical, psychological, 
emotional (…) needs (…).”18 
Distinction: diff. levels 
“Psychological needs: (…) continual emotional support to help 
the child.”1 
Interchangeably 
“Physical, emotional, and spiritual suffering“ 
“Physical, psychological and spiritual comfort“19 
Merging “Psychological-emotional needs”24 
S
o
ci
al
  
v
s.
 
P
sy
ch
o
so
ci
al
 Distinction: same level Separate domains: “psychosocial care” and “social care”17 
Interchangeably 
“(…) minimize the child’s physical, psychosocial, and spiritual 
(…) suffering” 
“(…) address physical, social (…) and spiritual needs of 
children”19 
S
p
ir
it
u
al
  
v
s.
 
R
el
ig
io
u
s 
  
  
  
E
x
is
te
n
ti
al
 Distinction: diff. levels 
“Spiritual care: (…) Formal caregivers address the child’s and 
family’s existential questions (…).”17 
Merging 
“Relieve suffering across multiple realms, including (…) 
existential or spiritual (why is this happening?)”25 
Distinction: same level 
“Formal caregivers determine what distinguishes spiritual 
from religious practice”17 
Distinction: diff. levels “Spiritual needs: (…) religious background.”1 
Merging “Spiritual and/or religious care” or “spiritual/religious”18 
Note. Diff. = Different. PC = Palliative care; PPC = Pediatric palliative care. 
 
Physical care is mostly identified with pain. Pain is used to indicate not only physical, but 
also psychosocial, spiritual19, and emotional aspects of pain16. Frequently, the physical and 
emotional aspects of pain are grouped into broader categories of symptom management or 
pain management. Finally, one document uses the terms “clinical needs” and “physical 
needs” interchangeably when referring to children’s needs that require physical care1. 
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Psychological care is often used inconsistently across documents because the concept is not 
sufficiently demarcated from emotional care (table 2). First, some documents distinguish 
these two as different concepts. They either clearly distinguish psychological needs from 
emotional ones on the same level of definition18, or they consider emotions to be a 
subcategory (different level of definition) of the broader psychological domain1,19. Second, 
one of the documents only uses the term emotional care and does not mention psychological 
care when referring to this particular need of a child22. Third, in one case the two terms are 
merged into a single domain of psychological-emotional care24. Conceptual inconsistency can 
be found not only across, but also within one and the same document. For example, two 
documents list emotional care as a PPC domain, thereby either implying that it covers 
psychological care or that psychological care is not a domain of PPC, but then clearly 
distinguish psychological from emotional support elsewhere, thereby apparently referring to 
different concepts 18,20. Furthermore, one document lists both psychological well-being and 
the emotional impact of an illness as two separate subcategories of PPC’s domain of 
psychosocial care, thereby distinguishing emotional and psychological on the same level and 
subordinating both terms to psychosocial care17. Finally, in some cases both terms are used 
interchangeably19,25, for example, one document first lists realms of a child’s suffering as 
follows: physical, psychological, practical, and spiritual, before it later enumerates  “physical, 
(…), emotional, practical and spiritual needs of the child”, thereby apparently equating 
emotional and psychological needs across the two enumerations25,p.968. 
 
Social care is another concept that is used inconsistently both across, but especially within 
documents because it is not sufficiently demarcated from psychosocial care (table 2). One 
document uses the terms “social care” and “psychosocial care” to indicate two separate 
domains by providing a separate section for each of them17, thereby distinguishing them on 
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the same level. Most guidelines, however, only use social care to designate this particular 
core domain of PPC1,16-22,24,25. In some cases, the term is  coherently  used throughout the 
text, hence avoiding conceptual vagueness1,18,22, but in others it was used interchangeably 
with psychosocial care16,19,20,24,25. For example, one document first refers to the social domain 
(besides the psychological, spiritual and physical) that is addressed by PPC and later states 
that “psychosocial (…) domains of distress” or “psychosocial (…) needs” have to be 
addressed (besides physical, emotional, practical, and spiritual needs), thereby using both 
terms to describe the same domain and a fortiori equating both terms25. Another one uses the 
two terms interchangeably across two analogous enumerations of care domains (table 2); the 
document uses “psychosocial” in the first enumeration, and the term “social” in the second19. 
Moreover, one document uses the psychosocial domain to define PC in general, but the social 
domain to define PPC, indicating that this represents a conceptual difference either between 
social and psychosocial or between PC for children (this particular PC includes the social 
domain) and adults (this particular PC includes the psychosocial domain)20. 
 
Spiritual care is frequently mentioned in connection with existential care (table 2). One 
document distinguishes the two concepts on different levels by subordinating existential to 
spiritual care17. A few guidelines only use the term spiritual care, thereby avoiding 
conceptual vagueness19,24. Finally, one document lists spiritual care as a separate domain in 
the headings, but makes references to “spiritual/existential” or “existential or spiritual” 
throughout the text 25, thereby creating a merged domain. Other documents set spiritual care 
alongside religious care (table 2). One document mentions the “religious background” as an 
aspect of spiritual needs, thereby subordinating religious to spiritual care1. Furthermore, two 
documents differentiate spiritual and religious care on the same level, one as separate parts of 
an end-of-life plan20, the other one requires formal caregivers to distinguish spiritual from 
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religious practice17. Finally, both terms are merged to create one domain: for example, 
“access to spiritual and/or religious care” and “spiritual/religious worker”18. 
 
Composition of PPC Team 
With the exception of three guidelines19,22,23, all other documents discuss the particular 
multiprofessional composition of the PPC team and insist on its interdisciplinary 
collaboration. The most frequently listed members are: physicians and nurses (all 8 
documents), followed by social workers who were not listed in one document16, 
psychologists1,17,18,21,24, chaplains16,17,21,24,25, volunteers16,17,21,24,25 (5 documents), and 
physiotherapists1,20,21,24 (4 documents). Three documents listed occupational therapists1,20,21. 
Child-life therapists17,18 and pharmacists17,21 are mentioned in 2 documents; spiritual advisors 
in 118. All documents require the PPC team to collaborate with the family and the child. 
Several documents highlight the importance of a designated person who coordinates the PPC 
services, such as a care coordinator18,19,24, key worker18, navigator17, lead doctor and nurse22. 
However, no clear indications are given on how the team members (how, when, under what 
circumstances, authorities, procedures etc.) can or should collaborate. 
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Discussion 
 
In the analyzed documents, there is a broad consensus on the set of four core domains that 
constitute the holistic approach of PPC. However, across and even within some of the 
documents three domains lack conceptual clarity, as the use of the terms is often inconsistent. 
Since an effective approach to quality PC necessitates an agreement on definitions of terms, it 
is paramount to examine how this conceptual confusion might affect the quality of PPC.  
 
Pediatric Palliative Core Domains 
First, it remains unclear what separates psychological from emotional care, social from 
psychosocial care, and spiritual from religious or existential care. Whereas the term 
“psychological” embraces both cognitive and emotional aspects, the term “emotional” refers 
to affective states (e.g. pleasant, unpleasant) and thus has a narrower focus than psychological 
care26,27. An enhanced and broadened focus would better respect a child’s right to 
development (enshrined in article 6 of the United Nations Convention on the Rights of the 
Child (UNCRC) which, among other factors, requires support for intellectual 
development28,29. For the PPC context, intellectual needs are cognitive aspects of care, such 
as those related to a child’s growth in knowledge, critical thinking, learning new things, or 
making sense of the illness experience. These aspects reach beyond mere schooling and 
education, which represent rather formalized areas of children’s intellectual development, and 
need to be made available. Apart from neglecting the cognitive needs of children, an overly 
narrow focus on emotional needs might reinforce the assumption that children, due to their 
age and developmental stage, are cognitively impaired, lack decisional capacity, and need 
surrogate decision-makers. This reinforcement decreases the likelihood of children’s 
involvement in the decision-making process, for example, on whether to start PC. Including 
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children in these decisions is unanimously recommended by all guidelines, as well as by the 
UNCRC29. Therefore, the term psychological is preferable as it encourages health care 
providers to involve children, simultaneously identifying and meeting both cognitive and 
emotional needs. 
Furthermore, not sufficiently demarcating social from psychosocial care leaves the question 
open of how these types of care are different. Unlike “social,” the term “psychosocial” 
pertains to the interwoven psychological and social aspects of care as well as to the social 
determinants of health30. In contrast, social care more narrowly focuses on the social relations 
and significant others themselves (e.g. family, friends). However, social relations sui generis 
have a direct impact on the psychological state of an individual, and therefore, the 
psychological dimension is always implicitly considered by social care. That being said, one 
can legitimately raise the question what the term “psychosocial care” actually adds to social 
care? Ultimately, the term “psychosocial” more directly refers to the twofold meaning of 
social relations, namely the relations themselves and their impact on the psychological state. 
Given this blurred demarcation, it is unsurprising that studies have shown that the provision 
of psychosocial care is hampered due to unclear responsibilities among team members31. 
Especially with respect to psychosocial care, it is therefore important to not just articulate that 
team members work together, but to critically examine the collaboration31. 
Finally, spiritual care lacks conceptual clarity as it is narrowly connected with existential or 
religious care, but the relations among these terms remains blurry. Given the subordination of 
existential and religious care to spiritual care, spiritual care appears to be the most suitable 
term in order to designate this particular core domain. This is further backed up by experts’ 
understanding of spirituality as composed of various elements, such as religious and 
existential aspects32. Using spiritual care as the most inclusive term might also align with 
modern pluralistic societies and suggests a neutral, inclusive stance of medical guidelines.     
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Second, diverging definitions of psychological, spiritual, and social care might hinder an 
adequate understanding of the core domains of PPC, and this may influence the creation and 
coordination of an effective PPC team. The members of the team can only reach an 
agreement on how to operate if they have a clear understanding of their roles and 
responsibilities. Misunderstandings about each other’s tasks, skills and expertise might cause 
interpersonal conflicts and competition33. For example, a study has shown that with respect to 
psychosocial care, PC team members exhibit a lack of clear role boundaries. Some members 
believe that any team member can meet the patient’s psychosocial needs31. Interestingly, 
nonspecialist psychosocial team members perceived these unclear roles as positive, specialist 
psychosocial team members as negative. This situation causes a division of the team as it 
leads to so-called “contested realms”, that is, team members attribute specialist expertise to 
themselves while doubting the expertise of colleagues31.  
Due to their nature as multiskilled professionals, pediatric nurses are especially prone to 
facing overlapping roles and responsibilities when working in a multidisciplinary team. 
Again, a shared understanding of language that avoids ambiguous terms and a clear 
understanding of individual roles facilitate skillful communication within the team. Members 
of the team, and nurses in particular, need to be able to articulate their expertise and 
knowledge in order to maximize the benefit from the numerous skills of the team members33.  
Literature also shows that reflective practice among team members, for example hearing 
narratives of experiences by other members, can additionally improve teamwork34. However, 
in order to improve practice in such a way, it is necessary that the team members share the 
same terminology and use it consistently. 
In an efficient team that works successfully towards its goals, every member needs to have a 
clear understanding of their own contribution to the team35. Besides interpersonal conflicts 
and competition, differing uses of terms among team members can result in partially 
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conflicting understandings of one owns contribution, and thereby in different types of care, in 
involving different experts, and possibly in not meeting a child’s needs sufficiently.  
The term psychosocial care indicates the need to focus on the impact that social relations 
have on the child’s psychological state, for example through psychotherapy or psychiatric 
drugs. Social care, puts more emphasis on the social relations themselves that can be 
addressed by a social worker through involving significant others within a systems approach. 
Even though psychological care refers to both a child’s intellectual needs, for example 
explaining the cause of the disease in a developmentally appropriate way, and emotional 
needs, for example dealing with despair with the help of a psychooncologist, the guidelines 
sometimes represent only the emotional aspect and neglect the intellectual one. Finally, if 
spiritual care is limited to providing religious care, a chaplain might be the best choice, but if 
it rather embraces existential care, an occupational therapist, which helps to make hand prints 
for reminiscence is better meeting the requirements. As apparent from the preceding 
examples, the particular understanding of one core domain determines not only which 
occupational group is involved, but also the factual care outcome. 
 
Composition of Team 
First, all analyzed documents emphasize that PPC should be put into practice by a 
multiprofessional team whose work is not limited to the hospital setting, but that works 
across several health care settings and adapts care dependent on a child’s particular needs. 
The team members should collaborate in an interdisciplinary way.  
Results of the analysis revealed that the core of the hospital’s PPC team is comprised of a 
physician and a nurse. Social workers represent the second most-mentioned group; 
psychologists, clergy, and volunteers the third. Other staff members, for example 
pharmacists, are listed only occasionally. The results confirm findings of other studies which 
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show that for PC experts the core team is composed by physicians and nurses (absolute 
minimum), psychologists, social workers, and physiotherapists36. However, in the same study 
controversies were found regarding psychologists and chaplains which are somehow mirrored 
by the fact that some of the analyzed documents do not list these groups.  
Second, the question of how the team members’ interdisciplinary collaboration should look 
like was not addressed substantially, as this best practice advice was only mentioned but not 
elaborated in depth. This is unfortunate, since, according to Remke and Schermer, a shared 
vision of how the team’s objectives will be achieved promotes successful team work by 
increasing the degree of efficiency, of trusting one another, and of satisfaction with the own 
role37. Besides, it is vital for pediatric nurses not only to know the team members, but to be 
provided with basic information on the interdisciplinary approach14.  
The disagreements regarding the final team composition and the unspecified interdisciplinary 
collaboration represent a double-edged sword. On the one hand, this unfixed model takes 
account of the necessity of a flexible, individual-based, and context-sensitive approach of 
PPC by preserving open-endedness and adaptability of care38. On the other hand, it opens the 
doors to interpersonal conflicts in light of team members’ tendency to protect their own 
expertise in case of overlapping skills33. 
Third, most guidelines agreed on designating a coordinating person that serves as both a port 
of call for the family and, at the same time, as a centre of convergence for important care-
related issues. Recent studies emphasize that coordination of a multiprofessional teamwork is 
crucial for providing quality PC and reaches beyond only one single coordinating person, for 
example to multidisciplinary team meetings or team training programs31,35. However, one 
designated coordinating person seems to conform to a minimum of coordination which has to 
be at hand in every team at every moment. A coordinating person should address the task of 
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monitoring the team composition and collaboration, thereby helping to avoid interpersonal 
conflicts among team members and unmet needs of the child.  
Because pediatric nurses are key team members who provide multiple domains of care and 
spend significant amounts of time with the child and family, they represent a suitable 
candidate for coordinating care that is in the best interest of the child. In fact, a study has 
shown that referral rates were greater in PPC teams with an advanced nurse practitioner39.  
Fourth, the two analyses (domains and team composition) converge because the four 
identified core domains of PPC can be covered by those occupational groups which are 
considered members of a PPC team by the majority of the guidelines.  
 
Limitations 
First, only guidelines that were written in English or German were included. Second, 
important guidelines might have been overlooked because of the search terms that were 
chosen for the literature search. Third, to some extent linguistic differences reflect cultural 
and historical differences which may have an impact on the concrete form of PC and on 
terminology. Consequently, differences in terminology will continue to exist and are 
legitimate, but this study’s findings rather reflect differences due to conceptual confusion and 
a not sufficiently attentive use of terminology.   
 
Conclusion 
Our analysis indicates a broad consensus on four core domains. At the same time it reveals a 
lack of conceptual clarity for three domains. This is problematic insofar as conceptual clarity 
is an important prerequisite for quality PPC. Consequently, these terms need clarification, 
whereby the avoidance of using multiple terms for designating the same domain can serve as 
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a first step. The terms should be used more deliberately, considering (seemingly) small 
linguistic differences and their (likely) effects on clinical practice.  
Since pediatric nurses are involved in all core domains of PPC, an unambiguous terminology 
that facilitates quality PPC is especially beneficial for them. Despite the benefits of shared 
terminology, the authors acknowledge that several barriers complicate a consensus. With 
respect to terminology countries differ considerably regarding history and language. 
Similarly, a study on understandings of PC, highlights the different historical developments 
of PC among European countries as potentially hindering36, and considers the specific nature 
of PC as set out by the WHO to be a barrier to reaching an agreement on the scope of PC. 
Still, any PC definition should be based on patient needs and corresponding domains of care. 
Apart from affecting medical practice, conceptual vagueness might magnify the already 
existing knowledge gap of PC among the lay public. This pathway is mediated by the 
inconsistent use of terminology among professionals. Inconsistent guidelines lead to an 
inconsistent use of terminology among health care professionals which eventually contributes 
to laypeople’s knowledge gap and confusion; Bergstraesser has rightly stressed this 
interplay2. It is self-evident that greater knowledge, less confusion, and raised awareness for 
PPC on the part of the lay public (but also within academia and clinical practice) promotes 
higher acceptance and consequently, in the long run, more resources allocated to PC. 
With respect to team composition, guidelines agree on a standard that contains physicians and 
nurses, and that is complemented by several other professions. The guidelines neither specify 
how these occupational groups should collaborate nor who should be part of the 
complementary group. This situation comes along with benefits and risks. It is of crucial 
importance to work toward further improvement, for example by designating a coordinator 
who utilizes this ambiguity to tailor PC to a child’s specific needs. 
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Finally, the authors acknowledge that PPC must be an individually tailored endeavor that 
cannot be fully formalized. Aiming for a shared understanding of domains in order to 
facilitate optimal care does not contradict this notion. On the contrary, quality care requires 
pre-existing structures and expertise on which the team can build best possible care, thereby 
meeting a child’s needs by adapting to the particular illness profile6. This study contends that 
the quality of PC can be facilitated by a consistent use of language, as expressed by R.W. 
Emerson: “thought is the bud, language is the blossom, and action the fruit behind it”. 
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Summary 
 
Decision-making capacity (DMC) is the sine qua non of informed consent, since the latter is 
only valid if it is provided voluntarily, knowingly, and rationally1. This, in turn, requires a 
patient’s DMC to understand, appreciate, and use the information that was disclosed2. 
Further, to become legally binding a competent patient’s decision necessitates DMC. Most 
legislations presume a patient to be competent from the age of 18 onwards1,2. However, 
applying the concept of DMC in the pediatric setting entails various challenges3. One main 
reason is the persisting view of children as a cognitively impaired class that lacks decisional 
capacity1,4. As a consequence, in clinical practice parents mediate the (minor) patient-
physician relationship as surrogate decision-makers resulting in a triadic constellation of 
shared decision-making3,5. Having considered this, the question arises whether such an 
understanding of capacity that mainly refers back to adult-centred notions (e.g. autonomy) 
can facilitate children’s involvement in decision-making. 
 
Conceptual and Definitory Challenges             
Despite lacking legal competence, children are increasingly involved in decision-making as a 
result of ethical guidelines’ recommendations6 and, at the same time, are generally less 
perceived as impaired adults but rather as active beings that are part of the society7. 
Nevertheless, adequate implementation of children’s involvement still proves to be difficult 
because of numerous barriers6,8. From a conceptual perspective it remains unclear what is 
meant by “having DMC”. There are two main conceptualizations of DMC. On the one hand 
there is the mainstream account according to which DMC should be assessed based on the 
process regardless of the decision outcome9. Here, DMC is conceptualized procedurally as a 
mental ability determined by the principles of logic and rationality10. Theorizing DMC as a 
process of rationality is strongly linked to notions of autonomy and informed consent which 
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perceive persons as rational agents. On the other hand several criticism of such a cognitivist 
model of capacity prepared the ground for alternative models11-14. The latter share the 
conviction that the former neglects the interdependence of the self and argue that other 
determinants of DMC need to be acknowledged (e.g. social, political). Further, they express 
the concern that a narrow cognitivist and rationalist conceptualization of DMC could lead to a 
discrimination of cognitively impaired persons (e.g. children). Therefore, they argue for 
considering so called substantive or non-cognitive factors (e.g. emotions, beliefs, values)15. 
Besides differing conceptualizations of children’s DMC, various attempts to develop an 
empirical assessment tool have been made. However, these tests are based on the underlying 
definitions of and assumptions regarding DMC16. For example, Hein et al. have developed an 
instrument for children by modifying the MacArthur Competence Assessment Tool for 
clinical research17,18. The latter focuses on cognitive criteria for capacity as set out by 
Appelbaum and Grisso19. Again, this focus on cognition is normatively laden as it is derived 
from the ideal of an autonomous and self-directed adult20.      
Bearing in mind the different conceptualizations of DMC and their perpetuation into different 
definitions of DMC and, in the end, into various assessment tools for DMC, we propose to re-
think the traditional cognitivist model by approaching DMC through the lens of Gallie’s 
notion of essential contestability21. Therefore, in what follows, we outline the seven criteria 
of essential contestability according to Gallie as well as their applicability to DMC. 
 
Essentially Contested Concept: Criteria and Applicability to Decision-Making Capacity 
When the philosopher Walter Bryce Gallie introduced the notion of essentially contested 
concepts six decades ago21,22, he was primarily concerned with the way concepts are used and 
applied within societal debates and not so much with the philosophical nature of concepts23. 
He defined essentially contested concepts as “concepts the proper use of which inevitably 
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involves endless disputes about their proper uses” that are unresolvable through the use of 
rational arguments21,p 169. It is important to note that this definition does not refer to 
conceptual confusion or to strongly disputed concepts, which represent rather practical 
problems and, in principle, are resolvable24,25. In contrast, a concept is essentially contestable 
if it inheres the potential to generate discussions that are somehow undecidable26.    
Gallie provided seven criteria for essentially contested concepts21. Criterion I: they have to be 
evaluative, that is they have to convey a value judgement. Assessing the capacity of a person 
always implicitly expresses a normative statement, namely whether a person should be 
allowed to make decisions. Criterion II: as they embrace various dimensions, they are 
internally complex. DMC contains a number of internal components, such as procedures, 
rational cognition, social and individual factors etc. Criterion III: Because of the second 
criterion they offer an immense number of conceptions. Depending on the focus of the 
respective approach, different conceptions of DMC exist. Criterion IV: they have to be open-
ended and dynamic in nature. Besides the existence of various approaches to DMC, the 
openness criterion is also evident in the fact that the set of conceptions of DMC is changing 
over time, for example “reasonableness” was required for DMC27. Also, conceptions may be 
adapted in face of changed circumstances, as it is the case with the variable standard for 
DMC (e.g. greater levels of capacity for more complex decisions). The aforementioned 
concepts represent “the four most important necessary conditions to which any essentially 
contested concept must comply”21,p 172. There are three further criteria. Criterion V: 
essentially contested concepts are interpreted differently and used aggressively and 
defensively against other users’ conceptions. Without any doubt, this is the case for DMC. 
Criterion VI: these concepts are exemplar that is they agree on a shared minimum28. The 
various approaches portray DMC as a gatekeeper to autonomy. Criterion VII: the ongoing 
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disputes about an essentially contested concept cause improved understanding and a fuller 
realization of these concepts. In the following, we will explore in how far this is fulfilled.  
 
Conclusion: Usefulness for Decision-Making in Pediatrics 
The current predominant perception of DMC as a cognitive ability residing within an 
individual obscures the multidimensional determination of capacity (relational, cultural, 
cognitive etc.) and suggests that capacity could objectively assessed. Thereby, it neglects the 
fact that capacity always evolves within a cultural framework which shapes that same 
capacity. Generally, understanding capacity as an essentially contested concept gives space 
for alternative approaches and emphasizes the questionability of the current mainstream 
model of DMC. Particularly, it enables to question the cognitivist standards that are 
underlying children’s capacity assessments which not only shifts away from narrowly 
focusing on cognitive abilities when assessing DMC, at the same time it refers to the 
possibility to enhance capacity by taking into account extra-individual factors29,30. 
Since children are still seen as lacking cognitive abilities of “normal adults”, they are not 
granted the assumption of having decisional capacity, but carry the burden of proof for 
capacity31. This is not to deny that children are still developing and lack certain cognitive 
abilities, but to underscore that children, to a great extent, are emotionally, socially, and 
financially dependent on others32. As a result, their capacity might be hindered by parental 
attitudes and physicians’ experience, workload, and values.  
In conclusion, non-cognitive determinants of children’s DMC need to be considered. This 
requires a shift away from a deficit model of capacity (lacking cognitive abilities) to one of 
shared responsibility, where all parties involved in decision-making contribute to capacity6,31. 
Defining DMC as an essentially contested concept and, thereby, allowing alternative models 
does not inhibit, but facilitates such a shift.         
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1 Integrating Empirical Results and Ethical Analysis 
 
This section is arranged in three parts (figure 1). The first part presents results related to the 
conceptual background of SDM with a focus on the conceptualizations of PPC and decision-
making capacity. The second part illuminates pre-existing conditions of SDM, such as 
perceptions of involved parties, evaluations of children’s capacities, treatment-related burden, 
and barriers to the implementation of PPC. The third part discusses the process of SDM, 
namely a child’s involvement, the parents’ roles, and the structure of decision-making. 
 
 Figure 1. Synopsis of main findings 
 
 
1.1 Conceptual Background of Shared Decision-Making  
With respect to the core domains of PPC, the conceptual vagueness within and across 
guidelines (chapter 8) underscores the need for a shared understanding and unambiguous 
terminology. A mutual understanding of these terms is a prerequisite for the provision of 
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quality PPC1. As demonstrated, failure to achieve a shared understanding leads to 
interpersonal conflicts and competition within the PPC team, affects the factual care outcome, 
and colors the perception of children and their decisional capacity. For example, by narrowly 
focusing on emotional needs, cognitive needs are likely neglected, which might reinforce the 
perception of children as cognitively impaired and, in the end, increase the likelihood of their 
exclusion. As such, a consistent use of language not only helps to facilitate quality PPC and 
intra-team collaboration, but also improves children’s involvement. 
The proposed recognition of decision-making capacity as an essentially contested concept 
(chapter 9) overcomes the rationality-centered approach to capacity that originates from an 
individualistic understanding of autonomy. This is important, because solely reifying capacity 
as a cognitive ability of a child overshadows social, biographical, and cultural determinants. 
This is of course not to say that practitioners should refuse to assess capacity, but rather to 
point out that conceptualizations of capacity cannot be found or detected  as if capacity is a 
mere matter of fact, instead they are always selected, for example from within a given 
cultural framework2. Doing justice to the complexity of the concept of capacity as well as to 
children’s actual capacities requires analysis beyond a determination solely on the basis of 
measurable cognitive properties2. Any ethically sound conceptualization of decision-making 
must analyze how capacity is determined. In doing so, the reported study (chapter 9) 
concluded with recognizing capacity as an essentially contested concept, thereby, allowing 
alternative approaches to inform and enrich the ongoing debate.  
The reported findings on the domains of PPC (chapter 8) and on the conceptualization of 
decision-making capacity (chapter 9) have a point of convergence. The former warns against 
reinforcing the assumption of cognitively-impaired children and the latter rejects identifying 
capacity as an exclusively cognitive trait and, thus, de-emphasizes the significance of 
cognition for conceptualizing and assessing capacity. Interestingly, both neglecting and 
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overemphasizing cognitive aspects are likely to result in children’s decreased involvement in 
SDM. Neither bypassing cognitive aspects nor exclusively considering them accurately 
assigns the value to children’s cognitive capacities when thinking about their role in decision-
making. Finally, the fact that cognitive aspects are sometimes neglected and sometimes 
overemphasized mirrors the difficulties to construe minors’ decisional capacity.  
Furthermore, an important insight into how the conceptualization of PPC has changed over 
the past decades is provided (chapter 7). Within more recent guidelines (2010-2015), the role 
of end-of-life issues has become less important, while the notion of quality of life has 
garnered more attention. This change may have contributed to the conceptual confusion 
between palliative and hospice care among the lay public and physicians, and it leads to the 
question, has the pendulum swung too far away from end-of-life issues3. Whilst turning away 
from an emphasis on end-of-life issues may help to sharpen the focus on quality of life, it is 
questionable whether this refocus actually represents the lived realities of families whose 
experiences, in face of cancer, often are characterized by contemplation of death and dying. 
Related to the decoupling of PPC from death and dying, a final concern (chapter 5) is that 
although pediatric oncology providers are aware of the PPC principles outlined by the WHO, 
they insisted that it is best provided when the disease is unresponsive to curative treatment. 
How to implement such a philosophy into medical practice remains a lingering challenge4. 
Today, practitioners in Switzerland are confronted with a dilemma. Either they attempt to 
rebrand PPC, for example as comfort or supportive care, to counter families’ feelings of 
abandonment and avoid associations with end-of-life, or they continue to use the term with its 
associated connotations. While the former loses sight of the original aim and risks to deny the 
significance of death and dying in PPC, the latter continues to make families uncertain and, 
thereby, impedes the acceptance of palliative care among the public. As long as this situation 
prevails, proper implementation of PPC and discussion of PPC within SDM are hindered. 
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1.2 Pre-existing Conditions of Shared Decision-Making  
This thesis identified various conditions that already exist when SDM is initiated. First, 
reported findings reveal some characteristics of the parties involved in SDM. The disparity 
between parent and physician perspectives (chapter 2) indicates systematically different 
views of the child. Parents deemed their children more capable than physicians did regarding 
the child’s understanding of the diagnosis and prognosis. Additionally, compared to 
physicians, parents evaluated the impact of the disease on their children as worse (e.g. more 
suffering, longer duration), and finally, parents believed their children to be more satisfied 
with decision-making than physicians did. Regardless of which outlook is closer to the truth, 
it should be acknowledged that these varying perceptions might negatively affect SDM due to 
a limited understanding of the other party’s perspective or due to disputes about the child’s 
capacities and health status. SDM, which requires parties to (a) share information, (b) work 
towards a consensus, and (c) reach an agreement5,6, becomes an empty formula without 
serious consideration for how these parties differ from each other. This finding is important 
as it reminds everyone involved in SDM of the underlying perspectivity of what seem to be 
factual and intersubjectively shared (by physicians and parents) assessments. Whether they 
are shared cannot be assumed, but warrants active research.  
The reported findings on how treatment comprehension and decision-making capacity are 
evaluated in children (chapter 2) support assessment of capacity based on the type of 
decision, among other factors7. While understanding diagnosis and the response to treatment 
were judged to be the easiest (turning points: 6.5 and 6.0 years), making treatment decisions 
was considered as more difficult (turning point: 11.5 years). Again, SDM always refers to a 
particular decision that determines whether (and to which extent) or not a child should be 
involved. In this respect, decisional capacity aims to align the decision’s difficulty and 
subject with the child’s characteristics. Similar to this, another study (chapter 3) shows that 
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most children older than 13 years of age were involved in decisions regarding palliative care 
(turning point: 13.5 years), suggesting that end-of-life decisions were evaluated as most 
difficult. Overall, findings on the evaluation of children’s capacity (chapter 2 and 3) 
underline the necessity to think of capacity as changing across decisions.           
Second, results of the reported studies reveal treatment-related variables that influence SDM. 
As described, children suffering from cancer and their families face a significant burden of 
treatment that goes beyond just side effects (chapter 4). Adherence to the treatment regime 
has highly disruptive effects on families’ daily lives, for example on working lives, social 
lives, and leisure activities. This study’s findings advocate for thinking about burden of 
treatment from a family perspective. Thus, health care professionals must be aware of the 
disruptive effects that pervade the entire family unit. Also, recognizing the family as one unit 
of care means to apply a systemic approach to SDM: to address individuals as members of a 
family unit, instead of each individual separately, and to be aware of the importance of the 
stability of family structure for the child. Finally, a high level of burden of treatment deprives 
families of personal (e.g. engaging in leisure activities) and social (e.g. sustaining 
friendships) resources that cannot be used for the challenges at hand (including participating 
in SDM), which, eventually, amplifies a child’s vulnerability. Another essential finding is 
that leukemia patients are confronted with an even higher burden of treatment, as measured 
by number of inpatient stays, inpatient visit duration, and the likelihood of dying in the 
hospital (chapter 4). This translates itself into a higher burden for the entire family. It is 
important not to (unintentionally) underestimate leukemia patients’ burden of treatment 
because of their comparably good prognosis8. In sum, better understanding a family’s burden 
due to treatment adherence improves the understanding of a family’s situation which 
improves SDM and helps to live up to the bioethical ideal of minimally disruptive medicine9. 
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Moreover, two studies report that PPC consultations occurred late in the illness trajectory and 
palliative care began close to death (chapter 3 and 6). This finding is not in line with 
recommendations of international health organizations, which recommend that palliative care 
begins at diagnosis10-12. Although PPC initiation should be tailored to each individual child, 
evidence of late PPC initiation highlights need for improvement at the aggregated population 
level. To better meet PPC guidelines, barriers to timely initiation need to be overcome. The 
broad evidence of late PPC initiation suggests that strict adherence to the standards set out by 
the guidelines may not always correspond to the best interests of the patient at an individual 
level. Finally, the initiation of PPC occurred even later in the illness trajectory for leukemia 
patients (chapter 3). While the better prognosis might be the reason for this, practitioners 
need to be cautious not to withhold the benefits of PPC from this group. 
Third, barriers to proper implementation of PPC, but also specific barriers to adequate SDM 
on PPC were identified. Results revealed the following barriers to SDM on PPC (chapter 7): 
operational factors (e.g. physicians’ lack of time and education) and familial factors (e.g. fear 
of abandonment, cultural values, misunderstood treatment goals). Lastly, another study 
employing focus groups with health care professionals (chapter 5) revealed parental 
misunderstanding of PPC and different cultural backgrounds of families as main barriers to 
timely implementation of PPC. It is self-evident that the aforementioned barriers are likely to 
negatively impact decision-making. Once they are known, they need to be tackled and, if 
possible, overcome. Whereas tackling structural and financial barriers at an institutional level 
is a costly endeavor, most personal barriers on the part of the involved parties can be 
overcome with a comparatively small amount of resources. For example, proactively 
reflecting on (individually and within the team) and subsequently addressing these barriers 
early in SDM (when talking to the family) could facilitate overcoming them. 
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1.3 Process of Shared Decision-Making  
Reported results show that parents’ actual roles in SDM did not match their preferred roles in 
one-third of the cases (chapter 2), even though physicians were able to correctly assess the 
preferred roles. Parents’ actual role was typically more passive than they wanted. Enabling 
parents to hold their desired role is crucial because holding less active roles was shown to be 
associated with lower satisfaction with SDM13. However, this requires constant assessment of 
parental roles, both preferred and actual. Related to this, findings on information provision by 
physicians (chapter 2) offer a consistent pattern of parents rating the amount of information 
they received as less satisfactory than physicians rated them. Again, this supports the need for 
practitioners to actively assess whether the proffered information was correctly understood. 
Having considered this, it appears that physicians need to engage in a proactive, continuous, 
and critical practice of ensuring that parents are on the same page. 
Children’s involvement in SDM is predicted by their age and gender (chapter 2). While it is 
in line with international guidelines that older children are more likely to be involved, the 
greater involvement of girls, as seen in evidence, is not. The earlier maturation of girls is a 
popular truism that appears to be backed up by neurobiological evidence that points to faster 
brain maturation for girls14. In some countries, this evidence translates into legislation in 
which male and female minors are generally considered competent starting at different 
ages15. Subject to further research, the effect of sex on brain maturation underpins the 
consideration of this variable both at a conceptual as well as at the practical assessment level. 
Moreover, if additional evidence substantiates faster maturation of female brains, it calls for 
further debate as to whether this factor should be incorporated in policies and legislation.  
In the Swiss medical setting, minor patients from 12 years onwards are mostly expected to be 
capable of judgement. Still, a considerable minority of children 12 years of age or older were 
not involved in SDM on treatment-related issues or on PPC (chapter 2 and 3). Despite 
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recommendations to decide about a child’s involvement on a case by case basis, these results 
suggest a stronger involvement of children who are at least twelve years of age as well as 
more caution not to underestimate their level of understanding16. Finally, one reported study 
finds that leukemia patients were less likely to receive palliative care (chapter 3). This also 
means that those patients are deprived of the opportunity to participate in SDM and to 
exercise their right to be heard. There might be prognostic reasons for not initiating PPC, but 
these children unfortunately died without the opportunity to benefit from palliative care.   
Reported findings on the process of decision-making reveal a spectrum spanning from no 
involvement of children at all to full participation in SDM (chapter 3). Overall, the diverse 
pattern  eight types of how decisions are made were identified  indicates that there is no 
standardized way of SDM and can be interpreted as a hint to fulfilling the decision-making 
criteria of adaptivity and family-centeredness. However, SDM was the most often utilized 
approach. This might be a consequence of the imperative for SDM in pediatrics. Conversely, 
in some cases, information was withheld from children because of explicit parental wishes. 
Only considering parents’ wishes with the implicit assumption of their decisional authority or 
with the aim to preserve the stability of family structure does not sufficiently appreciate a 
child’s right (and need) to be involved. Generally, in those scenarios, a deliberate weighing of 
a child’s right to be involved and respecting parental preferences is required. However, in 
cases of children who are deemed capable both respecting parental wishes and prioritizing the 
preservation of the stability of family structure are hardly justifiable. Denying them the 
opportunity to participate in SDM impairs their capacity and degrades their trust. Moreover, 
since making decisions regarding health, illness, and well-being is an inalienable right and a 
need of a child17-19, in cases of capable children the principle of involving them should trump 
the other two principles of respecting parents’ wishes and of preserving the stability of family 
structure and thus, the capable child should be involved. 
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2    Relating the Empirical and the Normative 
 
As outlined in the background of this thesis, there are several ways to integrate the empirical 
and the normative. In the following section, the selected approach to empirical bioethics, 
Critical Applied Ethics (CAE), is discussed in context of the reported findings. The 
significance of the “is” for the “ought” is also presented. 
   
2.1 The Five Stages of Critical Applied Ethics 
In the following, it is illustrated how the five stages of CAE are applied within the reported 
research on SDM in pediatric oncology20,21. According to Leget and colleagues, a bioethical 
analysis of an ethical problem is a perpetual endeavor characterized by ongoing evaluation 
and re-evaluation20. Sharing this conviction, this thesis neither claims to represent an 
exhaustive bioethical analysis of SDM in pediatric oncology nor pretends to sufficiently 
explore the subject at all five stages. Rather, it offers valuable contributions to the overall 
bioethical analysis of SDM in pediatric oncology at various stages (of CAE).   
1. Determination of the Problem 
Ethically relevant shortcomings surrounding SDM in pediatric oncology were outlined in the 
first chapter (1.3.1): a dearth of knowledge on ways to realize favorable participation of the 
child, limited inclusion of children, unfulfillment of preferred parental roles in decision-
making, late or non-referrals to PPC, lack of formalized training for physicians. It is 
important to note that already at this first stage, empirical and normative analyses co-
determined the subject of subsequent research. The ethico-legal imperative (1.1.3) provided 
the normative background against which medical practice in pediatric oncology can be 
evaluated based on empirical data. Bringing the normative and empirical together resulted in 
the realization that decision-making in pediatric oncology needs further improvement.   
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2. Description of the Problem1 
Once the problem has been identified, it needs to be described in greater detail from both 
normative and empirical perspectives. The thorough description of (different aspects of) the 
problem was mainly outlined in the results sections of the included manuscripts. The ethical 
analysis of (hidden) values and understandings that were imported through concepts and 
terminology (used to discover the moral problem) dealt with the conceptualizations of 
decision-making capacity and of PPC. This critical look at the concepts and terminology 
drew attention to the underlying assumptions that are normatively loaded, for example, an 
individualistic understanding of autonomy fostering an excessively rationalistic 
conceptualization of decision-making capacity or the close identification of comprehensive 
PPC with four core domains of care. In such instances, the concepts used to determine the 
problem inherently involve normative power.  
In addition to the ethical analysis, empirical research at this stage has carefully shown how 
clinical practice manifests itself. By employing multiple empirical methods, the conducted 
research was able to “to cross-check, verify or ‘fine tune’ the applicability of theoretic 
analyses, guidelines and policies in real world practice”22,p.206. Subjects of interest were SDM 
(while considering pre-existing conditions such as burden of treatment or the parents’ and 
physicians’ perspectives with respect to evaluations of children’s capacity), and timely 
integration of PPC; furthermore, based on stakeholders’ expertise, the implementation of the 
rather philosophical definition of PPC was examined. Again, this stage demonstrated the 
dynamic interaction between normative and empirical contributions. 
 
 
 
                                                 
1 Important insights into how SDM in Swiss pediatric oncology occurs were already provided by the research 
that was part of the first phase of the project. However, these results cannot be reported in detail here. 
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3. Effects and Alternatives 
Consequences of decisions or policies were explored within the conducted research. It should 
be noted that research describing the problem (stage two) and outlining the effects and 
alternatives (stage three) overlap significantly because describing the current clinical practice 
and examining the effects of recommendations cannot be fully dissociated. Therefore, both 
appear primarily in the results and discussion sections of the included manuscripts. Empirical 
analysis focused on aspects surrounding SDM which are clearly related to an “ought”, such 
as the recommendations to improve child involvement, share decision-making responsibilities 
(e.g. information provision by physicians, roles of parents), and initiate palliative care in a 
timely manner. Effects of these recommendations were empirically analyzed, and the 
respective findings concluded that these standards are not being fully met in clinical practice. 
At the same time, normative ethics provided important considerations at this stage. It 
highlights and counters any premature conclusions drawn from the empirical evidence. For 
example, in the face of parental wishes to withhold information from their children, one could 
hastily conclude that given these circumstances, parental authority should be prioritized under 
all circumstances. Such a dichotomous approach would not accurately capture the full 
complexity of the ethical issue, and as such, normative ethics prevents from drawing this 
conclusion: generally, by highlighting the disconnection between moralities that are 
supported by data and those supported by ethical theory, as well as by referring to concepts 
like relational autonomy and SDM.  
4. Normative Weighing 
This stage represents the very nucleus of empirical bioethics. Normative weighing within this 
thesis took place in the discussion sections of the included manuscripts and is summarized in 
the first part of this chapter (10.1). Empirical analysis contextualized the respective normative 
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theories and provided actual experiences from medical practice. For example, by exploring 
pre-existing conditions of SDM, empirical analysis refers to aspects which need to be taken 
into account by normative considerations on SDM.        
Normative ethics, in turn, warns against an unconditional acceptance of the status quo. In the 
face of late initiation of or even non-referrals to palliative care, it urges towards changing this 
practice in order to come closer to the articulated “ought”. Further, normative theory 
challenges statistical normativity as it “stands over and against the idea that the majority [a 
given clinical practice] creates the moral rules”20,p.233. On the other hand, empirical data 
informs normative theory and determines ethical conclusions through a balancing process 
that seeks coherence of relevant considerations (e.g. empirical, theoretical) and that meets the 
criteria of rationality and consistency23. In particular, bearing in mind the ethico-legal 
imperative for SDM, this thesis discussed the empirical findings, and thereby, evaluated the 
medical practice from this perspective.                            
5. Evaluation of the Effects of a Decision 
This thesis concludes with several recommendations with respect to SDM regarding 
palliative care in pediatric oncology (10.1.1 - 10.1.3, 10.4). The goal is to improve clinical 
practice. Research’s responsibility is to map out the realized effects of stated 
recommendations. Such an evaluation of effects needs to be addressed within further 
research.     
Further Remarks 
Finally, as recommended by Davies et al., three questions must be discussed within an 
empirical bioethics project23. First, the raised ethical concerns (10.1 and 10.4) were justified 
through coherence of the following aspects: normative theory (1.1.3), empirical results 
(results of chapters 2-9), and ethical judgements by the research team (discussions of chapters 
2-9, as well as 10.1 and 10.4). By a priori assigning the same epistemic status to normative 
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theory and empirical analysis, CAE allows empirical data to inform and potentially refine 
normative theory. For example, two literature reviews (on timing of palliative care initiation, 
chapter 6; and on articles that discuss medical guidelines, chapter 7) showed that the 
normative theories (e.g. WHO: starting from diagnosis onwards) might not always be 
appropriate within the context of pediatric oncology. Second, within our consultative 
approach to empirical bioethics, the interdisciplinary research team represents “the thinker” 
who arrives at ethical concerns. Participants were consulted to gather relevant data, but were 
not included in the ethical reflection. Third, although the focus was on pediatric oncology, a 
variety of findings on SDM can be applied to the pediatric setting in general; for example, the 
differing parental and physician perceptions or the parental perception that information 
provided by physicians is insufficient.  
             
2.2 The Contribution of “Is” to “Ought”  
Building on the typology of Kon24, the functions of empirical data within this empirical 
bioethics research project are briefly summarized. The empirical analysis fulfilled four main 
functions, as will be described in the present section. Detailed descriptions of the four means 
of contribution appear in the respective chapters.  
First, it provided “lay of the land” research by describing the current practice of SDM 
regarding palliative care in pediatric oncology (results sections of chapters 2, 3, 5, 6). Second, 
it compared the status quo regarding SDM and the initiation of PPC with an articulated ideal 
(results and discussion sections of chapters 2, 3, 5, 6). Third, it examined how practice can be 
improved (discussion sections of chapters 2-9). Fourth, it recommended amendments of 
normative theories based on the previous three levels (discussion sections of chapters 2-9, as 
well as 10.1 and 10.4).   
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3    Limitations and Implications for Further Research 
 
Studies presented in this thesis were conducted as part of the project “Attitudes and motives 
concerning end-of-life decisions: Competency and autonomy of children and adolescents in 
paediatric oncology.” The following sections discuss methodological limitations and 
implications for further research. 
 
3.1 Limitations 
Limitations of the included studies are discussed in the respective chapters (see chapters 2-9). 
Moreover, there are limitations that stem from the overall mixed-methods approach and from 
the empirical bioethics methodology.  
First, the presented research consists of empirical (quantitative and qualitative) and 
theoretical (conceptual) findings whose compatibility is not immediately apparent. However, 
SDM embraces both theoretical constructs (e.g. decision-making capacity) and empirical 
patterns (e.g. a child’s involvement) and thus, must consider both perspectives. The different 
findings were organized in three separate sections to avoid confusion.  
Second, the scope of application must be carefully considered. The reported qualitative 
results cannot be generalized because the sample cohort did not represent a random sampling 
from the target population (Swiss pediatric oncology providers) and was limited in number. 
Still, they offer a contextualized understanding of an insufficiently researched subject, 
namely pediatric oncology providers’ attitudes towards PPC, and can be transferred to other 
settings by readers who can evaluate the extent to which the findings apply to other 
contexts25. Further, all reported empirical studies were conducted in Switzerland and thus, 
primarily capture clinical practice of the participating SPOG centers. Despite natio4nal 
particularities, the reported findings have limited transferability because: (a) studies from 
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other countries revealed comparable results13, (b) of a widespread reliance on protocols 
childhood curative treatment regimes are similar across different countries, and (c) 
preliminary quantitative results, for example on the dyad-perspectives on the same child, 
point towards systematic differences between physicians and parents and, therefore, can be 
generalized to larger populations.  
Third, the perspective of children was not consistently captured directly. Yet, children’s 
perspectives were gathered indirectly through surveying parents and physicians. They were 
also gathered directly in the first part of the project. 
Fourth, the relationship between the empirical and the normative represents a challenging 
task containing many potential pitfalls. Drawing normative conclusions by balancing certain 
empirical and normative considerations is inherently limited and might leave out other 
important considerations. Moreover, the set of normative premises that constitute the 
normative framework was chosen because it represents the relevant ethico-legal background 
of SDM in pediatric oncology. However, that should not obscure the fact that other normative 
premises could have been chosen and that those used within this thesis are culturally 
determined. However, the research team - being culturally and professionally diverse itself - 
sought to capture the most relevant and internationally accepted normative premises.    
Fifth, the author of this thesis has a background in Psychology and Applied Ethics, which 
might impact the planning and conducting of the research, as well as the discussion of the 
results. Yet, this constricted perspective was counterbalanced through contributions from and 
constant discussions with other members of the research team who had diverse backgrounds 
and varied epistemological and ontological stances (e.g. Philosophy, Gerontology, 
Biomedicine, Medicine, Psychology, Theology, Bioethics, and Statistics).   
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3.2 Implications for Further Research 
This thesis provides numerous recommendations (10.1.1 - 10.1.3, 10.4) for clinical practice 
and further research. It is of cardinal importance to map out the effects of the respective 
recommendations. 
At the theoretical level, more research is needed to explore concepts linked to SDM, such as 
decision-making capacity, and the question of what is understood by the term PPC among 
different occupational groups and across different countries. Conceptual clarification is 
necessary to achieve a shared understanding, which facilitates the actual provision of PPC 
(including SDM) and research on these issues. Agreement on the terms also fosters the 
acceptance of PPC among the public. Second, with respect to SDM itself, children’s 
perspectives need to be captured more directly by future research. Only by including 
children’s views and attitudes an applicable model of SDM can be developed. Further, 
children’s decision-making capacity requires further empirical investigation in order to 
involve them in an adequate way. Third, SDM (and related concepts, such as autonomy and 
capacity) should be studied within different clinical settings. Reported findings showed that, 
for example, the evaluation of children’s abilities depended on the type of decision (e.g. end-
of-life versus related to curative treatment). Therefore, approaches to SDM need to be 
grounded in the respective clinical setting. Finally, future research should develop evidence-
based tools for clinical practice to support practitioners in face of their challenging tasks (e.g. 
capacity assessment tools, a vademecum for communication with the family, short reminders 
of potential pitfalls within SDM), without losing sight of the notion that every child 
represents an individual case.      
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4    Conclusions 
 
The overall goal of this thesis was to propose ethically sound and practically feasible ways to 
facilitate SDM regarding palliative care in pediatric oncology. The preceding chapters 
provide insights into important aspects of SDM, such as underlying conceptualizations, pre-
existing conditions, and the process of SDM itself. This thesis concludes with the formulation 
of several recommendations for clinical practice and theory (figure 2) which arise from 
integrated empirical and normative analyses and express the very essence of the findings. 
Naturally, they are not fully distinct, but partially overlapping. 
 
Figure 2. Recommendations for practice and theory 
    
 
1. Working towards a Shared Understanding 
A shared understanding and a common language among health professionals are a 
prerequisite for quality PPC and implementable research outcomes because each goal 
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requires effective dialogue among researchers and practitioners. Working towards an 
unambiguous use of terms related to PPC among health professionals represents a necessary 
cornerstone on which to enhance clinical practice. Otherwise, it remains likely that 
misunderstandings (e.g. between team members, between family and staff, between inpatient 
and outpatient setting, between policy makers and pediatric oncology providers, between lay 
public and professionals) will continue to impede development and provision of PPC. 
Therefore, any efforts to provide PPC should entail clarification of the used terminology. 
2. Proactive and Continuous Communication within the Team  
Proactive and continuous communication among the team members is crucial to quality PPC 
as it serves multiple functions that reach beyond regular treatment-related discussions. First, 
it prevents misunderstandings based on terminological differences and with respect to care 
responsibilities. Discussing the various and differing understandings helps to establish a 
shared vision of PPC and facilitates a team’s capability to work together. Second, besides 
fostering care and communication, frequent team meetings can provide a necessary 
framework for reciprocal supervision. Being able to address uncertainties and burdening 
experiences is beneficial for mental hygiene among team members. Third, exchanging 
narratives of experiences improves team collaboration. Fourth, it prevents from neglecting 
principles of medical ethics by utilizing collective attention to discover cases of violated 
rights of a child, for example, not including a capable adolescent in decision-making because 
of explicit parental wishes. The latter case contravenes a key principle of medical ethics and, 
therefore, presents an opportunity for retrospective evaluation and future improvement. In 
sum, regularly held round table meetings that not only discuss medical questions, but also 
offer space for reciprocal supervision and the exchange of narratives should be implemented. 
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3. Proactive and Continuous Communication with the Family 
A proactive and continuous approach to communication with the family is necessary to 
adequately address potential sources of confusion among the involved parties. For example, 
with respect to the underlying perspectivity of evaluations of the child and with respect to 
information provision by physicians, pediatric oncology providers need to assess whether 
both parties hold similar views of the child and whether parents correctly understood the 
information provided. Generally, communication is a process between a sender and a 
recipient influenced by various variables. Even under normal circumstances, communication 
often fails. In the face of a child’s illness or even imminent death, communication is fraught 
with uncertainty and fear, with systematically differing perceptions between the treating staff 
and parents, and with misinterpretation. To better detect differing perceptions and 
misinterpretations, pediatric oncology providers should carefully examine whether the 
involved parties are on the same page and should not take for granted that what they intended 
to say matches what the other party understood. A small and continuously updated 
vademecum on relevant features of communication with the family could be a helpful tool.   
4. Ongoing (Re-)Evaluation of Decisions and Decision-Making Practices 
SDM regarding palliative care in pediatric oncology currently does not fully meet the 
standards recommended by international guidelines: involving children in decision-making 
processes, realizing preferred parental roles, or timely initiation of PPC consultation. 
Considering these shortcomings, but also because of the high standards for SDM in pediatric 
oncology, a monitoring system should be installed at two levels. First, at an institutional 
level, decision-making practices should be regularly discussed within the team and outcomes 
should be regularly documented in the medical records. Second, at an aggregated and trans-
institutional level, decision-making practices and outcomes should be collected and 
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supervised, for example by a specialized clinical ethicist or similar expert. At both levels, a 
standardized form for the recording of discussions not only improves record keeping, but at 
the same time could expedite the evaluation of SDM. Such a two-level system is of course 
not limited to the evaluation of decision-making practices to address shortcomings. More 
importantly, it provides simultaneous evaluation of emerging trends and challenges that may 
require implementation of new or adaption of existing policies. For example, ethical 
supervision should be developed with tactful respect for parental attitudes that are contrary to 
their child’s best interest, such as possible preferences for herbal supplements over 
conventional analgesics among parents.          
5. Applying a Systemic Approach 
Parents and siblings are strongly influenced by the illness of the child and the accompanying 
burden of treatment. At the same time, children are highly dependent on their parents and 
social networks. Having considered these aspects of relationality and dependency that are 
particularly relevant for children, it is evident that the entire family embodies the unit of care 
and must be recognized as such also in SDM. Thus, pediatric oncology providers should 
provide care from a family perspective and should see the preservation of the stability of 
family structure as an important tenet of PPC.   
6. Defining Inadequate Practice a priori 
It was shown that there is no universal way to provide PPC that can be applied across 
different children and their families. This is due to the fact that children and their families 
have highly individual needs that can span various realms, such as physical, psychological, 
social, or spiritual needs. Therefore, the concrete form of adequate PPC for a particular child 
cannot be positively (and exhaustively) defined a priori. However, with respect to SDM 
regarding PPC inadequate practice can be defined a priori. Such ex negativo approaches have 
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the advantage of clearly determining what is off-limits while maintaining the necessary 
degrees of freedom for individually tailored care. They define a threshold below which 
practice becomes ethically unjustifiable, for example excluding a capable adolescent from 
SDM based on parental wishes, a physician using a single assessment of capacity towards 
many types of decisions (that require separate assessments), withholding information from 
parents or children, or disregarding relational aspects of a child’s autonomy by exclusively 
focusing on rationality. By drawing explicit boundaries, an ex negativo approach can 
facilitate the enforcement of principles of medical ethics. A list of negatively defined 
principles about what not to do could serve as a handy tool for practitioners in their daily 
clinical practice and as a framework of reference, for example, during multidisciplinary round 
table meetings. 
7. Identification of Empirical Patterns as Malleable Entities  
Empirical patterns related to SDM in pediatric oncology, such as the decision-making 
capacity of a child, parental preferences regarding SDM, a child’s condition, or a child’s 
participation, are dynamic and constantly changing over time as well as across situations. 
Consequently, applying this awareness to clinical practice means to scrutinize universal 
statements based on inductive generalizations and to instead refer to situational statements 
that relate to the specific circumstances, such as the type of decision in case of capacity 
assessment. Moreover, dynamic empirical patterns need to be captured by fluid 
conceptualizations. Otherwise, they remain hardly applicable and misleading. Therefore, 
practitioners should understand empirical patterns related to SDM as malleable and should be 
cautious with universal statements regarding the latter.  
 
These closing recommendations reflect the complexity of the presented research subject as 
well as the difficulty to shape decision-making in an ethically sound way that satisfies all 
Chapter 10  General Discussion 
249 
 
parties involved. However, beyond any attempt to facilitate the SDM process, there remains a 
residual of SDM regarding palliative care in pediatric oncology that appears immune to any 
form of facilitation. When a child is diagnosed with cancer, parents and the child are 
confronted with death and dying and sometimes go through anticipatory grieving. This 
situation engenders overwhelming emotions. Moreover, the prognostic uncertainty of 
childhood cancer creates a brutal vacillation between two realities along the illness trajectory: 
hope and despair. Today, almost one in five children dies due to cancer. However, children 
are supposed to outlive their parents, they “are not supposed to die, but they do”26,p.10. Losing 
a child to cancer is an unutterably traumatic experience which touches the deepest and most 
profound layers of human existence and which parents metaphorically described as “being 
covered in a wet and dark blanket”.  
The blanket was already present and covered the parents when the child was in its palliative 
phase. To see the child suffer was emotionally arduous, but facing the child's imminent 
death could be even more difficult. (…) The grief was at this moment [of death] intensified 
and thus the blanket was experienced to become even wetter and darker. (…) Gradually, the 
blanket dried little by little, but it still felt overwhelming. Sometimes, when emotionally 
hard memories came forth, it “rained” grief and pain and the blanket would once again 
become more wet, dark and heavy. With time, the rain did not come as often as before. A 
way of handling the grief could be to live in the moment since the future felt too uncertain. 
As years pass, the blanket became drier and life became brighter and less oppressed, but in 
some ways it would always be present.27,p.42 
All this testifies of the existentiality of experiencing childhood cancer. With that in mind, this 
thesis acknowledges the boundaries of the presented research. Still, as demonstrated 
throughout this thesis, sharing the process of decision-making is one ethically sound way to 
reduce burden on the involved parties. Correspondingly, this thesis was written in the modest 
and compassionate hope of facilitating the sharing of decision-making in face of childhood 
cancer and, ultimately, of reducing burden for children with cancer and their families.   
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Interview Guide for Focus Groups (Chapter 5) 
 
 
Attitudes and motives concerning end-of-life decisions:  
Competency and autonomy of children and adolescents in paediatric oncology 
 
A. INTRODUCE US AND THE PROJECT 
 
B. SET THE GROUND RULES:  
 
C. INTRODUCTION  
 
D. FOCUS GROUP QUESTIONS:  
 
1. Since the goal of the project is to understand palliative care in Swiss pediatric 
oncology, we would like to start by knowing YOUR understanding of pediatric 
palliative care.  
 
2. Could you please tell us how pediatric palliative care is defined in your SPOG?  
a. Is there a protocol or guideline in place in your SPOG? 
b. Ask about supportive care. 
c. Specific palliative care teams. 
d. Multidisciplinary care 
e. Integrative approach 
 
 
3. Please describe the most recent patient whom you referred to palliative case?  
 
4. Thinking about the same case, what were according to you the difficulties/barriers to 
implement PPC?  
 
5. When and under what circumstances do you meet with an ethical committee in order 
to discuss the further treatment or shift to EOL care (or to PPC care exclusively)? 
 
6. Now, we are interested in knowing the process of communication (with the family: 
parents and children) that happens:  
a. First, when the information is given to them that the patient is no longer 
curative and palliative care could be provided.  
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b. Second, the decisions that take place in organizing continued care at SPOG, at 
home and other alternative treatments.  
 
7. What role does the family have in these decisions? 
a. Is this role same as it has always been during the course of earlier treatment? 
 
8. We have prepared a short case for you to read so that we can discuss decision to enter 
palliative care and what happens thereafter.   
 
9. What do you think should be done to improve palliative care in pediatric oncology? 
a. Mention WHO palliative guideline.  
 
10. Is there anything that we have not discussed, but you would like to add?  
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Questionnaires (Chapter 2) 
 
 
1. Parents 
Lieber Teilnehmer/in: Vielen Dank für Ihre Zustimmung zur Teilnahme an dieser Studie und ebenfalls 
dafür, dass Sie dazu bereit sind Informationen über die Erkrankung Ihres Kindes mit uns zu teilen. Die 
Informationen, die wir durch diese Studie zu erwerben hoffen, sind sehr wertvoll, da sie uns helfen zu 
verstehen, wie Kinder in der Schweiz mit Krebs leben. Insbesondere die Art und Weise wie Sie ihr Kind 
in den Entscheidungsprozess zur Behandlung einbezogen haben, wird anderen Eltern sowie 
betreuenden Ärzten in einer ähnlichen Situation möglicherweise helfen. Bitte vervollständigen Sie die 
Angaben in diesem Fragebogen zu Ihnen und Ihrem Kind, welches entweder in einem der Schweizer 
Pädiatrischen Onkologie Zentren diagnostiziert und/oder behandelt wird/wurde. Die Fragen 
behandeln Daten zu Ihrer Person, zur Diagnose und Prognose Ihres Kindes und zu eventuellen 
sterbebegleitenden Behandlungen. Selbstverständlich werden Ihre Daten und Antworten anonym 
und vertraulich behandelt, da wir nur ihren Identifizierungscode benutzen werden und nie Ihren 
Namen oder andere Informationen.   
Instruktion zum Ausfüllen des Fragebogens: Bitte beantworten Sie die folgenden Fragen bezüglich 
ihres Kindes. Kreuzen Sie die Antworten an, die am besten passen.   
 
Eltern Identifizierungscode:           
Grund für den heutigen Besuch:   
 Mein Kind hat eine Krebsdiagnose erhalten (neuer Fall)    Kontroll- oder Behandlungstermin 
 
1. Demografische Informationen für Eltern:         
a. Alter:      ___________   Geburtsjahr:      _____________ 
b. Geschlecht:   männlich   weiblich 
c. Nationalität:  Schweizer/in        Andere  – Herkunftsland:             
d. Sprachen:            
e. Familienstand:   verheiratet       geschieden    verwitwet   
    ledig      anderes (bitte angeben):        
f. Religion:   katholisch   evangelisch    andere (bitte angeben):        
g. Ausbildung:   keine Ausbildung           Berufsausbildung  
 Abitur/Matura  Fachhochschulabschluss    
Universitätsabschluss   
h. Anzahl der Kinder:       
 
j.    Bitte beschreiben Sie Ihre Arbeitssituation und die Ihres Ehepartners:    
 beide vollzeitbeschäftigt  ein Partner vollzeitbeschäftigt, der andere  in Teilzeit,  
 ein Partner vollzeitbeschäftigt und der andere komplett Zuhause    
 beide Partner in Teilzeit beschäftigt  Selbständig 
 
 
2. Generelle und krankheitsbezogene Informationen über Ihr Kind: 
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a. Alter:        Geburtsjahr:         
b. Geschlecht:   männlich  weiblich 
c. Nationalität:  Schweizer/in       Andere  – Herkunftsland:            
d. Datum der Krebsdiagnose:        (mm/jjjj) 
e. Art der Diagnose (Krebsart):       
f. Derzeitige Prognose:  ausgezeichnet   sehr gut     gut      schlecht     sehr schlecht 
g. Wer wurde über die Diagnose informiert?     
 nur ich    ich und mein Partner      mein Kind und ich     alle zusammen 
Dritte 
h. Wer wurde über die Prognose informiert?     
 nur ich    ich und mein Partner       mein Kind und ich     alle zusammen  
Dritte 
i. Bitte kreuzen Sie an, welche der nachfolgenden Behandlungen empfohlen wurden:  
 Chemotherapie   Bestrahlung   monoklonale Antikörper 
 Operation   Knochenmarktransplantation   
 andere (bitte angeben):       
j. Mein Kind ist in Behandlung seit: 
 <1 Monat   1 – 6 Monate   7-12 Monate 
  1 – 2 Jahre   2 – 4 Jahre   Länger als 4 Jahre  
k. Die erwartete Behandlungsdauer für mein Kind beträgt:  
 <1 Jahr   1 – 2 Jahre   2 – 4 Jahre   
 Länger als 4 Jahre   keine Angabe 
 
l. Bitte kreuzen Sie an, welche Symptome mit der Erkrankung Ihres Kindes einhergehen:  
 Schmerzen   Müdigkeit   Verstopfung 
 Übelkeit             Durchfall   Schwindel 
 vermindertes Bewusstsein/Benommenheit  Schwäche  
 andere Symptome (bitte angeben: neurologisch, das Herz betreffend, Atmung, etc):       
m. Bitte bewerten Sie das mit den Symptomen verbundene Leid ihres Kindes 
 erheblich   stark   etwas  wenig   keins 
n. Leidet Ihr Kind an einer weiteren Erkrankung (bitte angeben):       
o. Geht Ihr Kind noch zur Schule? (Grundschule, weiterführende Schule etc.)  ja  nein 
 
3. Bitte bewerten Sie die Qualität der Informationen, die Sie von Ihrem Arzt erhalten haben: 
Information Type Vollständige 
Information 
Nahezu 
vollständige 
Information 
Information 
erfolgte 
teilweise 
Sehr 
begrenzte 
Information 
Keine 
Information 
Bitte geben Sie an, ob 
Ihr Kind während 
diesen Gesprächen 
zugegen war. 
Diagnose       ja  nein 
Behandlungsoptione
n 
      ja  nein 
Prognose       ja  nein 
Krebsursache       ja  nein 
Ansprache auf die 
Behandlung 
      ja  nein 
Teilnahme an 
klinischen Studien* 
      ja  nein 
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*Eine klinische Studie dient dem Zwecke der medizinischen Forschung, um die Sicherheit und Wirkung von neuen Medikamenten oder 
Geräten zu testen.  
4. Bitte bewerten Sie die Fähigkeiten Ihres Kindes, die folgenden Punkte zu verstehen: 
Mein Kind kann/ist Stimme absolut 
zu 
Stimme 
zu 
Weder noch Lehne ab Ich 
widerspreche  
die erhaltene Diagnose verstehen      
die erhaltene Prognose verstehen      
die Ursache für die Erkrankung 
verstehen 
     
die Informationen zur Ansprache auf die 
Behandlung verstehen 
     
 reif genug, um Entscheidungen 
bezüglich der eigenen Behandlung zu 
treffen 
     
reif genug, um über die Teilnahme an 
einer klinischen Studien zu entscheiden 
     
 
5. Wurde die Erkrankung Ihres Kindes als lebensbedrohlich eingeschätzt (Einschränkung der Lebenszeit): 
  
 ja                                                                                nein       
 ich weiss es nicht      ich möchte es nicht wissen 
 
6. Bitte beantworten Sie die folgenden Fragen:  
a. Welche Behandlungsentscheidungen wurden bisher getroffen:  
 Chemotherapie  Bestrahlung   monoklonale Antikörper 
 Operation   Knochenmarktransplantation   
 Andere (bitte angeben)       
b. Im ersten Schritt kreuzen Sie bitte an, wer bei der Entscheidung anwesend war.  
 Eltern, Kind und Onkologe  Eltern und Onkologe  Kind und Onkologe  
 Eltern und Kind    nur die Eltern   nur der Onkologe 
c. Wie zufrieden sind SIE mit der getroffenen Entscheidung (1=sehr zufrieden; 5=sehr unzufrieden):       
d. Wie zufrieden war der Arzt mit der getroffenen Entscheidung (1=sehr zufrieden; 5=sehr unzufrieden): 
      
e. Wie zufrieden war Ihr Kind mit der getroffenen Entscheidung (1=sehr zufrieden; 5=sehr unzufrieden): 
      
 
 
 
 
 
 
 
 
7. Rolle der Eltern im Entscheidungsprozess (bitte angeben welche Entscheidung) 
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a. Tatsächliche Entscheidungsfindung: Bitte kreisen Sie die Antwort, die auf Sie zutrifft. 
 
 
 
 
 
 
 
b: Bevorzugte Entscheidungsfindung: Bitte kreisen Sie die Antwort ein, die auf Sie zutrifft. 
 
 
 
 
 
 
c: Die Entscheidungen sollten gleichberechtigt vom Kind, dem Arzt und den Eltern getroffen 
werden: 
 stimme völlig zu       stimme zu  weder noch  lehne ab  lehne völlig ab  
  
1 = Ich 
habe die 
Entscheid
ung ohne 
Einbezieh
ung der 
Meinung 
des Arztes 
getroffen. 
2 = Ich habe 
die 
Entscheidu
ng mit 
geringer 
Einbeziehu
ng der 
Meinung 
des Arztes  
getroffen. 
3 = Ich habe 
die 
Entscheidun
g nach 
Abwägung 
der durch 
den Arzt 
angegeben 
Information
en 
getroffen. 
4 = Der Arzt 
und ich 
haben die 
Entscheidung 
gemeinsam 
getroffen. 
5 = Der Arzt 
meines Kindes 
hat die 
Entscheidung 
nach 
Abwägung 
meiner 
Meinung 
getroffen. 
6 = Der Arzt 
meines 
Kindes hat 
die 
Entscheidun
g mit ein 
wenig 
Einbeziehun
g meiner  
Meinung 
getroffen. 
7 = Der Arzt 
meines 
Kindes hat 
die 
Entscheidun
g ohne 
Einbeziehun
g meiner 
Meinung 
getroffen. 
1 = Ich 
möchte 
die 
Entscheid
ung ohne 
Einbezieh
ung der 
Meinung 
des Arztes 
treffen. 
2 = Ich 
möchte die 
Entscheidu
ng mit 
geringer 
Einbeziehu
ng der 
Meinung 
des Arztes  
treffen. 
3 = Ich 
möchte die 
Entscheidung 
nach 
Abwägung 
der 
ärztlichen 
Meinung 
treffen.  
4 = Ich 
möchte, dass 
ich und der 
Arzt die 
Entscheidung 
gemeinsam 
treffen. 
5 = Ich möchte, 
dass der Arzt die 
Entscheidung 
trifft, nachdem 
er meine 
Meinung gehört 
hat. 
6 = Ich 
möchte, 
dass der 
Arzt die 
Entscheidun
g mit ein 
wenig 
Einbeziehun
g meiner 
Meinung 
trifft. 
7 = Ich 
möchte, 
dass der 
Arzt die 
Entscheidun
g völlig 
ohne 
Einbeziehun
g meiner 
Meinung 
trifft. 
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2. Physicians 
 
Lieber Teilnehmer/in: Vielen Dank, dass Sie sich entschlossen haben an dieser Studie teilzunehmen 
und uns mit studienrelevanten Informationen zu versorgen. Die Informationen, die wir durch diese 
Studie erwerben sind möglicherweise wertvoll, da sie uns helfen zu verstehen, wie Kinder in der 
Schweiz mit Krebs leben. Bitte nutzen Sie den Fragebogen für alle Ihnen bekannten Fälle von 
Krebserkrankungen bei Kindern (keine Altersbeschränkung), die entweder in Ihrer Institution in der 
Zeit von dd/mm/2012 – dd/mm/2013 behandelt und/oder diagnostiziert wurden. Die kommenden 
Fragen erfassen demografische Daten, die Diagnose des Kindes, die Prognose und Entscheidungen am 
Lebensende. Selbstverständlich werden Ihre Daten und Antworten anonym sowie vertraulich 
behandelt, da wir nur ihren Identifizierungscode benutzen werden und nie Ihren Namen oder andere 
Informationen. 
Instruktion zum Ausfüllen des Fragebogens: Bitte beantworten Sie die folgenden Fragen bezüglich 
ihres Patienten. Kreuzen Sie die Antworten an, die am besten passen.   
 
Arzt Identifizierungscode:           
Grund für den heutigen Besuch:   
 Patient hat Krebsdiagnose erhalten (neuer Fall)   Kontroll- oder Behandlungstermin 
 
1. Patienteninformation 
a) Alter:        Geburtsjahr:       
b) Geschlecht:   männlich   weiblich 
c) Nationalität:  Schweizer/in        Andere  – Herkunftsland:             
 
2. Informationen bezüglich der Erkrankung des Patienten 
p. Datum der Krebsdiagnose:        (mm/jjjj) 
q. Art der Diagnose (Krebsart):       
r. Derzeitige Prognose:  ausgezeichnet      sehr gut     gut     schlecht   sehr schlecht 
s. Wer wurde über die Diagnose informiert?     
 ein Elternteil beide Eltern   ein Elternteil und das Kind      beide Eltern und das Kind   
Dritte 
t. Wer wurde über die Prognose informiert?     
 ein Elternteil  beide Eltern  ein Elternteil und das Kind      beide Eltern und das Kind   
Dritte 
u. Bitte kreuzen Sie an, welche der nachfolgenden Behandlungen empfohlen wurden:  
 Chemotherapie   Bestrahlung   monoklonale Antikörper 
 Operation   Knochenmarktransplantation   
 andere (bitte angeben):       
v. Der Patient ist in Behandlung seit: 
 <1 Monat   1 – 6 Monate   7-12 Monate 
  1 – 2 Jahre   2 – 4 Jahre   Länger als 4 Jahre  
w. Die erwartete Behandlungsdauer für den Patienten beträgt:  
 <1 Jahr   1 – 2 Jahre    2 – 4 Jahre   
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 Länger als 4 Jahre   keine Angabe 
x. Bitte kreuzen Sie an, welche Symptome mit der Erkrankung des Patienten einhergehen:  
 Schmerzen    Müdigkeit  Verstopfung 
 Übelkeit              Durchfall  Schwindel 
 Bewusstlosigkeit   Schwäche  
 andere Symptome (bitte angeben: neurologisch, das Herz betreffend, Atmung, etc):       
y. Bitte bewerten Sie das mit den Symptomen verbundene Leid des Patienten: 
 erheblich   stark   etwas  wenig   keins 
z. Leidet der Patient an einer weiteren Erkrankung (bitte angeben):       
aa. Geht der Patient noch zur Schule? (Grundschule, weiterführende Schule etc.):   ja  nein 
bb. Es  arbeiten beide Eltern Vollzeit, ein Elternteil arbeitet Vollzeit, während der andere  Teilzeit 
beschäftigt ist,  Ein Elternteil arbeitet Vollzeit, der andere Partner bleibt komplett Zuhause  
 beide Partner in Teilzeit beschäftigt. 
 
3. a. Bitte bewerten Sie den Umfang der Informationen, die Sie den Patienten mitgeteilt haben: 
Information Type Vollständige 
Information 
Nahezu 
vollständige 
Information 
Information 
erfolgte 
teilweise 
Sehr 
begrenzte 
Information 
Keine 
Information 
Bitte geben Sie an, ob der 
Patient während diesen 
Gesprächen zugegen war. 
Diagnose       ja  nein 
Behandlungsoption
en 
      ja  nein 
Prognose       ja  nein 
Krebsursache       ja  nein 
Ansprache auf die 
Behandlung 
      ja  nein 
Teilnahme an 
klinischen Studien 
      ja  nein 
 
b. Bitte bewerten Sie die Fähigkeiten des Patienten, die folgenden Punkte zu verstehen: 
Der Patient kann/ist:  Stimme absolut zu Stimme zu Weder noch Lehne ab Ich widerspreche 
die erhaltene Diagnose verstehen      
die erhaltene Prognose verstehen      
die Ursache für die Erkrankung verstehen      
die Ansprache auf die Behandlung 
verstehen 
     
fähig, um Entscheidungen bezüglich der 
eigenen Behandlung zu treffen 
     
fähig, um über die Teilnahme an 
klinischen Studien zu entscheiden 
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4. Wurde die Erkrankung des Patienten als lebensbedrohlich eingeschätzt (Limitierung der Lebenszeit):
   ja (falls ja, überspringen Sie bitte Frage 5)   nein 
 
5. Falls der Patient eine kurative Behandlung für eine nicht lebensbedrohliche Krebserkrankung erhält, 
bitte beantworten Sie die folgenden Fragen:  
a. Welche Behandlungsentscheidungen wurden bisher getroffen:  
 Chemotherapie  Bestrahlung   monoklonale Antikörper 
 Operation   Knochenmarktransplantation   
 Andere (bitte angeben)       
b. Kreuzen Sie bitte an, wer bei der Entscheidung anwesend war.  
 Eltern, Patient und Onkologe  Eltern und Onkologe  Patient und Onkologe  
 Eltern und Patient    nur die Eltern   nur der Onkologe 
c. Wie zufrieden sind SIE mit der getroffenen Entscheidung (1=sehr zufrieden; 5=sehr unzufrieden):       
d. Wie zufrieden waren die Eltern mit der getroffenen Entscheidung (1=sehr zufrieden; 5=sehr 
unzufrieden):       
e. Wie zufrieden war der Patient mit der getroffenen Entscheidung (1=sehr zufrieden; 5=sehr 
unzufrieden):       
 
6. Bitte beantworten Sie die folgenden Fragen, falls der Patient sterbebegleitende Behandlungen oder 
Palliativpflege erhält:  
a. Gibt es andere Behandlungsmöglichkeiten:                       ja          nein 
b. Falls ja, welche:       
c. Wäre eine andere Behandlungsmöglichkeit hilfreich:                 ja   nein 
d. Nimmt/nahm der Patient an einer klinischen Studie teil:    ja   nein 
e. Falls ja, welche:       
f. Sind die Vorteile von klinischen Studien bekannt: Eltern:         ja   nein;  Patient:      ja     
nein 
g. Haben Sie sterbebegleitende Themen diskutiert, mit: Eltern:         ja   nein;  Patient:      ja     
nein 
 
h. Falls eine der folgenden Entscheidungen getroffen wurde, kreuzen Sie bitte an von wem und mit wem. 
Bitte bewerten Sie die Möglichkeiten zusätzlich. 
Art der Entscheidung   Ich Patient Eltern Bewertung 1 bis 7.  
1= sehr wichtig; 7= 
unwichtig 
Zufriedenheit mit der getroffenen 
Entscheidung: 1=sehr zufrieden; 
5=sehr unzufrieden 
1. Stopp der Medikamentengabe      
2. Entscheidung zur  
Hospitzpflege 
     
3. Entscheidung zur 
Palliativpflege 
     
4. Teilnahme an klinischen 
Studien 
     
5. Stopp von lebenserhaltenden 
Massnahmen 
     
6. Krebsbehandlungsart      
7. Verzicht auf Reanimation 
(DNR) 
     
8. Andere, getroffene 
Entscheidungen (bitte 
angeben) 
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i. Wurden Massnahmen zur Vorbereitung des Lebensendes angeboten, akzeptiert oder abgelehnt? 
Service: angeboten akzeptiert abgelehnt Gründe für die Ablehnung 
1. Palliativpflege     
2. Hospitzpflege     
3. Pflege Zuhause     
4. Intensivpflege     
5. Psychologische 
Betreuung  
    
6. Trauerbewältigung     
7. Andere (bitte 
angeben) 
    
 
7. Ihre demografischen Daten:         
i. Alter:        Geburtsjahr:        
j. Geschlecht:   männlich   weiblich 
k. Nationalität:  Schweizer/in        Andere  – Herkunftsland:            
l. Sprachen:   deutsch         französisch  italienisch    
  englisch   andere (bitte angeben):       
m. Familienstand:   verheiratet       geschieden   verwitwet   
n.    unverheiratet    anderes (bitte angeben):       
o. Bitte geben Sie Ihr medizinisches Spezialgebiet an:       
p. Wie viele Jahre haben Sie Erfahrung im Bereich pädiatrische Onkologie:   
 0 – 4 Jahre      5 – 8 Jahre  9 – 12 Jahre    Mehr als 12 Jahre   
q. Religion:     katholisch  evangelisch    andere (bitte angeben:)       
 
8. Ihre Einschätzung, welche Rolle Eltern gerne im Entscheidungsprozess bezüglich der weiteren 
Behandlung Ihres Kindes hätten: 
a.  Bitte kreisen Sie die Antwort, die Sie für die zutreffendste halten ein.   
 
 
 
 
 
 
b. Die Entscheidungen sollten gleichberechtigt vom Patienten, dem Arzt und den Eltern getroffen werden: 
 stimme völlig zu       stimme zu  weder noch  lehne ab  lehne völlig ab  
 
 
 
 
 
1 = Elternteil 
möchte die 
Entscheidung 
ohne 
Einbeziehung 
der Meinung 
des Arztes 
treffen. 
 
2 = 
Elternteil 
möchte die 
Entscheidun
g mit 
geringer 
Einbeziehun
g der 
Meinung 
des Arztes 
treffen. 
3 = Elternteil 
möchte die 
Entscheidung 
nach 
Abwägung der 
ärztlichen 
Meinung 
treffen. 
4 = Elternteil 
möchte, dass 
er/sie und der 
Arzt die 
Entscheidung 
gemeinsam 
treffen. 
 
5 = Elternteil 
möchte, dass 
der Arzt die 
Entscheidung 
trifft, nachdem 
er die elterliche 
Meinung 
gehört hat. 
6 = Elternteil 
möchte, dass 
der Arzt die 
Entscheidung 
mit ein wenig 
Einbeziehung 
der Meinung 
von den Eltern 
trifft.  
7 = Elternteil 
möchte, dass 
der Arzt die 
Entscheidung 
völlig ohne 
Einbeziehung 
der Meinung 
der Eltern 
trifft. 
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Medical Records Data Extraction Sheet (Chapter 3, 4) 
 
 
Medical Records Data Extraction Sheet: End-of-life project Pediatric Oncology 
Instruction: Please use this data extraction sheet to record information as indicated in 
the medical records of each patient.   
 
i. Health and Demographic information 
Sex:       _______Male ____________Female 
Month and year of birth: 
Initial Diagnosis:  
Date (month and year) of diagnosis:  
Indicate the tumour stage at diagnosis (include indications of the malignity grade and 
whether the tumour is localized or metastatic):  
 
Information on Relapse(s) 
Total number of relapses:  
 Specify relapse 1:  
Indicate the date (month and year) of 1st relapse(s):  
Indicate the tumour stage at 1st relapse(s):  
Specify relapse 2:  
Indicate the date (month and year) of 2nd relapse:  
Indicate the tumour stage at 2nd relapse: 
Specify relapse 3:  
Indicate the date (month and year) of 3rd relapse:  
Indicate the tumour stage at 3rd relapse:  
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Add information for further relapses:  
 
ii. Treatment Information – list of diagnosis1 
A1. Indicate whether a protocol was followed at diagnosis:  
If yes, indicate which one (name): 
If not, which treatment was followed:  
Record data what was done as part of that treatment (e.g., cycles of chemotherapy, fractions of 
radiotherapy, surgery etc.). 
Record respective treatment responses (complete, partial, no response, progressive):  
 
Record the side effect(s) of the respective treatments:  
 
A2. Which treatment was followed at 1st relapse:  
Indicate treatment name: 
Was it an oncological and/or supportive treatment?  
Record what was done as part of that treatment (e.g., if supportive: cells, platelets, fluids, pain, 
and antibiotics provided).  
Record respective treatment responses (complete, partial, no response, progressive):  
 
Record the side effect(s) of the respective treatments:  
 
A3. Which treatment was followed at 2nd relapse:  
Indicate treatment name: 
Was it an oncological treatment and/or supportive treatment?  
Record what was done as part of that treatment:  
                                                            
1 Repeat treatment information based on the number of relapse. 
Appendix 
265 
 
Record respective treatment responses (complete, partial, no response, progressive):  
 
Record the side effect(s) of the respective treatment:  
 
B. Describe the team discussion and decisions regarding treatment 
● at diagnosis:  
● at relapse(s):  
 
C. Were other centres (both national and international), specialists or tumor boards 
consulted?:  
D. Specify whether the patient followed any complementary or alternative treatment(s):  
 
iii. Transition from curative to palliative care 
A. Is there any clear indication that the disease is progressive? _______Yes    ______No 
If yes, please specify:  
 
B. Is there any indication in the course of the treatment of the following: 
(1) decreased intensity of oncological treatment?   ____Yes       ____No 
If yes, please specify:  
 (2) increased intensity of supportive treatment?   ____Yes       ____No 
 If yes, please specify:  
 (3) an explicit experimental treatment? ____Yes       ____No 
If yes, please specify:  
(4)  palliative treatment? ____Yes       ____No 
If yes, please specify: 
 (5) stopping treatment?    ____Yes       ____No 
If yes, please specify:  
 
 
C. Was there a consultation with the pain team?  
 
If yes, please specify which pain treatment(s) was provided (e.g., pharmacological and 
non-pharmacological, length of pain treatment):  
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D. Was there an AD HOC ethical committee consultation? 
 If yes, please indicate the date:  
and specify: 
(1) who was part of the committee:  
(2) if there was a Do Not Attempt-Resuscitation order:   
(3) if a withdrawal of life-support occurred: 
E. Please note any information about the transition from curative to palliative phase 
(determined by physiological factors, parent agreement etc.):  
 
F. Please indicate whether the transition was discussed among the medical team members: 
G. Was there an indication of discussions with the child’s paediatrician and Spitex?  
If yes, specify: 
H. Discussion regarding the switch to palliative care took place with patient and family?   
_______ Yes (with both patients and parents) 
_______  Yes (only with the parents)              
_______ No           
_______ Data not available 
If yes, record all information related to what was discussed:  
 
I. Was there any suggestion (on the part of the physician) or wish (on the part of the child or 
parent) to go home? 
 
J. If home care was sought, please indicate information about the homecare team:  
 
K. When did death occur and where (month and year):  
iv. Further Notes: 
 
